The present invention relates to surgical systems and, in various arrangements, to grasping instruments that are designed to grasp the tissue of a patient, dissecting instruments configured to manipulate the tissue of a patient, clip appliers configured to clip the tissue of a patient, and suturing instruments configured to suture the tissue of a patient, among others.
Various features of the embodiments described herein, together with advantages thereof, may be understood in accordance with the following description taken in conjunction with the accompanying drawings as follows:
Corresponding reference characters indicate corresponding parts throughout the several views. The exemplifications set out herein illustrate various embodiments of the invention, in one form, and such exemplifications are not to be construed as limiting the scope of the invention in any manner.
Applicant of the present application owns the following U.S. Patent Applications that were filed on Aug. 24, 2018 and which are each herein incorporated by reference in their respective entireties:
Applicant of the present application owns the following U.S. Patent Applications that were filed on May 1, 2018 and which are each herein incorporated by reference in their respective entireties:
Applicant of the present application owns the following U.S. Patent Applications that were filed on Feb. 28, 2018 and which are each herein incorporated by reference in their respective entireties:
Applicant of the present application owns the following U.S. Patent Applications that were filed on Oct. 30, 2017 and which are each herein incorporated by reference in their respective entireties:
Applicant of the present application owns the following U.S. Provisional Patent Applications, filed on Dec. 28, 2017, the disclosure of each of which is herein incorporated by reference in its entirety:
Applicant of the present application owns the following U.S. Provisional Patent Applications, filed on Mar. 28, 2018, each of which is herein incorporated by reference in its entirety:
Applicant of the present application owns the following U.S. Patent Applications, filed on Mar. 29, 2018, each of which is herein incorporated by reference in its entirety:
Applicant of the present application owns the following U.S. Patent Applications, filed on Mar. 29, 2018, each of which is herein incorporated by reference in its entirety:
Applicant of the present application owns the following U.S. Patent Applications, filed on Mar. 29, 2018, each of which is herein incorporated by reference in its entirety:
Applicant of the present application owns the following U.S. Provisional Patent Applications, filed on Mar. 30, 2018, each of which is herein incorporated by reference in its entirety:
Applicant of the present application owns the following U.S. Provisional Patent Application, filed on Apr. 19, 2018, which is herein incorporated by reference in its entirety:
Numerous specific details are set forth to provide a thorough understanding of the overall structure, function, manufacture, and use of the embodiments as described in the specification and illustrated in the accompanying drawings. Well-known operations, components, and elements have not been described in detail so as not to obscure the embodiments described in the specification. The reader will understand that the embodiments described and illustrated herein are non-limiting examples, and thus it can be appreciated that the specific structural and functional details disclosed herein may be representative and illustrative. Variations and changes thereto may be made without departing from the scope of the claims.
The terms “comprise” (and any form of comprise, such as “comprises” and “comprising”), “have” (and any form of have, such as “has” and “having”), “include” (and any form of include, such as “includes” and “including”), and “contain” (and any form of contain, such as “contains” and “containing”) are open-ended linking verbs. As a result, a surgical system, device, or apparatus that “comprises,” “has,” “includes”, or “contains” one or more elements possesses those one or more elements, but is not limited to possessing only those one or more elements. Likewise, an element of a system, device, or apparatus that “comprises,” “has,” “includes”, or “contains” one or more features possesses those one or more features, but is not limited to possessing only those one or more features.
The terms “proximal” and “distal” are used herein with reference to a clinician manipulating the handle portion of the surgical instrument. The term “proximal” refers to the portion closest to the clinician and the term “distal” refers to the portion located away from the clinician. It will be further appreciated that, for convenience and clarity, spatial terms such as “vertical”, “horizontal”, “up”, and “down” may be used herein with respect to the drawings. However, surgical instruments are used in many orientations and positions, and these terms are not intended to be limiting and/or absolute.
Various exemplary devices and methods are provided for performing laparoscopic and minimally invasive surgical procedures. However, the reader will readily appreciate that the various methods and devices disclosed herein can be used in numerous surgical procedures and applications including, for example, in connection with open surgical procedures. As the present Detailed Description proceeds, the reader will further appreciate that the various instruments disclosed herein can be inserted into a body in any way, such as through a natural orifice, through an incision or puncture hole formed in tissue, etc. The working portions or end effector portions of the instruments can be inserted directly into a patient's body or can be inserted through an access device that has a working channel through which the end effector and elongate shaft of a surgical instrument can be advanced.
A surgical instrument, such as a grasper, for example, can comprise a handle, a shaft extending from the handle, and an end effector extending from the shaft. In various instances, the end effector comprises a first jaw and a second jaw, wherein one or both of the jaws are movable relative to the other to grasp the tissue of a patient. That said, an end effector of a surgical instrument can comprise any suitable arrangement and can perform any suitable function. For instance, an end effector can comprise first and second jaws configured to dissect or separate the tissue of a patient. Also, for instance, an end effector can be configured to suture and/or clip the tissue of a patient. In various instances, the end effector and/or shaft of the surgical instrument are configured to be inserted into a patient through a trocar, or cannula, and can have any suitable diameter, such as approximately 5 mm, 8 mm, and/or 12 mm, for example. U.S. patent application Ser. No. 11/013,924, entitled TROCAR SEAL ASSEMBLY, now U.S. Pat. No. 7,371,227, is incorporated by reference in its entirety. The shaft can define a longitudinal axis and at least a portion of the end effector can be rotatable about the longitudinal axis. Moreover, the surgical instrument can further comprise an articulation joint which can permit at least a portion of the end effector to be articulated relative to the shaft. In use, a clinician can rotate and/or articulate the end effector in order to maneuver the end effector within the patient.
A surgical instrument system is depicted in
Referring again to
Further to the above, referring again to
Further to the above, referring again to
Further to the above, the power module 1200, when attached to the drive module 1100, comprises a pistol grip which can allow a clinician to hold the handle 1000 in a manner which places the drive module 1100 on top of the clinician's hand. The power module 1300, when attached to the drive module 1100, comprises an end grip which allows a clinician to hold the handle 1000 like a wand. The power module 1200 is longer than the power module 1300, although the power modules 1200 and 1300 can comprise any suitable length. The power module 1200 has more battery cells than the power module 1300 and can suitably accommodate these additional battery cells owing to its length. In various instances, the power module 1200 can provide more power to the drive module 1100 than the power module 1300 while, in some instances, the power module 1200 can provide power for a longer period of time. In some instances, the housing 1110 of the drive module 1100 comprises keys, and/or any other suitable features, which prevent the power module 1200 from being connected to the second module connector 1120′ and, similarly, prevent the power module 1300 from being connected to the first module connector 1120. Such an arrangement can assure that the longer power module 1200 is used in the pistol grip arrangement and that the shorter power module 1300 is used in the wand grip arrangement. In alternative embodiments, the power module 1200 and the power module 1300 can be selectively coupled to the drive module 1100 at either the first module connector 1120 or the second module connector 1120′. Such embodiments provide a clinician with more options to customize the handle 1000 in a manner suitable to them.
In various instances, further to the above, only one of the power modules 1200 and 1300 is coupled to the drive module 1100 at a time. In certain instances, the power module 1200 can be in the way when the shaft assembly 4000, for example, is attached to the drive module 1100. Alternatively, both of the power modules 1200 and 1300 can be operably coupled to the drive module 1100 at the same time. In such instances, the drive module 1100 can have access to power provided by both of the power modules 1200 and 1300. Moreover, a clinician can switch between a pistol grip and a wand grip when both of the power modules 1200 and 1300 are attached to the drive module 1100. Moreover, such an arrangement allows the power module 1300 to act as a counterbalance to a shaft assembly, such as shaft assemblies 2000, 3000, 4000, or 5000, for example, attached to the drive module 1100.
Referring to
Referring to
The control system 1800 is in communication with the motor assembly 1600 and the electrical power circuit of the drive module 1100. The control system 1800 is configured to control the power delivered to the motor assembly 1600 from the electrical power circuit. The electrical power circuit is configured to supply a constant, or at least nearly constant, direct current (DC) voltage. In at least one instance, the electrical power circuit supplies 3 VDC to the control system 1800. The control system 1800 comprises a pulse width modulation (PWM) circuit which is configured to deliver voltage pulses to the motor assembly 1600. The duration or width of the voltage pulses, and/or the duration or width between the voltage pulses, supplied by the PWM circuit can be controlled in order to control the power applied to the motor assembly 1600. By controlling the power applied to the motor assembly 1600, the PWM circuit can control the speed of the output shaft of the motor assembly 1600. In addition to or in lieu of a PWM circuit, the control system 1800 can include a frequency modulation (FM) circuit. As discussed in greater detail below, the control system 1800 is operable in more than one operating mode and, depending on the operating mode being used, the control system 1800 can operate the motor assembly 1600 at a speed, or a range of speeds, which is determined to be appropriate for that operating mode.
Further to the above, referring again to
Similar to the above, the drive system 2700 comprises a rotatable drive shaft 2710 which is operably coupled to the rotatable drive shaft 1710 of the handle 1000 when the shaft assembly 2000 is assembled to the drive module 1100 such that the drive shaft 2710 rotates with the drive shaft 1710. To this end, the drive shaft 2710 comprises a splined proximal end 2720 which mates with the splined distal end 1720 of the drive shaft 1710 such that the drive shafts 1710 and 2710 rotate together when the drive shaft 1710 is rotated by the motor assembly 1600. Given the nature of the splined interconnection between the drive shafts 1710 and 2710 and the electrical interconnection between the frames 1510 and 2510, the shaft assembly 2000 is assembled to the handle 1000 along a longitudinal axis; however, the operable interconnection between the drive shafts 1710 and 2710 and the electrical interconnection between the frames 1510 and 2510 can comprise any suitable configuration which can allow a shaft assembly to be assembled to the handle 1000 in any suitable manner.
As discussed above, referring to
Further to the above, the biasing springs 1146 hold the latches 1140 in their locked positions. The distal ends 1142 are sized and configured to prevent, or at least inhibit, relative longitudinal movement, i.e., translation along a longitudinal axis, between the shaft assembly 2000 and the drive module 1100 when the latches 1140 are in their locked positions. Moreover, the latches 1140 and the latch windows 1240 are sized and configured to prevent relative lateral movement, i.e., translation transverse to the longitudinal axis, between the shaft assembly 2000 and the drive module 1100. In addition, the latches 1140 and the latch windows 2140 are sized and configured to prevent the shaft assembly 2000 from rotating relative to the drive module 1100. The drive module 1100 further comprises release actuators 1150 which, when depressed by a clinician, move the latches 1140 from their locked positions into their unlocked positions. The drive module 1100 comprises a first release actuator 1150 slideably mounted in an opening defined in the first side of the handle housing 1110 and a second release actuator 1150 slideably mounted in an opening defined in a second, or opposite, side of the handle housing 1110. Although the release actuators 1150 are actuatable separately, both release actuators 1150 typically need to be depressed to completely unlock the shaft assembly 2000 from the drive module 1100 and allow the shaft assembly 2000 to be detached from the drive module 1100. That said, it is possible that the shaft assembly 2000 could be detached from the drive module 1100 by depressing only one release actuator 1150.
Once the shaft assembly 2000 has been secured to the handle 1000 and the end effector 7000, for example, has been assembled to the shaft 2000, the clinician can maneuver the handle 1000 to insert the end effector 7000 into a patient. In at least one instance, the end effector 7000 is inserted into the patient through a trocar and then manipulated in order to position the jaw assembly 7100 of the end effector assembly 7000 relative to the patient's tissue. Oftentimes, the jaw assembly 7100 must be in its closed, or clamped, configuration in order to fit through the trocar. Once through the trocar, the jaw assembly 7100 can be opened so that the patient tissue fit between the jaws of the jaw assembly 7100. At such point, the jaw assembly 7100 can be returned to its closed configuration to clamp the patient tissue between the jaws. The clamping force applied to the patient tissue by the jaw assembly 7100 is sufficient to move or otherwise manipulate the tissue during a surgical procedure. Thereafter, the jaw assembly 7100 can be re-opened to release the patient tissue from the end effector 7000. This process can be repeated until it is desirable to remove the end effector 7000 from the patient. At such point, the jaw assembly 7100 can be returned to its closed configuration and retracted through the trocar. Other surgical techniques are envisioned in which the end effector 7000 is inserted into a patient through an open incision, or without the use of the trocar. In any event, it is envisioned that the jaw assembly 7100 may have to be opened and closed several times throughout a surgical technique.
Referring again to
Further to the above, the control system 2800 of the shaft assembly 2000 comprises a printed circuit board (PCB) 2810, at least one microprocessor 2820, and at least one memory device 2830. The board 2810 can be rigid and/or flexible and can comprise any suitable number of layers. The microprocessor 2820 and the memory device 2830 are part of a control circuit defined on the board 2810 which communicates with the control system 1800 of the handle 1000. The shaft assembly 2000 further comprises a signal communication system 2900 and the handle 1000 further comprises a signal communication system 1900 which are configured to convey data between the shaft control system 2800 and the handle control system 1800. The signal communication system 2900 is configured to transmit data to the signal communication system 1900 utilizing any suitable analog and/or digital components. In various instances, the communication systems 2900 and 1900 can communicate using a plurality of discrete channels which allows the input gates of the microprocessor 1820 to be directly controlled, at least in part, by the output gates of the microprocessor 2820. In some instances, the communication systems 2900 and 1900 can utilize multiplexing. In at least one such instance, the control system 2900 includes a multiplexing device that sends multiple signals on a carrier channel at the same time in the form of a single, complex signal to a multiplexing device of the control system 1900 that recovers the separate signals from the complex signal.
The communication system 2900 comprises an electrical connector 2910 mounted to the circuit board 2810. The electrical connector 2910 comprises a connector body and a plurality of electrically-conductive contacts mounted to the connector body. The electrically-conductive contacts comprise male pins, for example, which are soldered to electrical traces defined in the circuit board 2810. In other instances, the male pins can be in communication with circuit board traces through zero-insertion-force (ZIF) sockets, for example. The communication system 1900 comprises an electrical connector 1910 mounted to the circuit board 1810. The electrical connector 1910 comprises a connector body and a plurality of electrically-conductive contacts mounted to the connector body. The electrically-conductive contacts comprise female pins, for example, which are soldered to electrical traces defined in the circuit board 1810. In other instances, the female pins can be in communication with circuit board traces through zero-insertion-force (ZIF) sockets, for example. When the shaft assembly 2000 is assembled to the drive module 1100, the electrical connector 2910 is operably coupled to the electrical connector 1910 such that the electrical contacts form electrical pathways therebetween. The above being said, the connectors 1910 and 2910 can comprise any suitable electrical contacts. Moreover, the communication systems 1900 and 2900 can communicate with one another in any suitable manner. In various instances, the communication systems 1900 and 2900 communicate wirelessly. In at least one such instance, the communication system 2900 comprises a wireless signal transmitter and the communication system 1900 comprises a wireless signal receiver such that the shaft assembly 2000 can wirelessly communicate data to the handle 1000. Likewise, the communication system 1900 can comprise a wireless signal transmitter and the communication system 2900 can comprise a wireless signal receiver such that the handle 1000 can wirelessly communicate data to the shaft assembly 2000.
As discussed above, the control system 1800 of the handle 1000 is in communication with, and is configured to control, the electrical power circuit of the handle 1000. The handle control system 1800 is also powered by the electrical power circuit of the handle 1000. The handle communication system 1900 is in signal communication with the handle control system 1800 and is also powered by the electrical power circuit of the handle 1000. The handle communication system 1900 is powered by the handle electrical power circuit via the handle control system 1800, but could be directly powered by the electrical power circuit. As also discussed above, the handle communication system 1900 is in signal communication with the shaft communication system 2900. That said, the shaft communication system 2900 is also powered by the handle electrical power circuit via the handle communication system 1900. To this end, the electrical connectors 1910 and 2010 connect both one or more signal circuits and one or more power circuits between the handle 1000 and the shaft assembly 2000. Moreover, the shaft communication system 2900 is in signal communication with the shaft control system 2800, as discussed above, and is also configured to supply power to the shaft control system 2800. Thus, the control systems 1800 and 2800 and the communication systems 1900 and 2900 are all powered by the electrical power circuit of the handle 1000; however, alternative embodiments are envisioned in which the shaft assembly 2000 comprises its own power source, such as one or more batteries, for example, an and electrical power circuit configured to supply power from the batteries to the handle systems 2800 and 2900. In at least one such embodiment, the handle control system 1800 and the handle communication system 1900 are powered by the handle electrical power system and the shaft control system 2800 and the handle communication system 2900 are powered by the shaft electrical power system.
Further to the above, the actuation of the clamping trigger 2610 is detected by the shaft control system 2800 and communicated to the handle control system 1800 via the communication systems 2900 and 1900. Upon receiving a signal that the clamping trigger 2610 has been actuated, the handle control system 1800 supplies power to the electric motor 1610 of the motor assembly 1600 to rotate the drive shaft 1710 of the handle drive system 1700, and the drive shaft 2710 of the shaft drive system 2700, in a direction which closes the jaw assembly 7100 of the end effector 7000. The mechanism for converting the rotation of the drive shaft 2710 to a closure motion of the jaw assembly 7100 is discussed in greater detail below. So long as the clamping trigger 2610 is held in its actuated position, the electric motor 1610 will rotate the drive shaft 1710 until the jaw assembly 7100 reaches its fully-clamped position. When the jaw assembly 7100 reaches its fully-clamped position, the handle control system 1800 cuts the electrical power to the electric motor 1610. The handle control system 1800 can determine when the jaw assembly 7100 has reached its fully-clamped position in any suitable manner. For instance, the handle control system 1800 can comprise an encoder system which monitors the rotation of, and counts the rotations of, the output shaft of the electric motor 1610 and, once the number of rotations reaches a predetermined threshold, the handle control system 1800 can discontinue supplying power to the electric motor 1610. In at least one instance, the end effector assembly 7000 can comprise one or more sensors configured to detect when the jaw assembly 7100 has reached its fully-clamped position. In at least one such instance, the sensors in the end effector 7000 are in signal communication with the handle control system 1800 via electrical circuits extending through the shaft assembly 2000 which can include the electrical contacts 1520 and 2520, for example.
When the clamping trigger 2610 is rotated distally out of its proximal position, the switch 2115 is opened which is detected by the shaft control system 2800 and communicated to the handle control system 1800 via the communication systems 2900 and 1900. Upon receiving a signal that the clamping trigger 2610 has been moved out of its actuated position, the handle control system 1800 reverses the polarity of the voltage differential being applied to the electric motor 1610 of the motor assembly 1600 to rotate the drive shaft 1710 of the handle drive system 1700, and the drive shaft 2710 of the shaft drive system 2700, in an opposite direction which, as a result, opens the jaw assembly 7100 of the end effector 7000. When the jaw assembly 7100 reaches its fully-open position, the handle control system 1800 cuts the electrical power to the electric motor 1610. The handle control system 1800 can determine when the jaw assembly 7100 has reached its fully-open position in any suitable manner. For instance, the handle control system 1800 can utilize the encoder system and/or the one or more sensors described above to determine the configuration of the jaw assembly 7100. In view of the above, the clinician needs to be mindful about holding the clamping trigger 2610 in its actuated position in order to maintain the jaw assembly 7100 in its clamped configuration as, otherwise, the control system 1800 will open jaw assembly 7100. With this in mind, the shaft assembly 2000 further comprises an actuator latch 2630 configured to releasably hold the clamping trigger 2610 in its actuated position to prevent the accidental opening of the jaw assembly 7100. The actuator latch 2630 can be manually released, or otherwise defeated, by the clinician to allow the clamping trigger 2610 to be rotated distally and open the jaw assembly 7100.
The clamping trigger system 2600 further comprises a resilient biasing member, such as a torsion spring, for example, configured to resist the closure of the clamping trigger system 2600. The torsion spring can also assist in reducing and/or mitigating sudden movements and/or jitter of the clamping trigger 2610. Such a torsion spring can also automatically return the clamping trigger 2610 to its unactuated position when the clamping trigger 2610 is released. The actuator latch 2630 discussed above can suitably hold the clamping trigger 2610 in its actuated position against the biasing force of the torsion spring.
As discussed above, the control system 1800 operates the electric motor 1610 to open and close the jaw assembly 7100. The control system 1800 is configured to open and close the jaw assembly 7100 at the same speed. In such instances, the control system 1800 applies the same voltage pulses to the electric motor 1610, albeit with different voltage polarities, when opening and closing the jaw assembly 7100. That said, the control system 1800 can be configured to open and close the jaw assembly 7100 at different speeds. For instance, the jaw assembly 7100 can be closed at a first speed and opened at a second speed which is faster than the first speed. In such instances, the slower closing speed affords the clinician an opportunity to better position the jaw assembly 7100 while clamping the tissue. Alternatively, the control system 1800 can open the jaw assembly 7100 at a slower speed. In such instances, the slower opening speed reduces the possibility of the opening jaws colliding with adjacent tissue. In either event, the control system 1800 can decrease the duration of the voltage pulses and/or increase the duration between the voltage pulses to slow down and/or speed up the movement of the jaw assembly 7100.
As discussed above, the control system 1800 is configured to interpret the position of the clamping trigger 2610 as a command to position the jaw assembly 7100 in a specific configuration. For instance, the control system 1800 is configured to interpret the proximal-most position of the clamping trigger 2610 as a command to close the jaw assembly 7100 and any other position of the clamping trigger as a command to open the jaw assembly 7100. That said, the control system 1800 can be configured to interpret the position of the clamping trigger 2610 in a proximal range of positions, instead of a single position, as a command to close the jaw assembly 7100. Such an arrangement can allow the jaw assembly 7000 to be better responsive to the clinician's input. In such instances, the range of motion of the clamping trigger 2610 is divided into ranges—a proximal range which is interpreted as a command to close the jaw assembly 7100 and a distal range which is interpreted as a command to open the jaw assembly 7100. In at least one instance, the range of motion of the clamping trigger 2610 can have an intermediate range between the proximal range and the distal range. When the clamping trigger 2610 is in the intermediate range, the control system 1800 can interpret the position of the clamping trigger 2610 as a command to neither open nor close the jaw assembly 7100. Such an intermediate range can prevent, or reduce the possibility of, jitter between the opening and closing ranges. In the instances described above, the control system 1800 can be configured to ignore cumulative commands to open or close the jaw assembly 7100. For instance, if the closure trigger 2610 has already been fully retracted into its proximal-most position, the control assembly 1800 can ignore the motion of the clamping trigger 2610 in the proximal, or clamping, range until the clamping trigger 2610 enters into the distal, or opening, range wherein, at such point, the control system 1800 can then actuate the electric motor 1610 to open the jaw assembly 7100.
In certain instances, further to the above, the position of the clamping trigger 2610 within the clamping trigger range, or at least a portion of the clamping trigger range, can allow the clinician to control the speed of the electric motor 1610 and, thus, the speed in which the jaw assembly 7100 is being opened or closed by the control assembly 1800. In at least one instance, the sensor 2115 comprises a Hall Effect sensor, and/or any other suitable sensor, configured to detect the position of the clamping trigger 2610 between its distal, unactuated position and its proximal, fully-actuated position. The Hall Effect sensor is configured to transmit a signal to the handle control system 1800 via the shaft control system 2800 such that the handle control system 1800 can control the speed of the electric motor 1610 in response to the position of the clamping trigger 2610. In at least one instance, the handle control system 1800 controls the speed of the electric motor 1610 proportionately, or in a linear manner, to the position of the clamping trigger 2610. For example, if the clamping trigger 2610 is moved half way through its range, then the handle control system 1800 will operate the electric motor 1610 at half of the speed in which the electric motor 1610 is operated when the clamping trigger 2610 is fully-retracted. Similarly, if the clamping trigger 2610 is moved a quarter way through its range, then the handle control system 1800 will operate the electric motor 1610 at a quarter of the speed in which the electric motor 1610 is operated when the clamping trigger 2610 is fully-retracted. Other embodiments are envisioned in which the handle control system 1800 controls the speed of the electric motor 1610 in a non-linear manner to the position of the clamping trigger 2610. In at least one instance, the control system 1800 operates the electric motor 1610 slowly in the distal portion of the clamping trigger range while quickly accelerating the speed of the electric motor 1610 in the proximal portion of the clamping trigger range.
As described above, the clamping trigger 2610 is movable to operate the electric motor 1610 to open or close the jaw assembly 7100 of the end effector 7000. The electric motor 1610 is also operable to rotate the end effector 7000 about a longitudinal axis and articulate the end effector 7000 relative to the elongate shaft 2200 about the articulation joint 2300 of the shaft assembly 2000. Referring primarily to
Referring primarily to
In various embodiments, further to the above, the first and second sensors comprise switches which are mechanically closable by the detectable element of the annular ring 1422. When the annular ring 1422 is rotated in the first direction from a center position, the detectable element closes the switch of the first sensor. When the switch of the first sensor is closed, the control system 1800 operates the electric motor 1610 to rotate the end effector 7000 in the first direction. When the annular ring 1422 is rotated in the second direction toward the center position, the detectable element is disengaged from the first switch and the first switch is re-opened. Once the first switch is re-opened, the control system 1800 cuts the power to the electric motor 1610 to stop the rotation of the end effector 7000. Similarly, the detectable element closes the switch of the second sensor when the annular ring 1422 is rotated in the second direction from the center position. When the switch of the second sensor is closed, the control system 1800 operates the electric motor 1610 to rotate the end effector 7000 in the second direction. When the annular ring 1422 is rotated in the first direction toward the center position, the detectable element is disengaged from the second switch and the second switch is re-opened. Once the second switch is re-opened, the control system 1800 cuts the power to the electric motor 1610 to stop the rotation of the end effector 7000.
In various embodiments, further to the above, the first and second sensors of the rotation actuator 1420 comprise proximity sensors, for example. In certain embodiments, the first and second sensors of the rotation actuator 1420 comprise Hall Effect sensors, and/or any suitable sensors, configured to detect the distance between the detectable element of the annular ring 1422 and the first and second sensors. If the first Hall Effect sensor detects that the annular ring 1422 has been rotated in the first direction, then, as discussed above, the control system 1800 will rotate the end effector 7000 in the first direction. In addition, the control system 1800 can rotate the end effector 7000 at a faster speed when the detectable element is closer to the first Hall Effect sensor than when the detectable element is further away from the first Hall Effect sensor. If the second Hall Effect sensor detects that the annular ring 1422 has been rotated in the second direction, then, as discussed above, the control system 1800 will rotate the end effector 7000 in the second direction. In addition, the control system 1800 can rotate the end effector 7000 at a faster speed when the detectable element is closer to the second Hall Effect sensor than when the detectable element is further away from the second Hall Effect sensor. As a result, the speed in which the end effector 7000 is rotated is a function of the amount, or degree, in which the annular ring 1422 is rotated. The control system 1800 is further configured to evaluate the inputs from both the first and second Hall Effect sensors when determining the direction and speed in which to rotate the end effector 7000. In various instances, the control system 1800 can use the closest Hall Effect sensor to the detectable element of the annular ring 1422 as a primary source of data and the Hall Effect sensor furthest away from the detectable element as a confirmational source of data to double-check the data provided by the primary source of data. The control system 1800 can further comprise a data integrity protocol to resolve situations in which the control system 1800 is provided with conflicting data. In any event, the handle control system 1800 can enter into a neutral state in which the handle control system 1800 does not rotate the end effector 7000 when the Hall Effect sensors detect that the detectable element is in its center position, or in a position which is equidistant between the first Hall Effect sensor and the second Hall Effect sensor. In at least one such instance, the control system 1800 can enter into its neutral state when the detectable element is in a central range of positions. Such an arrangement would prevent, or at least reduce the possibility of, rotational jitter when the clinician is not intending to rotate the end effector 7000.
Further to the above, the rotation actuator 1420 can comprise one or more springs configured to center, or at least substantially center, the rotation actuator 1420 when it is released by the clinician. In such instances, the springs can act to shut off the electric motor 1610 and stop the rotation of the end effector 7000. In at least one instance, the rotation actuator 1420 comprises a first torsion spring configured to rotate the rotation actuator 1420 in the first direction and a second torsion spring configured to rotate the rotation actuator 1420 in the second direction. The first and second torsion springs can have the same, or at least substantially the same, spring constant such that the forces and/or torques applied by the first and second torsion springs balance, or at least substantially balance, the rotation actuator 1420 in its center position.
In view of the above, the reader should appreciate that the clamping trigger 2610 and the rotation actuator 1420 are both operable to rotate the drive shaft 2710 and either, respectively, operate the jaw assembly 7100 or rotate the end effector 7000. The system that uses the rotation of the drive shaft 2710 to selectively perform these functions is described in greater detail below.
Referring to
In various instances, further to the above, the articulation range of the end effector 7000 is limited and the control system 1800 can utilize the encoder system discussed above for monitoring the rotational output of the electric motor 1610, for example, to monitor the amount, or degree, in which the end effector 7000 is rotated in the first direction. In addition to or in lieu of the encoder system, the shaft assembly 2000 can comprise a first sensor configured to detect when the end effector 7000 has reached the limit of its articulation in the first direction. In any event, when the control system 1800 determines that the end effector 7000 has reached the limit of articulation in the first direction, the control system 1800 can cut the power to the electric motor 1610 to stop the articulation of the end effector 7000.
Similar to the above, the second push button 1434 comprises a second switch that is closed when the second push button 1434 is depressed. The handle control system 1800 is configured to sense the closure of the second switch and, moreover, the closure of the second articulation control circuit. When the handle control system 1800 detects that the second articulation control circuit has been closed, the handle control system 1800 operates the electric motor 1610 to articulate the end effector 7000 in a second direction about the articulation joint 2300. When the second push button 1434 is released by the clinician, the second articulation control circuit is opened which, once detected by the control system 1800, causes the control system 1800 to cut the power to the electric motor 1610 to stop the articulation of the end effector 7000.
In various instances, the articulation range of the end effector 7000 is limited and the control system 1800 can utilize the encoder system discussed above for monitoring the rotational output of the electric motor 1610, for example, to monitor the amount, or degree, in which the end effector 7000 is rotated in the second direction. In addition to or in lieu of the encoder system, the shaft assembly 2000 can comprise a second sensor configured to detect when the end effector 7000 has reached the limit of its articulation in the second direction. In any event, when the control system 1800 determines that the end effector 7000 has reached the limit of articulation in the second direction, the control system 1800 can cut the power to the electric motor 1610 to stop the articulation of the end effector 7000.
As described above, the end effector 7000 is articulatable in a first direction (
In addition to or in lieu of the above, the handle control system 1800 can be configured to re-center the end effector 7000. In at least one such instance, the handle control system 1800 can re-center the end effector 7000 when both of the articulation buttons 1432 and 1434 of the articulation actuator 1430 are depressed at the same time. When the handle control system 1800 comprises an encoder system configured to monitor the rotational output of the electric motor 1610, for example, the handle control system 1800 can determine the amount and direction of articulation needed to re-center, or at least substantially re-center, the end effector 7000. In various instances, the input system 1400 can comprise a home button, for example, which, when depressed, automatically centers the end effector 7000.
Referring primarily to
Referring primarily to
Referring primarily to
Further to the above, referring to
Referring to
Referring primarily to
As discussed above, the control system 1800 is configured to actuate the electric motor 1610 to perform three different end effector functions—clamping/opening the jaw assembly 7100 (
In various instances, further to the above, the shaft 2510 and/or the shaft 1510 comprise a flexible circuit including electrical traces which form part of the clutch control circuits. The flexible circuit can comprise a ribbon, or substrate, with conductive pathways defined therein and/or thereon. The flexible circuit can also comprise sensors and/or any solid state component, such as signal smoothing capacitors, for example, mounted thereto. In at least one instance, each of the conductive pathways can comprise one or more signal smoothing capacitors which can, among other things, even out fluctuations in signals transmitted through the conductive pathways. In various instances, the flexible circuit can be coated with at least one material, such as an elastomer, for example, which can seal the flexible circuit against fluid ingress.
Referring primarily to
When the first clutch 6110 is in its disengaged position (
As described above, the first electromagnetic actuator 6140 is configured to generate magnetic fields to move the first clutch 6110 between its disengaged (
Further to the above, referring to
Notably, further to the above, the first clutch lock 6150 is also configured to lockout the jaw assembly drive when the first clutch 6110 is in its disengaged position. More specifically, referring again to
Moreover, further to the above, the threads of the threaded portions 6160 and 7160 can be configured to prevent, or at least resist, backdriving of the jaw drive. In at least one instance, the thread pitch and/or angle of the threaded portions 6160 and 7160, for example, can be selected to prevent the backdriving, or unintentional opening, of the jaw assembly 7100. As a result of the above, the possibility of the jaw assembly 7100 unintentionally opening or closing is prevented, or at least reduced.
Referring primarily to
When the second clutch 6210 is in its disengaged position, referring to
As described above, the second electromagnetic actuator 6240 is configured to generate magnetic fields to move the second clutch 6210 between its disengaged (
Further to the above, referring to
Notably, further to the above, the second clutch lock 6250 is also configured to lockout the rotation of the end effector 7000 when the second clutch 6210 is in its disengaged position. More specifically, referring again to
Referring primarily to
Referring primarily to
When the third clutch 6310 is in its disengaged position, referring to
As described above, the third electromagnetic actuator 6340 is configured to generate magnetic fields to move the third clutch 6310 between its disengaged (
Further to the above, the third electromagnetic actuator 6340 is configured to emit a magnetic field EFD which pulls, or drives, the third clutch 6310 toward the third drive ring 6320 when the third clutch assembly 6300 is in its engaged state. The coils of the third electromagnetic actuator 6340 generate the magnetic field EFD when current flows in a second, or opposite, direction through the third electrical clutch circuit. The control system 1800 is configured to apply an opposite voltage polarity to the third electrical shaft circuit to create the current flowing in the opposite direction. The control system 1800 can continuously apply the opposite voltage polarity to the third electric shaft circuit to continuously hold the third clutch 6310 in its engaged position and maintain the operable engagement between the third drive ring 6320 and the articulation drive 6330. Alternatively, the third clutch 6210 can be configured to become wedged within the third drive ring 6320 when the third clutch 6310 is in its engaged position and, in such instances, the control system 1800 may not need to continuously apply a voltage polarity to the third shaft electrical circuit to hold the third clutch assembly 6300 in its engaged state. In such instances, the control system 1800 can discontinue applying the voltage polarity once the third clutch 6310 has been sufficiently wedged in the third drive ring 6320. In any event, the end effector 7000 is articulatable in a first direction or a second direction, depending on the direction in which the drive shaft 2730 is rotated, when the third clutch assembly 6300 is in its engaged state.
Further to the above, referring to
Further to the above, the radially-extending lockout slot 2334 depicted in
Referring primarily to
As described above, the clutches 6110, 6210, and/or 6310 can be held in their disengaged positions so that they do not unintentionally move into their engaged positions. In various arrangements, the clutch system 6000 comprises a first biasing member, such as a spring, for example, configured to bias the first clutch 6110 into its disengaged position, a second biasing member, such as a spring, for example, configured to bias the second clutch 6210 into its disengaged position, and/or a third biasing member, such as a spring, for example, configured to bias the third clutch 6110 into its disengaged position. In such arrangements, the biasing forces of the springs can be selectively overcome by the electromagnetic forces generated by the electromagnetic actuators when energized by an electrical current. Further to the above, the clutches 6110, 6210, and/or 6310 can be retained in their engaged positions by the drive rings 6120, 6220, and/or 6320, respectively. More specifically, in at least one instance, the drive rings 6120, 6220, and/or 6320 are comprised of an elastic material which grips or frictionally holds the clutches 6110, 6210, and/or 6310, respectively, in their engaged positions. In various alternative embodiments, the clutch system 6000 comprises a first biasing member, such as a spring, for example, configured to bias the first clutch 6110 into its engaged position, a second biasing member, such as a spring, for example, configured to bias the second clutch 6210 into its engaged position, and/or a third biasing member, such as a spring, for example, configured to bias the third clutch 6110 into its engaged position. In such arrangements, the biasing forces of the springs can be overcome by the electromagnetic forces applied by the electromagnetic actuators 6140, 6240, and/or 6340, respectively, as needed to selectively hold the clutches 6110, 6210, and 6310 in their disengaged positions. In any one operational mode of the surgical system, the control assembly 1800 can energize one of the electromagnetic actuators to engage one of the clutches while energizing the other two electromagnetic actuators to disengage the other two clutches.
Although the clutch system 6000 comprises three clutches to control three drive systems of the surgical system, a clutch system can comprise any suitable number of clutches to control any suitable number of systems. Moreover, although the clutches of the clutch system 6000 slide proximally and distally between their engaged and disengaged positions, the clutches of a clutch system can move in any suitable manner. In addition, although the clutches of the clutch system 6000 are engaged one at a time to control one drive motion at a time, various instances are envisioned in which more than one clutch can be engaged to control more than one drive motion at a time.
In view of the above, the reader should appreciate that the control system 1800 is configured to, one, operate the motor system 1600 to rotate the drive shaft system 2700 in an appropriate direction and, two, operate the clutch system 6000 to transfer the rotation of the drive shaft system 2700 to the appropriate function of the end effector 7000. Moreover, as discussed above, the control system 1800 is responsive to inputs from the clamping trigger system 2600 of the shaft assembly 2000 and the input system 1400 of the handle 1000. When the clamping trigger system 2600 is actuated, as discussed above, the control system 1800 activates the first clutch assembly 6100 and deactivates the second clutch assembly 6200 and the third clutch assembly 6300. In such instances, the control system 1800 also supplies power to the motor system 1600 to rotate the drive shaft system 2700 in a first direction to clamp the jaw assembly 7100 of the end effector 7000. When the control system 1800 detects that the jaw assembly 7100 is in its clamped configuration, the control system 1800 stops the motor assembly 1600 and deactivates the first clutch assembly 6100. When the control system 1800 detects that the clamping trigger system 2600 has been moved to, or is being moved to, its unactuated position, the control system 1800 activates, or maintains the activation of, the first clutch assembly 6100 and deactivates, or maintains the deactivation of, the second clutch assembly 6200 and the third clutch assembly 6300. In such instances, the control system 1800 also supplies power to the motor system 1600 to rotate the drive shaft system 2700 in a second direction to open the jaw assembly 7100 of the end effector 7000.
When the rotation actuator 1420 is actuated in a first direction, further to the above, the control system 1800 activates the second clutch assembly 6200 and deactivates the first clutch assembly 6100 and the third clutch assembly 6300. In such instances, the control system 1800 also supplies power to the motor system 1600 to rotate the drive shaft system 2700 in a first direction to rotate the end effector 7000 in a first direction. When the control system 1800 detects that the rotation actuator 1420 has been actuated in a second direction, the control system 1800 activates, or maintains the activation of, the second clutch assembly 6200 and deactivates, or maintains the deactivation of, the first clutch assembly 6100 and the third clutch assembly 6300. In such instances, the control system 1800 also supplies power to the motor system 1600 to rotate the drive shaft system 2700 in a second direction to rotate the drive shaft system 2700 in a second direction to rotate the end effector 7000 in a second direction. When the control system 1800 detects that the rotation actuator 1420 is not actuated, the control system 1800 deactivates the second clutch assembly 6200.
When the first articulation actuator 1432 is depressed, further to the above, the control system 1800 activates the third clutch assembly 6300 and deactivates the first clutch assembly 6100 and the second clutch assembly 6200. In such instances, the control system 1800 also supplies power to the motor system 1600 to rotate the drive shaft system 2700 in a first direction to articulate the end effector 7000 in a first direction. When the control system 1800 detects that the second articulation actuator 1434 is depressed, the control system 1800 activates, or maintains the activation of, the third clutch assembly 6200 and deactivates, or maintains the deactivation of, the first clutch assembly 6100 and the second clutch assembly 6200. In such instances, the control system 1800 also supplies power to the motor system 1600 to rotate the drive shaft system 2700 in a second direction to articulate the end effector 7000 in a second direction. When the control system 1800 detects that neither the first articulation actuator 1432 nor the second articulation actuator 1434 are actuated, the control system 1800 deactivates the third clutch assembly 6200.
Further to the above, the control system 1800 is configured to change the operating mode of the stapling system based on the inputs it receives from the clamping trigger system 2600 of the shaft assembly 2000 and the input system 1400 of the handle 1000. The control system 1800 is configured to shift the clutch system 6000 before rotating the shaft drive system 2700 to perform the corresponding end effector function. Moreover, the control system 1800 is configured to stop the rotation of the shaft drive system 2700 before shifting the clutch system 6000. Such an arrangement can prevent the sudden movements in the end effector 7000. Alternatively, the control system 1800 can shift the clutch system 600 while the shaft drive system 2700 is rotating. Such an arrangement can allow the control system 1800 to shift quickly between operating modes.
As discussed above, referring to
The above being said, referring again to
In at least one instance, further to the above, the drive module 1100 comprises an input switch and/or sensor in communication with the control system 1800 via the input system 1400, and/or the control system 1800 directly, which, when actuated, causes the control system 1800 to unlock the end effector 7000. In various instances, the drive module 1100 comprises an input screen 1440 in communication with the board 1410 of the input system 1400 which is configured to receive an unlock input from the clinician. In response to the unlock input, the control system 1800 can stop the motor system 1600, if it is running, and unlock the end effector 7000 as described above. The input screen 1440 is also configured to receive a lock input from the clinician in which the input system 1800 moves the second clutch assembly 6200 and/or the third clutch assembly 6300 into their unactuated states to lock the end effector 7000 to the shaft assembly 2000.
The second sensor 6280′ is in signal communication with the control system 1800 as part of a second sensing circuit. The second sensing circuit comprises signal wires extending through the longitudinal passage 2535′; however, the second sensing circuit can comprise a wireless signal transmitter and receiver to place the second sensor 6280′ in signal communication with the control system 1800. The second sensor 6280′ is positioned and arranged to detect the position of the second clutch 6210 of the first clutch assembly 6200. Based on data received from the second sensor 6280′, the control system 1800 can determine whether the second clutch 6210 is in its engaged position, its disengaged position, or somewhere in-between. With this information, the control system 1800 can assess whether or not the second clutch 6210 is in the correct position given the operating state of the surgical instrument. For instance, if the surgical instrument is in its end effector rotation operating state, the control system 1800 can verify whether the second clutch 6210 is properly positioned in its engaged position. In such instances, the control system 1800 can also verify that the first clutch 6110 is in its disengaged position via the first sensor 6180′ and, further to the below, the control system 1800 can also verify that the third clutch 6310 is in its disengaged position via the third sensor 6380′. Correspondingly, the control system 1800 can verify whether the second clutch 6110 is properly positioned in its disengaged position if the surgical instrument is not in its end effector rotation state. To the extent that the second clutch 6210 is not in its proper position, the control system 1800 can actuate the second electromagnetic actuator 6240 in an attempt to properly position the second clutch 6210. Likewise, the control system 1800 can actuate the electromagnetic actuators 6140 and/or 6340 to properly position the clutches 6110 and/or 6310, if necessary.
The third sensor 6380′ is in signal communication with the control system 1800 as part of a third sensing circuit. The third sensing circuit comprises signal wires extending through the longitudinal passage 2535′; however, the third sensing circuit can comprise a wireless signal transmitter and receiver to place the third sensor 6380′ in signal communication with the control system 1800. The third sensor 6380′ is positioned and arranged to detect the position of the third clutch 6310 of the third clutch assembly 6300. Based on data received from the third sensor 6380′, the control system 1800 can determine whether the third clutch 6310 is in its engaged position, its disengaged position, or somewhere in-between. With this information, the control system 1800 can assess whether or not the third clutch 6310 is in the correct position given the operating state of the surgical instrument. For instance, if the surgical instrument is in its end effector articulation operating state, the control system 1800 can verify whether the third clutch 6310 is properly positioned in its engaged position. In such instances, the control system 1800 can also verify that the first clutch 6110 is in its disengaged position via the first sensor 6180′ and that the second clutch 6210 is in its disengaged position via the second sensor 6280′. Correspondingly, the control system 1800 can verify whether the third clutch 6310 is properly positioned in its disengaged position if the surgical instrument is not in its end effector articulation state. To the extent that the third clutch 6310 is not in its proper position, the control system 1800 can actuate the third electromagnetic actuator 6340 in an attempt to properly position the third clutch 6310. Likewise, the control system 1800 can actuate the electromagnetic actuators 6140 and/or 6240 to properly position the clutches 6110 and/or 6210, if necessary.
Further to the above, the clutch position sensors, i.e., the first sensor 6180′, the second sensor 6280′, and the third sensor 6380′ can comprise any suitable type of sensor. In various instances, the first sensor 6180′, the second sensor 6280′, and the third sensor 6380′ each comprise a proximity sensor. In such an arrangement, the sensors 6180′, 6280′, and 6380′ are configured to detect whether or not the clutches 6110, 6210, and 6310, respectively, are in their engaged positions. In various instances, the first sensor 6180′, the second sensor 6280′, and the third sensor 6380′ each comprise a Hall Effect sensor, for example. In such an arrangement, the sensors 6180′, 6280′, and 6380′ can not only detect whether or not the clutches 6110, 6210, and 6310, respectively, are in their engaged positions but the sensors 6180′, 6280′, and 6380′ can also detect how close the clutches 6110, 6210, and 6310 are with respect to their engaged or disengaged positions.
The sensor 7190″, further to the above, is configured to detect when the magnetic element 6190″ is adjacent to the sensor 7190″ such that the control system 1800 can use this data to determine that the jaw assembly 7100 has reached the end of its clamping stroke. At such point, the control system 1800 can stop the motor assembly 1600. The sensor 7190″ and the control system 1800 are also configured to determine the distance between where the drive screw 6130″ is currently positioned and where the drive screw 6130″ should be positioned at the end of its closure stroke in order to calculate the amount of closure stroke of the drive screw 6130″ that is still needed to close the jaw assembly 7100. Moreover, such information can be used by the control system 1800 to assess the current configuration of the jaw assembly 7100, i.e., whether the jaw assembly 7100 is in its open configuration, its closed configuration, or a partially closed configuration. The sensor system could be used to determine when the jaw assembly 7100 has reached its fully open position and stop the motor assembly 1600 at that point. In various instances, the control system 1800 could use this sensor system to confirm that the first clutch assembly 6100 is in its actuated state by confirming that the jaw assembly 7100 is moving while the motor assembly 1600 is turning. Similarly, the control system 1800 could use this sensor system to confirm that the first clutch assembly 6100 is in its unactuated state by confirming that the jaw assembly 7100 is not moving while the motor assembly 1600 is turning.
Referring to
Further to the above, an instrument system including a handle and a shaft assembly attached thereto can be configured to perform a diagnostic check to assess the state of the clutch assemblies 6100, 6200, and 6300. In at least one instance, the control system 1800 sequentially actuates the electromagnetic actuators 6140, 6240, and/or 6340—in any suitable order—to verify the positions of the clutches 6110, 6210, and/or 6310, respectively, and/or verify that the clutches are responsive to the electromagnetic actuators and, thus, not stuck. The control system 1800 can use sensors, including any of the sensors disclosed herein, to verify the movement of the clutches 6110, 6120, and 6130 in response to the electromagnetic fields created by the electromagnetic actuators 6140, 6240, and/or 6340. In addition, the diagnostic check can also include verifying the motions of the drive systems. In at least one instance, the control system 1800 sequentially actuates the electromagnetic actuators 6140, 6240, and/or 6340—in any suitable order—to verify that the jaw drive opens and/or closes the jaw assembly 7100, the rotation drive rotates the end effector 7000, and/or the articulation drive articulates the end effector 7000, for example. The control system 1800 can use sensors to verify the motions of the jaw assembly 7100 and end effector 7000.
The control system 1800 can perform the diagnostic test at any suitable time, such as when a shaft assembly is attached to the handle and/or when the handle is powered on, for example. If the control system 1800 determines that the instrument system passed the diagnostic test, the control system 1800 can permit the ordinary operation of the instrument system. In at least one instance, the handle can comprise an indicator, such as a green LED, for example, which indicates that the diagnostic check has been passed. If the control system 1800 determines that the instrument system failed the diagnostic test, the control system 1800 can prevent and/or modify the operation of the instrument system. In at least one instance, the control system 1800 can limit the functionality of the instrument system to only the functions necessary to remove the instrument system from the patient, such as straightening the end effector 7000 and/or opening and closing the jaw assembly 7100, for example. In at least one respect, the control system 1800 enters into a limp mode. The limp mode of the control system 1800 can reduce a current rotational speed of the motor 1610 by any percentage selected from a range of about 75% to about 25%, for example. In one example, the limp mode reduces a current rotational speed of the motor 1610 by 50%. In one example, the limp mode reduces the current rotational speed of the motor 1610 by 75%. The limp mode may cause a current torque of the motor 1610 to be reduced by any percentage selected from a range of about 75% to about 25%, for example. In one example, the limp mode reduces a current torque of the motor 1610 by 50%. The handle can comprise an indicator, such as a red LED, for example, which indicates that the instrument system failed the diagnostic check and/or that the instrument system has entered into a limp mode. The above being said, any suitable feedback can be used to warn the clinician that the instrument system is not operating properly such as, for example, an audible warning and/or a tactile or vibratory warning, for example.
When the clutch plates 6110′ are in their unactuated positions, as illustrated in
The first clutch assembly 6100a comprises clutch plates 6110a and drive rings 6120a and work in a manner similar to the clutch plates 6110′ and drive rings 6120′ discussed above. When the clutch pates 6110a are actuated by an electromagnetic actuator 6140a, the rotation of the drive input 6030a is transferred to an outer shaft housing 7200a. More specifically, the outer shaft housing 7200a comprises a proximal outer housing 7210a and a distal outer housing 7220a which is rotatably supported by the proximal outer housing 7210a and is rotated relative to the proximal outer housing 7210a by the drive input 6030a when the clutch plates 6110a are in their actuated position. The rotation of the distal outer housing 7220a rotates the jaw assembly 7100a about the longitudinal axis owing to fact that the pivot 7130a of the jaw assembly 7100a is mounted to the distal outer housing 7220a. As a result, the outer shaft housing 7200a rotates the jaw assembly 7100a in a first direction when the outer shaft housing 7200a is rotated in a first direction by the drive input 6030a. Similarly, the outer shaft housing 7200a rotates the jaw assembly 7100a in a second direction when the outer shaft housing 7200a is rotated in a second direction by the drive input 6030a. When the electromagnetic actuator 6140a is de-energized, the drive rings 6120a expand and the clutch plates 6110a are moved into their unactuated positions, thereby decoupling the end effector rotation drive from the drive input 6030a.
The second clutch assembly 6200a comprises clutch plates 6210a and drive rings 6220a and work in a manner similar to the clutch plates 6110′ and drive rings 6120′ discussed above. When the clutch pates 6210a are actuated by an electromagnetic actuator 6240a, the rotation of the drive input 6030a is transferred to an articulation drive 6230a. The articulation drive 6230a is rotatably supported within an outer shaft housing 7410a of an end effector attachment portion 7400a and is rotatably supported by a shaft frame 6050a extending through the outer shaft housing 7410a. The articulation drive 6230a comprises a gear face defined thereon which is operably intermeshed with a stationary gear face 7230a defined on the proximal outer housing 7210a of the outer shaft housing 7200a. As a result, the articulation drive 6230a articulates the outer shaft housing 7200a and the jaw assembly 7100a in a first direction when the articulation drive 6230a is rotated in a first direction by the drive input 6030a. Similarly, the articulation drive 6230a articulates the outer shaft housing 7200a and the jaw assembly 7100a in a second direction when the articulation drive 6230a is rotated in a second direction by the drive input 6030a. When the electromagnetic actuator 6240a is de-energized, the drive rings 6220a expand and the clutch plates 6210a are moved into their unactuated positions, thereby decoupling the end effector articulation drive from the drive input 6030a.
Further to the above, the shaft assembly 4000 is illustrated in
As discussed above, referring primarily to
As also discussed above, referring primarily to
Further to the above, referring primarily to
Referring primarily to
Further to the above, the actuation trigger 4610 further comprises a drive arm 4615 configured to engage and rotate the drive link 4640 proximally, and translate the actuation rod 4660 proximally, when the actuation trigger 4610 is actuated, i.e., moved closer to the proximal shaft housing 4110. In such instances, the proximal rotation of the drive link 4640 resiliently compresses a biasing member, such as a coil spring 4670, for example, positioned intermediate the drive link 4640 and the frame shaft 4510. When the actuation trigger 4610 is released, the compressed coil spring 4670 re-expands and pushes the drive link 4640 and the actuation rod 4660 distally to open the jaw assembly 8100 of the end effector 8000. Moreover, the distal rotation of the drive link 4640 drives, and automatically rotates, the actuation trigger 4610 back into its unactuated position. That being said, the clinician could manually return the actuation trigger 4610 back into its unactuated position. In such instances, the actuation trigger 4610 could be opened slowly. In either event, the shaft assembly 4000 further comprises a lock configured to releasably hold the actuation trigger 4610 in its actuated position such that the clinician can use their hand to perform another task without the jaw assembly 8100 opening unintentionally.
In various alternative embodiments, further to the above, the actuation rod 4660 can be pushed distally to close the jaw assembly 8100. In at least one such instance, the actuation rod 4660 is mounted directly to the actuation trigger 4610 such that, when the actuation trigger 4610 is actuated, the actuation trigger 4610 drives the actuation rod 4660 distally. Similar to the above, the actuation trigger 4610 can compress a spring when the actuation trigger 4610 is closed such that, when the actuation trigger 4610 is released, the actuation rod 4660 is pushed proximally.
Further to the above, the shaft assembly 4000 has three functions—opening/closing the jaw assembly of an end effector, rotating the end effector about a longitudinal axis, and articulating the end effector about an articulation axis. The end effector rotation and articulation functions of the shaft assembly 4000 are driven by the motor assembly 1600 and the control system 1800 of the drive module 1100 while the jaw actuation function is manually-driven by the jaw closure actuation system 4600. The jaw closure actuation system 4600 could be a motor-driven system but, instead, the jaw closure actuation system 4600 has been kept a manually-driven system such that the clinician can have a better feel for the tissue being clamped within the end effector. While motorizing the end effector rotation and actuation systems provides certain advantages for controlling the position of the end effector, motorizing the jaw closure actuation system 4600 may cause the clinician to lose a tactile sense of the force being applied to the tissue and may not be able to assess whether the force is insufficient or excessive. Thus, the jaw closure actuation system 4600 is manually-driven even though the end effector rotation and articulation systems are motor-driven.
The microcontroller 1840 may be any single core or multicore processor such as those known under the trade name ARM Cortex by Texas Instruments, for example. In at least one instance, the microcontroller 1840 is a LM4F230H5QR ARM Cortex-M4F Processor Core, available from Texas Instruments, for example, comprising on-chip memory of 256 KB single-cycle flash memory, or other non-volatile memory, up to 40 MHz, a prefetch buffer to improve performance above 40 MHz, a 32 KB single-cycle serial random access memory (SRAM), internal read-only memory (ROM) loaded with StellarisWare® software, 2 KB electrically erasable programmable read-only memory (EEPROM), one or more pulse width modulation (PWM) modules and/or frequency modulation (FM) modules, one or more quadrature encoder inputs (QEI) analog, one or more 12-bit Analog-to-Digital Converters (ADC) with 12 analog input channels, for example, details of which are available from the product datasheet.
In various instances, the microcontroller 1840 comprises a safety controller comprising two controller-based families such as TMS570 and RM4x known under the trade name Hercules ARM Cortex R4, also by Texas Instruments. The safety controller may be configured specifically for IEC 61508 and ISO 26262 safety critical applications, among others, to provide advanced integrated safety features while delivering scalable performance, connectivity, and memory options.
The microcontroller 1840 is programmed to perform various functions such as precisely controlling the speed and/or position of the drive nut 7150 of the jaw closure assembly, for example. The microcontroller 1840 is also programmed to precisely control the rotational speed and position of the end effector 7000 and the articulation speed and position of the end effector 7000. In various instances, the microcontroller 1840 computes a response in the software of the microcontroller 1840. The computed response is compared to a measured response of the actual system to obtain an “observed” response, which is used for actual feedback decisions. The observed response is a favorable, tuned, value that balances the smooth, continuous nature of the simulated response with the measured response, which can detect outside influences on the system.
The motor 1610 is controlled by the motor driver 1850. In various forms, the motor 1610 is a DC brushed driving motor having a maximum rotational speed of approximately 25,000 RPM, for example. In other arrangements, the motor 1610 includes a brushless motor, a cordless motor, a synchronous motor, a stepper motor, or any other suitable electric motor. The motor driver 1850 may comprise an H-bridge driver comprising field-effect transistors (FETs), for example. The motor driver 1850 may be an A3941 available from Allegro Microsystems, Inc., for example. The A3941 driver 1850 is a full-bridge controller for use with external N-channel power metal oxide semiconductor field effect transistors (MOSFETs) specifically designed for inductive loads, such as brush DC motors. In various instances, the driver 1850 comprises a unique charge pump regulator provides full (>10 V) gate drive for battery voltages down to 7 V and allows the A3941 to operate with a reduced gate drive, down to 5.5 V. A bootstrap capacitor may be employed to provide the above-battery supply voltage required for N-channel MOSFETs. An internal charge pump for the high-side drive allows DC (100% duty cycle) operation. The full bridge can be driven in fast or slow decay modes using diode or synchronous rectification. In the slow decay mode, current recirculation can be through the high-side or the lowside FETs. The power FETs are protected from shoot-through by resistor adjustable dead time. Integrated diagnostics provide indication of undervoltage, overtemperature, and power bridge faults, and can be configured to protect the power MOSFETs under most short circuit conditions. Other motor drivers may be readily substituted.
The tracking system 1860 comprises a controlled motor drive circuit arrangement comprising one or more position sensors, such as sensors 1880, 1890, 6180′, 6280′, 6380′, 7190″, and/or 6290′″, for example. The position sensors for an absolute positioning system provide a unique position signal corresponding to the location of a displacement member. As used herein, the term displacement member is used generically to refer to any movable member of the surgical system. In various instances, the displacement member may be coupled to any position sensor suitable for measuring linear displacement. Linear displacement sensors may include contact or non-contact displacement sensors. Linear displacement sensors may comprise linear variable differential transformers (LVDT), differential variable reluctance transducers (DVRT), a slide potentiometer, a magnetic sensing system comprising a movable magnet and a series of linearly arranged Hall Effect sensors, a magnetic sensing system comprising a fixed magnet and a series of movable linearly arranged Hall Effect sensors, an optical sensing system comprising a movable light source and a series of linearly arranged photo diodes or photo detectors, or an optical sensing system comprising a fixed light source and a series of movable linearly arranged photo diodes or photo detectors, or any combination thereof.
The position sensors 1880, 1890, 6180′, 6280′, 6380′, 7190″, and/or 6290′″, for example, may comprise any number of magnetic sensing elements, such as, for example, magnetic sensors classified according to whether they measure the total magnetic field or the vector components of the magnetic field. The techniques used to produce both types of magnetic sensors encompass many aspects of physics and electronics. The technologies used for magnetic field sensing include search coil, fluxgate, optically pumped, nuclear precession, SQUID, Hall-Effect, anisotropic magnetoresistance, giant magnetoresistance, magnetic tunnel junctions, giant magnetoimpedance, magnetostrictive/piezoelectric composites, magnetodiode, magnetotransistor, fiber optic, magnetooptic, and microelectromechanical systems-based magnetic sensors, among others.
In various instances, one or more of the position sensors of the tracking system 1860 comprise a magnetic rotary absolute positioning system. Such position sensors may be implemented as an AS5055EQFT single-chip magnetic rotary position sensor available from Austria Microsystems, AG and can be interfaced with the controller 1840 to provide an absolute positioning system. In certain instances, a position sensor comprises a low-voltage and low-power component and includes four Hall-Effect elements in an area of the position sensor that is located adjacent a magnet. A high resolution ADC and a smart power management controller are also provided on the chip. A CORDIC processor (for Coordinate Rotation Digital Computer), also known as the digit-by-digit method and Volder's algorithm, is provided to implement a simple and efficient algorithm to calculate hyperbolic and trigonometric functions that require only addition, subtraction, bitshift, and table lookup operations. The angle position, alarm bits, and magnetic field information are transmitted over a standard serial communication interface such as an SPI interface to the controller 1840. The position sensors can provide 12 or 14 bits of resolution, for example. The position sensors can be an AS5055 chip provided in a small QFN 16-pin 4×4×0.85 mm package, for example.
The tracking system 1860 may comprise and/or be programmed to implement a feedback controller, such as a PID, state feedback, and adaptive controller. A power source converts the signal from the feedback controller into a physical input to the system, in this case voltage. Other examples include pulse width modulation (PWM) and/or frequency modulation (FM) of the voltage, current, and force. Other sensor(s) may be provided to measure physical parameters of the physical system in addition to position. In various instances, the other sensor(s) can include sensor arrangements such as those described in U.S. Pat. No. 9,345,481, entitled STAPLE CARTRIDGE TISSUE THICKNESS SENSOR SYSTEM, which is hereby incorporated herein by reference in its entirety; U.S. Patent Application Publication No. 2014/0263552, entitled STAPLE CARTRIDGE TISSUE THICKNESS SENSOR SYSTEM, which is hereby incorporated herein by reference in its entirety; and U.S. patent application Ser. No. 15/628,175, entitled TECHNIQUES FOR ADAPTIVE CONTROL OF MOTOR VELOCITY OF A SURGICAL STAPLING AND CUTTING INSTRUMENT, which is hereby incorporated herein by reference in its entirety. In a digital signal processing system, absolute positioning system is coupled to a digital data acquisition system where the output of the absolute positioning system will have finite resolution and sampling frequency. The absolute positioning system may comprise a compare and combine circuit to combine a computed response with a measured response using algorithms such as weighted average and theoretical control loop that drives the computed response towards the measured response. The computed response of the physical system takes into account properties like mass, inertial, viscous friction, inductance resistance, etc., to predict what the states and outputs of the physical system will be by knowing the input.
The absolute positioning system provides an absolute position of the displacement member upon power up of the instrument without retracting or advancing the displacement member to a reset (zero or home) position as may be required with conventional rotary encoders that merely count the number of steps forwards or backwards that the motor 1610 has taken to infer the position of a device actuator, drive bar, knife, and the like.
A sensor 1880 comprising a strain gauge or a micro-strain gauge, for example, is configured to measure one or more parameters of the end effector, such as, for example, the strain experienced by the jaws 7110 and 7120 during a clamping operation. The measured strain is converted to a digital signal and provided to the processor 1820. In addition to or in lieu of the sensor 1880, a sensor 1890 comprising a load sensor, for example, can measure the closure force applied by the closure drive system to the jaws 7110 and 7120. In various instances, a current sensor 1870 can be employed to measure the current drawn by the motor 1610. The force required to clamp the jaw assembly 7100 can correspond to the current drawn by the motor 1610, for example. The measured force is converted to a digital signal and provided to the processor 1820. A magnetic field sensor can be employed to measure the thickness of the captured tissue. The measurement of the magnetic field sensor can also be converted to a digital signal and provided to the processor 1820.
The measurements of the tissue compression, the tissue thickness, and/or the force required to close the end effector on the tissue as measured by the sensors can be used by the controller 1840 to characterize the position and/or speed of the movable member being tracked. In at least one instance, a memory 1830 may store a technique, an equation, and/or a look-up table which can be employed by the controller 1840 in the assessment. In various instances, the controller 1840 can provide the user of the surgical instrument with a choice as to the manner in which the surgical instrument should be operated. To this end, the display 1440 can display a variety of operating conditions of the instrument and can include touch screen functionality for data input. Moreover, information displayed on the display 1440 may be overlaid with images acquired via the imaging modules of one or more endoscopes and/or one or more additional surgical instruments used during the surgical procedure.
As discussed above, the drive module 1100 of the handle 1000 and/or the shaft assemblies 2000, 3000, 4000, and/or 5000, for example, attachable thereto comprise control systems. Each of the control systems can comprise a circuit board having one or more processors and/or memory devices. Among other things, the control systems are configured to store sensor data, for example. They are also configured to store data which identifies the shaft assembly to the handle 1000. Moreover, they are also configured to store data including whether or not the shaft assembly has been previously used and/or how many times the shaft assembly has been used. This information can be obtained by the handle 1000 to assess whether or not the shaft assembly is suitable for use and/or has been used less than a predetermined number of times, for example.
A drive module 1100′ in accordance with at least one alternative embodiment is illustrated in
The actuator 1420′ is rotatable within a channel 1190′ defined in the housing 1110 in a first direction to rotate the end effector 7000 in the first direction and, similarly, in a second, or opposite, direction to rotate the end effector 7000 in the second direction. Similar to the drive module 1100, the drive module 1100′ comprises a sensor system in communication with the control system 1800 configured to detect the rotation of the actuator 1420′ about the longitudinal axis LA. In at least one instance, the sensor system comprises a first sensor 1422′ configured to detect the rotation of the actuator 1420′ about the longitudinal axis LA in the first direction (
Further to the above, the control system 1800 is configured to control the motor assembly 1600 and the clutch system 6000 to rotate the end effector 7000 about the longitudinal axis LA in the first direction when the actuator 1420′ is rotated about the longitudinal axis LA in the first direction. Similarly, the control system 1800 is configured to control the motor assembly 1600 and the clutch system 6000 to rotate the end effector 7000 about the longitudinal axis LA in the second direction when the actuator 1420′ is rotated about the longitudinal axis LA in the second direction. By associating the rotation of the end effector 7000 about the longitudinal axis LA with the rotation of the actuator 1420′ about the longitudinal axis LA, the clinician is provided with a system that is very intuitive to use.
As discussed above, the end effector 7000 is configured to rotate about a longitudinal axis within a socket defined in the distal attachment portion 2400 of the shaft assembly 2000. Depending on the amount of rotation desired, the end effector 7000 can be rotated less than 360 degrees or more than 360 degrees in either direction. In various instances, the end effector 7000 can be rotated through several rotations in either direction. In alternative embodiments, the rotation of the end effector 7000 about the longitudinal axis can be limited. In at least one embodiment, the shaft assembly 2000 comprises one or more stops which limit the rotation of the end effector 7000 to less than one rotation. In certain embodiments, the control system 1800 monitors the rotation of the drive shaft 1710, such as by an encoder and/or an absolute positioning sensor system, for example, and limits the rotation of the end effector 7000 by stopping or pausing the motor 1610 when the end effector 7000 has reached the end of its permitted range. In at least one instance, the control system 1800 can disengage the second clutch 6210 from the drive shaft 2730 to stop or pause the rotation of the end effector 7000 when the end effector 7000 has reached the end of its permitted range.
Further to the above, the drive module 1100′ and/or a shaft module attached to the drive module 1100′ can provide feedback to the clinician that the end effector 7000 has reached the end of its rotation. The drive module 1100′ and/or the shaft module attached thereto can comprise an indicator light 1427′, such as a red LED, for example, on a first side of the module housing 1110′ which is illuminated by the control system 1800 when the end effector 7000 has reached the end of its permitted rotation in the first direction, as illustrated in
In addition to or in lieu of the above, the drive module 1100′ and/or the shaft assembly attached thereto can comprise an annular series, or array, of indicator lights 1428′ extending around the perimeter thereof which is in communication with the control system 1800 and can indicate the rotational orientation of the end effector 7000. In at least one instance, the control system 1800 is configured to illuminate the particular indicator light which corresponds, or at least substantially corresponds, with the position in which the top of the end effector 7000 is oriented. In at least one instance, the center of the first jaw 7110 can be deemed the top of the end effector 7000, for example. In such instances, the illuminated light indicates the top-dead-center position of the end effector 7000. In other instances, the control system 1800 can illuminate the particular indicator light which corresponds, or at least substantially corresponds, with the position in which the bottom, or bottom-dead-center, of the end effector 7000 is oriented. In at least one instance, the center of the second jaw 7210 can be deemed the bottom of the end effector 7000, for example. As a result of the above, the illuminated indicator light can follow the rotation of the end effector 7000 around the array of indicator lights 1428′.
Further to the above, the actuator 1420′ is also rotatable, or tiltable, about a transverse axis TA within the housing channel 1190′. The sensor system of the drive module 1100′ is further configured to detect the rotation of the actuator 1420′ about the transverse axis TA in a first tilt direction and a second tilt direction. In at least one instance, the sensor system comprises a first tilt sensor 1423′ configured to detect the rotation of the actuator 1420′ about the longitudinal axis TA in the first tilt direction (
In various embodiments, further to the above, the entire actuator 1420′ comprises a magnetic ring of material which is detectable by the tilt sensors 1423′ and 1425′ of the drive module 1100′. In such embodiments, the rotation of the actuator 1420′ about the longitudinal axis LA would not create a compound motion relative to the tilt sensors when the actuator 1420′ is tilted. The magnetic ring of material can comprise a permanent magnet and/or can be comprised of iron and/or nickel, for example.
In any event, when the sensor system detects that the actuator 1420′ has been tilted in the first direction, as illustrated in
Further to the above, the actuator 1420′ comprises a biasing system configured to center the actuator 1420′ in its unrotated and untilted position. In various instances, the biasing system comprises first and second rotation springs configured to center the actuator 1420′ in its unrotated position and first and second tilt springs configured to center the actuator 1420′ in its untilted position. These springs can comprise torsion springs and/or linear displacement springs, for example.
As discussed above, the end effector 7000 rotates relative to the distal attachment portion 2400 of the shaft assembly 3000. Such an arrangement allows the end effector 7000 to be rotated without having to rotate the shaft assembly 3000, although embodiments are possible in which an end effector and shaft assembly rotate together. That said, by rotating the end effector 7000 relative to the shaft assembly 3000, all of the rotation of the surgical system occurs distally relative to the articulation joint 2300. Such an arrangement prevents a large sweep of the end effector 7000 when the end effector 7000 is articulated and then rotated. Moreover, the articulation joint 2300 does not rotate with the end effector 7000 and, as a result, the articulation axis of the articulation joint 2300 is unaffected by the rotation of the end effector 7000. In order to mimic this arrangement, the transverse axis TA does not rotate with the actuator 1420′; rather, the transverse axis TA remains stationary with respect to the drive module 1100′. That said, in alternative embodiments, the transverse axis TA can rotate, or track the end effector 7000, when the articulation joint rotates with the end effector. Such an arrangement can maintain an intuitive relationship between the motion of the actuator 1420′ and the motion of the end effector 7000.
Further to the above, the transverse axis TA is orthogonal, or at least substantially orthogonal, to the longitudinal axis LA. Similarly, the articulation axis of the articulation joint 2300 is orthogonal, or at least substantially orthogonal, to the longitudinal axis LA. As a result, the transverse axis TA is parallel to, or at least substantially parallel to, the articulation axis.
In various alternative embodiments, the tiltable actuator 1420′ is only used to control the articulation of the end effector 7000 and is not rotatable about the longitudinal axis LA. Rather, in such embodiments, the actuator 1420′ is only rotatable about the transverse axis TA. In at least one instance, the housing of the drive module 1100′ comprises two posts 1421′ (
In various instances, the drive module 1100 and/or the shaft assembly attached thereto can comprise a series, or array, of indicator lights 1438′ which is in communication with the control system 1800 and can indicate the articulation orientation of the end effector 7000. In at least one instance, the control system 1800 is configured to illuminate the particular indicator light which corresponds, or at least substantially corresponds, with the position in which the end effector 7000 is articulated. As a result of the above, the illuminated indicator light can follow the articulation of the end effector 7000. Such an array of indicator lights can assist a clinician in straightening the end effector 7000 before attempting to remove the end effector 7000 from a patient through a trocar. In various instances, an unstraightened end effector may not pass through a trocar and prevent the removable of the end effector from the patient.
A drive module 1100″ in accordance with at least one alternative embodiment is illustrated in
When the clutch 1730″ is in its unactuated position, as illustrated in
As surgical techniques continue to advance and develop, there is a need for specialized surgical instruments. With the advent of 3-D printing and additive manufacturing, new methods and techniques have been developed to produce specialized surgical instruments. Customized surgical instruments can allow a technician or surgeon to produce and use surgical instruments that are customized to a patient's physiological conditions or for a specific surgical procedure.
Out of an abundance of caution, many surgical instruments have become one-use devices to prevent the spread of contamination or diseases between patients. As surgical devices are becoming single patient and single-use devices, customizing the devices for the specific patient can allow for better results and faster recovery time for patients. As recovery time for patients is a substantial cost to the healthcare system, having customized surgical devices that allow surgeons to specifically target and resolve a patient's ailment can greatly reduce the overall healthcare spend.
Surgical instruments, such as surgical dissectors have been in widespread use in various surgical procedures. These instruments allow a surgeon to manipulate, separate, and remove specific areas of tissue of a patient. Having the ability to develop custom dissectors for specific surgical procedures and for a patient's physiological conditions can be of great value.
As different surgical procedures and patient conditions require different surgical instruments, the present disclosure relates to customized surgical devices, methods of producing customized devices, and means for producing customized surgical devices using various techniques, such as additive manufacturing and/or 3-D printing, for example.
In developing customized surgical devices, a surgeon can determine the specifics of the required device based upon the specific procedure, the general size of the patient, i.e., a child vs. an adult, or through scans and/or x-rays of the patient to determine the specific profile required for the surgical instrument.
When a surgeon is customizing a surgical instrument for a specific procedure, they may consult a directory of predefined surgical instrument shapes and configurations to determine which device may best suit the procedure at hand. Such procedures for the production of ultrasonic blades are discussed in U.S. Patent Application Publication No. 2018/0014844 A1 to Conlon, titled ULTRASONIC SURGICAL INSTRUMENT WITH AS HOC FORMED BLADE, the disclosure of which is incorporated by reference in its entirety.
Once the surgeon determines the desired device characteristics, the surgeon may take a base device, such as a end effector connector having a core or stub and use an additive manufacturing process to produce the selected end effector configuration. In addition, or in the alternative, a surgeon may use the size of a patient to determine the required size of the surgical instrument. The surgeon may use various physiological standards, such as the size of the patients hand, tibia, abdomen, or other physiological marker that can provide an adequate representation of the desired size of the surgical instrument. In addition, or in the alternative, the surgeon may conduct scans or x-rays of the patient to determine the specific size, shape, and characteristic of the surgical device needed to perform a desired procedure.
The first jaw portion 100006 of the end effector portion 100060 includes a core/stub portion 100010 that is adaptable through additive manufacturing techniques. The core/stub portion 100010 provides a base for building and customizing the geometry and characteristics of a customizable jaw 100012. Depending on various needs for the surgical procedure, the customizable jaw 100012 can be modified and adapted to meet the needs of the surgeon.
In certain embodiments, the surgical end effector 100000 can comprise a solid customizable region 100002. The solid customizable region 100002 can be made of various materials such as various metals and/or plastics, for example. When the surgeon determines the configuration required for the surgical procedure, the surgeon can use a manufacturing technique to remove the excess material to leave the desired shape of the customizable jaw 100012. In the alternative, the surgeon may start with a surgical end effector 100000 that does not have a core/stub portion 100100 and, instead, only has a standard connector portion 100050. With just the standard connector portion 100050, the surgeon can use a manufacturing process to create the desired shape and features of the customized jaw 100012 within the bounds of the customization region 100002.
In another embodiment, a surgical instrument may have a surgical end effector 100100, as illustrated in
The first jaw portion 100106 of the end effector portion 100160 includes a core/stub portion 100110 that is adaptable through additive manufacturing techniques. The core/stub portion 100110 provides a base for building and customizing the geometry and characteristics of a first customizable jaw 100112 and a second customizable jaw 100114. Depending on various needs for the surgical procedure, the first customizable jaw 100112 and the second customizable jaw 100114 can be modified and adapted to meet the needs of the surgeon. The first customizable jaw 100112 and the second customizable jaw 100114 have a plurality of proximal features 100118 and a plurality of distal features 100116. As illustrated in
In certain embodiments, the surgical end effector 100100 comprises a solid customized region 100102. The solid customizable region 100002 can be made of various materials such as various metals and/or plastics, for example. When the surgeon determines the configuration of the end effector 100100 required for the surgical procedure, the surgeon can use a manufacturing technique, such as grinding, wire EDMing, and/or polishing, for example, to remove the excess material to leave the desired shape of the customizable jaw 101012. In the alternative, the surgeon may start with a surgical end effector 100100 that only has a standard connector portion 100150. With just the standard connector portion 100150, the surgeon can use a manufacturing process to create the desired shape and features of the customized jaw 100112 within the bounds of the customization region 100102.
The customizable end effector portion 100260 can be customized within the customization region 100202, such that the diameter of the customization region 100202 is equal to or less than the diameter D of the shaft of the surgical instrument. With the customizable end effector portion 100260 being confined to the bounds of the customization region 100202, the surgical end effector 100200 can be inserted through a trocar into a patient's body cavity during minimally invasive surgical procedures.
The surgical end effector 100200 is illustrated as having various different customized jaw configurations 100212a-e. The various customized jaw configurations 100212a-e can be selected by a surgeon or clinician depending upon the type of procedure and a patient's physiological condition. The various customized jaw configurations 100212a-e can include different shape profiles, different diameters, different geometries, and can be comprised of various materials. In one embodiment, the various customized jaw configurations 100212a-e can be comprised of various plastics having different durometers and deformation characteristics. In another embodiment, the various customized jaw configurations 100212a-e can comprise metallic materials and materials having a greater rigidity. In addition, or in the alternative, the various customized jaw configurations 100212a-e can also comprise a combination of metallic and plastic materials to provide a desired characteristic to the surgical end effector 100200.
In certain embodiments, the various customized jaw configurations 100212a-e can have a metallic core with plastic and/or metal overlaid upon the core. The various materials used in the various customized jaw configurations 100212a-e can create end effectors meeting the needs of the surgeon, procedure, and/or patient.
The customizable end effector portion 100360 can be customized within the customization region 100302, such that, the diameter of the customization region 100302 is equal to or less than the diameter D of the shaft of the surgical instrument. With the customizable end effector portion 100360 being confined to the bounds of the customization region 100302, the surgical end effector 100300 can be inserted through a trocar into a patient's body cavity through minimally invasive surgical procedures.
The first jaw portion 100306 of the end effector portion 100360 includes a core/stub portion 100310 that is adaptable through additive manufacturing techniques. The core/stub portion 100310 provides a base for building and customizing the geometry and characteristics of a first customizable jaw 100312 and a second customizable jaw 100314. Depending on various needs for the surgical procedure, the first customizable jaw 100312 and the second customizable jaw 100314 can be modified and adapted to meet the needs of the surgeon. The first customizable jaw 100312 and the second customizable jaw 100314 have a plurality of proximal features 100318 and a plurality of distal features 100316. As illustrated in
The customizable end effector portion 100460 can be customized within the customization region 100402, such that the diameter of the customization region 100402 is equal to or less than the diameter D of the shaft of the surgical instrument. With the customizable end effector portion 100460 being confined to the bounds of the customization region 100402, the surgical end effector 100400 can be inserted through a trocar into a patient's body cavity through minimally invasive surgical procedures.
The first jaw portion 100406 of the end effector portion 100460 includes a core/stub portion 100410 that is adaptable through additive manufacturing techniques. The core/stub portion 100410 provides a base for building and customizing the geometry and characteristics of a first customizable jaw 100412 and a second customizable jaw 100414. Depending on various needs for the surgical procedure, the first customizable jaw 100412 and the second customizable jaw 100414 can be modified and adapted to meet the needs of the surgeon. The first customizable jaw 100412 and the second customizable jaw 100414 have a plurality of proximal features 100418 and a plurality of distal features 100416. As illustrated in
In addition, the first customizable jaw 100412 and the second customizable jaw 100414 have a plurality of features 100430 and 100432, respectively, that are positioned on the outer portion of the first and second customizable jaws 100412, 100414. As illustrated in
When selecting the configuration and various features for the surgical end effector 100400, the external features 100430, 100432, the proximal features 100418, the distal features 100416, the overall geometric shape of the first and second customizable jaws 100412, 100414, and the materials used in producing the customizable end effector portion 100460 are independent variables that are considered during the customization process. For example, when the surgical end effector 100400 is being customized for a minimally invasive surgical procedure, the various independent variables must result in an overall profile that falls within the customization region 100402 so that the surgical end effector 100400 can be inserted through a trocar and into a patient's body cavity.
The customizable end effector portion 100560 can be customized within a customization region 100502, such that the diameter of the customization region 100502 is equal to or less than the diameter D of the shaft of the surgical instrument. With the customizable end effector portion 100560 being confined to the bounds of the customization region 100502, the surgical end effector 100500 can be inserted through a trocar into a patient's body cavity through minimally invasive surgical procedures.
The customizable end effector portion 100560 can be produced through various additive manufacturing techniques to produce custom geometry and characteristics of a first customizable jaw 100512 and a second customizable jaw 100514. Depending on various needs for the surgical procedure, the first customizable jaw 100512 and the second customizable jaw 100514 can be modified and adapted to meet the needs of the surgeon. The first customizable jaw 100512 and the second customizable jaw 100514 have a plurality of proximal features 100518 and a plurality of distal features 100516. As illustrated in
The customizable end effector portion 100660 can be customized within a customization region 100602, such that the diameter of the customization region 100602 is equal to or less than the diameter D of the shaft of the surgical instrument. With the customizable end effector portion 100660 being confined to the bounds of the customization region 100602, the surgical end effector 100600 can be inserted through a trocar into a patient's body cavity through minimally invasive surgical procedures.
The customizable end effector portion 100660 can be produced through various additive manufacturing techniques to produce custom geometry and characteristics of a first customizable jaw 100612 and a second customizable jaw 100614. Depending on various needs for the surgical procedure, the first customizable jaw 100612 and the second customizable jaw 100614 can be modified and adapted to meet the needs of the surgeon. The first customizable jaw 100612 and the second customizable jaw 100614 have a plurality of proximal features 100618 and a plurality of distal features 100616. As illustrated in
The customizable end effector portion 100760 can be customized within a customization region 100702. The diameter of the customization region 100702 is equal to or less than the diameter D of the shaft of the surgical instrument. With the customizable end effector portion 100760 being confined to the bounds of the customization region 100702, the surgical end effector 100700 can be inserted through a trocar into a patient's body cavity through minimally invasive surgical procedures.
The customizable end effector portion 100760 can be produced through various additive manufacturing techniques to produce custom geometry and characteristics of a first customizable jaw 100712 and a second customizable jaw 100714. Depending on various requirements for the surgical procedure, the first customizable jaw 100712 and the second customizable jaw 100714 can be modified and adapted to meet the needs of the surgeon. The first customizable jaw 100712 and the second customizable jaw 100714 have a plurality of proximal features 100718 and a plurality of distal features 100716. As illustrated in
The customizable end effector portion 100860 can be customized within a customization region 100802, such that the diameter of the customization region 100802 is equal to or less than the diameter D of the shaft of the surgical instrument. With the customizable end effector portion 100860 being confined to the bounds of the customization region 100802, the surgical end effector 100800 can be inserted through a trocar into a patient's body cavity through minimally invasive surgical procedures.
The customizable end effector portion 100860 can be produced through various additive manufacturing techniques to produce custom geometry and characteristics of a first customizable jaw 100812 and a second customizable jaw 100814. Depending on various requirements for the surgical procedure, the first customizable jaw 100812 and the second customizable jaw 100814 can be modified and adapted to meet the needs of the surgeon. The first customizable jaw 100812 and the second customizable jaw 100814 have a plurality of proximal features 100818 and a plurality of distal features 100816. As illustrated in
The substantially smooth surface of low durometer material is only formed on a portion of the inner surfaces of the first customizable jaw 100812 and the second customizable jaw 100814. The substantially smooth surface can refer to a surface, for example, that is substantially free from projections or unevenness, generally flat or unruffled, and/or substantially of uniform consistency. In addition, the first customizable jaw 100812 and the second customizable jaw 100814 comprise external surface features 100830, 100832, respectively. As illustrated in
The customizable end effector portion 100960 can be customized within the customization region 100902. The diameter of the customization region 100902 is equal to or less than the diameter D of the shaft of the surgical instrument. With the customizable end effector portion 100960 being confined to the bounds of the customization region 100902, the surgical end effector 100900 can be inserted through a trocar into a patient's body cavity through minimally invasive surgical procedures.
The surgical end effector 100900 includes a core/stub portion 100910 that is adaptable through additive manufacturing techniques. The core/stub portion 100910 provides a base for building and customizing the geometry and characteristics of a first customizable jaw 100912 and a second customizable jaw 100914. Depending on various needs for the surgical procedure, the first customizable jaw 100912 and the second customizable jaw 100914 can be modified and adapted to meet the needs of the surgeon. The first customizable jaw 100912 and the second customizable jaw 100914 have a plurality of proximal features 100918 and a plurality of distal features 100916. As illustrated in
In addition, the first customizable jaw 100912 and the second customizable jaw 100914 have a plurality of features 100930 and 100932, respectively that are positioned on the outer portion of the first and second customizable jaws 100912, 100914. As illustrated in
When selecting the configuration and various features for the surgical end effector 100900, the external features 100930, 100932, the proximal features 100918, the distal features 100916, the overall geometric shape of the first and second customizable jaws 100912, 100914, and the materials used in producing the customizable end effector portion 100960 are independent variables that are considered during the customization process. For example, when the surgical end effector 100900 is being customized for a minimally invasive surgical procedure, the various independent variables must produce an overall profile of the surgical instrument that falls within the customization region 100902 so that the surgical end effector 100900 can be inserted through a trocar and into a patient's body cavity.
The customizable end effector portion 101060 can be customized within the customization region 101002. The diameter of the customization region 101002 is equal to or less than the diameter D of the shaft of the surgical instrument. With the customizable end effector portion 101060 being confined to the bounds of the customization region 101002, the surgical end effector 101000 can be inserted through a trocar into a patient's body cavity through minimally invasive surgical procedures.
The surgical end effector 101000 includes a core/stub portion 101010 that is adaptable through additive manufacturing techniques. The core/stub portion 101010 provides a base for building and customizing the geometry and characteristics of a first customizable jaw 101012 and a second customizable jaw 101014. Depending on various needs for the surgical procedure, the first customizable jaw 101012 and the second customizable jaw 101014 can be modified and adapted to meet the needs of the surgeon. The first customizable jaw 101012 and the second customizable jaw 101014 have a plurality of proximal features 101018 and a plurality of distal features 101016. As illustrated in
In addition, the first customizable jaw 101012 and the second customizable jaw 101014 have a plurality of features 101030a-d and 101032a-d, respectively that are positioned on the outer portion of the first and second customizable jaws 101012, 101014. As illustrated in
In addition, or in the alternative, various additional configurations for the features 101030a-d and 101032a-d are possible. The feature 101030a-d and 101032a-d can include ridges, and/or substantially smooth surfaces that allow the surgical end effector 101000 to engage, grasp, and/or manipulate an object, for example a patient's tissue.
When selecting the configuration and various features for the surgical end effector 101000, the external features 101030a-d, 101032a-d, the proximal features 101018, the distal features 101016, the overall geometric shape of the first and second customizable jaws 101012, 101014, and the materials used in producing the customizable end effector portion 101060 are independent variables that are considered during the customization process. For example, when the surgical end effector 101000 is being customized for a minimally invasive surgical procedure, the various independent variables must produce an overall profile that falls within the customization region 101002 so that the surgical end effector 101000 can be inserted through a trocar and into a patient's body cavity.
The various end effectors described above with respect to
The customized end effectors described above with respect to
When selecting the various attributes of the end effector, the clinician can use information gained from the patient or information about the particular procedure to guide their design of the end effector. When the clinician is using information regarding a particular patient, for example, the patient's information can come from various patient tests, such as MRIs, X-rays, CT Scans, and/or other medical tests. These testing results can be entered into the computer and used to control the design parameters of the end effector. When the clinician uses the results of an MRI, for example, to detect a patient's tumor, the size and shape of the patient's tumor can be used as design parameters when producing the customized end effector.
In addition, or in the alternative, the clinician can use parameters from the particular surgical procedure to design the customized end effector. When the end effector is being designed for various bariatric procedures, for example, the requirements of the specific procedure, such as the size of a gastric bypass reduction, can be used as the design parameters when producing the customized end effector.
In selecting the various features for the end effector, the clinician can use various software programs to design the desired features of the end effector. The clinician, for example, can input the patient's scans and/or medical test information into the computer and a software program can determine the design features of the end effector to match the patient's condition. Once the software program approximates the necessary features of the end effector, the clinician can review and/or modify the parameters of the end effector using the human-machine interface.
In addition, or in the alternative, the clinician can access a software program using the human-machine interface to design the features of the end effector. The clinician, for example, can access the software program and select various predetermined shapes, features, and/or designs to combine to produce an end effector having the desired features. The clinician may also use a free-form command in the software to freely design the desired features of the end effector.
Once the features of the customized end effector are determined, the clinician and/or manufacturing staff can insert a core/stub portion into a manufacturing device. The manufacturing device is in communication with the human-machine interface of the computer via a wired, wireless, and/or remote internet connection. The clinician, using the software program, can send the design parameters to the manufacturing device to produce the end effector.
The manufacturing device can be designed to use various manufacturing processes or techniques. The manufacturing device, for example, can be a metal injection molding device, a plastic injection molding device, a CNC machine, an EDM device, a 3-D printing device, and/or various other manufacturing devices, such as additive manufacturing devices.
After the design parameters are transferred from the computer to the manufacturing device, the software controlling the manufacturing device causes the manufacturing device to perform a manufacturing procedure to produce the customized end effector. The manufacture procedure can add material to the core/stub portion of the end effector. In the alternative, the manufacturing procedure can remove material from the core/stub portion of the end effector. The manufacturing device can use one or more of the techniques described above in the production of the customized end effector. Once the manufacturing device has completed the overall design and structure of the customized end effector, the customized end effector can be finished or polished using a finishing machine and/or process. The finishing machine may be part of the manufacturing device, or it can be a separate machine/device.
Once the structure of the customized end effector is completed, the customized end effector can be tested, cleaned, and/or sterilized. The testing process can ensure that the customized end effector is designed to the necessary standards for the particular medical device. The cleaning process can remove any excess residual material leftover from the manufacturing process. The sterilization process can sterilize the end effector so that it can be used in a surgical procedure. After the customized end effector is sterilized, it can be packaged for storing until it is needed in a surgical procedure or can be used directly by a clinician in a surgical procedure.
A method for producing a customized end effector comprises preparing an end effector connection portion for customization. The end effector connection portion comprises a proximal connector configured to attach to a distal end of a surgical instrument. The proximal connector comprises an actuator. Once a standard connection portion is prepared, the user determines through interaction with a patient a first desired characteristic of the surgical end effector and a second desired characteristic of the end effector. Once the characteristics of the end effector are determined, a first jaw member is created on the standard connection portion having the first desired characteristic. Next, a second jaw member is created on the standard connection portion having the second desired characteristic. The first and second jaw members can be created through an additive manufacturing process, such as 3-D printing.
Surgical instruments can comprise devices that use mechanical energy to perform surgical procedures. Certain end effectors, such as grasping forceps can be used to grasp a target, such as the tissue of a patient, for example. Other end effectors, such as dissectors, for example, can be used to separate and/or tear the tissue using mechanical forces. Other types of end effectors, such as electrosurgical end effectors, for example, can use electrosurgical energy to deliver energy to the tissue of a patient and destroy and/or remove targeted tissue. These types of surgical instruments have been used independently of one another.
Surgical dissectors, such as the dissectors disclosed in U.S. Patent Application Publication No. 2010/0198248, entitled SURGICAL DISSECTOR, the disclosure of which is incorporated by reference in its entirety, for example, use mechanical forces and mechanical features on the jaws of the dissector, such as teeth, for example, to manipulate a patient's tissue. The teeth can be used to stretch and/or tear a patient's tissue. Depending on the type and/or amount of tissue that a mechanical dissector encounters, the mechanical dissector can apply various amounts of mechanical force to the tissue.
Surgical dissectors comprise a pair of jaws that are rotatable between open and closed positions. Each jaw can comprise a plurality of features, such as teeth or ridges that can engage a patient's tissue on inner and/or outer surfaces of the jaw, for example. The features, such as teeth, on the inner surfaces of a pair of surgical dissector jaws can be used to gasp and/or manipulate tissue when the jaws are closed upon a portion of the patient's tissue. In addition, or in the alternative, when a pair of surgical dissector jaws comprise teeth and/or ridges on outer surfaces thereof, such teeth can increase the traction and interaction between the jaws and the patient's tissue when the jaws are moved into an open position, for example. As the pair of surgical dissector jaws are opened, the teeth on the outer surfaces of the jaws can grip, stretch, and/or tear the tissue.
Electrosurgical devices for applying electrical energy to tissue in order to treat and/or destroy the tissue are finding increasingly widespread applications in surgical procedures. An electrosurgical device typically includes a handpiece and an instrument having a distally-mounted end effector (e.g., one or more electrodes). The end effector can be positioned against the tissue such that electrical current is introduced into the tissue. Electrosurgical devices can be configured for bipolar and/or monopolar operation. During bipolar operation, current is introduced into and returned from the tissue by active and return electrodes, respectively, of the end effector. During monopolar operation, current is introduced into the tissue by an active electrode of the end effector and returned through a return electrode (e.g., a grounding pad) separately located on a patient's body. Heat generated by the current flowing through the tissue may form hemostatic seals within the tissue and/or between tissues and thus may be particularly useful for sealing blood vessels, for example. In some instances, the voltage and current used ablates the tissue. The end effector of an electrosurgical device also may include a cutting member that is movable relative to the tissue and the electrodes to transect the tissue.
Electrical energy applied by an electrosurgical device can be transmitted to the instrument by a generator in communication with the handpiece. The electrical energy may be in the form of radio frequency (RF) energy that may be in a frequency range described in EN 60601-2-2:2009+A11:2011, Definition 201.3.218—HIGH FREQUENCY, the entire disclosure of which is incorporated by reference. In certain instances, the frequencies in monopolar RF applications are typically restricted to less than 5 MHz, for example. However, in bipolar RF applications, the frequency can be any suitable frequency. Frequencies above 200 kHz can be typically used for monopolar applications in order to avoid the unwanted stimulation of nerves and muscles which would result from the use of low frequency current, for instance. Lower frequencies may be used for bipolar techniques if the risk analysis shows the possibility of neuromuscular stimulation has been mitigated to an acceptable level. Normally, frequencies above 5 MHz are not used in order to minimize the problems associated with high frequency leakage currents. However, higher frequencies may be used in the case of bipolar techniques. In many instances, a minimum of 10 mA is needed to create thermal effects within the tissue.
In application, an electrosurgical device can transmit low frequency RF energy through tissue, which causes ionic agitation, or friction—in effect resistive heating—thereby increasing the temperature of the affected tissue. Because a sharp boundary is created between the affected tissue and the surrounding tissue, a surgeon can operate with a high level of precision and control without sacrificing un-targeted adjacent tissue. The low operating temperatures of RF energy is useful for removing, shrinking, and/or sculpting soft tissue while simultaneously sealing blood vessels. RF energy works particularly well on connective tissue, which is primarily comprised of collagen and shrinks when contacted by heat.
Other electrical surgical instruments include, without limitation, irreversible and/or reversible electroporation, and/or microwave technologies, among others. The techniques disclosed herein are applicable to ultrasonic, bipolar or monopolar RF (electrosurgical), irreversible and/or reversible electroporation, and/or microwave-based surgical instruments, among others. U.S. Patent Application Publication No. 2017/0086914 A1, to Wiener, et al., titled TECHNIQUES FOR OPERATING GENERATOR FOR DIGITALLY GENERATING ELECTRICAL SIGNAL WAVEFORMS AND SURGICAL INSTRUMENTS provides examples of electrosurgical instruments and electrosurgical generators that can be used with the instruments described herein, the disclosure of which is incorporated by reference in its entirety.
The embodiments disclosed in
The frame 101102 of the surgical end effector jaw 101100 comprises a socket 101104. When the end effector jaw 101100 is used in a pair of jaws of a surgical instrument, the sockets 101104 of the two end effector jaws 101100 are aligned and a pin can be inserted through the sockets 101104. The pair of end effector jaws 101100 can be rotated about the pin between open and closed positions. The surgical instrument can also comprise an actuator that can move the end effector jaws 101100 between open and closed positions.
The surgical end effector jaw 101100 comprises a proximal portion 101106 and a distal portion 101110. The overall geometry of the end effector jaw 101100 is curved between the proximal portion 101106 and the distal portion 101110. In addition, the end effector jaw 101100 is tapered from the wider proximal portion 101106 to the narrower distal portion 101110. The tapered profile of the end effector jaw 101100 can permit a surgeon to target a specific location within a patient.
In addition, or in the alternative, the surgical end effector jaw 101100 can comprise other geometries, such as a symmetrical geometry and/or and a tapered geometry with a larger distal portion 101110 and a narrower proximal portion 101106, for example. When the surgical end effector jaw 101100 comprises a symmetrical profile, the surgical end effector jaw 101100 can grasp a patient's tissue evenly over the entire end effector jaw 101100. When the surgical end effector jaw 101100 comprises a tapered geometry with a larger distal portion 101110 and a narrower proximal portion 101106, the larger distal portion 101110 can allow the surgical end effector 101100 to grasp a larger portion of the patient's tissue.
The proximal portion 101106 of the outer surface 101108 comprises a substantially smooth surface. The substantially smooth surface can refer to a surface, for example, that is substantially free from projections or unevenness, generally flat or unruffled, and/or substantially of uniform consistency. The distal portion 101110 of the outer surface 101108 comprises a plurality of features. The plurality of features comprises central features 101120, peripheral features 101122, and lateral features 101132, and/or any other suitable features.
The central features 101120, peripheral features 101122, and lateral features 101132 comprise ridges, or teeth, but could comprise any suitable configuration. The central features 101120, peripheral features 101122, and lateral features 101132 can be comprised of various materials. The central, peripheral, and/or lateral features 101120, 101122, 101132 can be comprised of a first material and the outer surface 101108 of the end effector jaw 101100 can be comprised of a second material. The first material can have a greater elasticity than the second material. The second material can have a greater rigidity than the first material. With a less rigid and more elastic material, the central, peripheral, and/or lateral features 101120, 101122, 101132 can deform against a target, such as a patient's tissue, and increase the traction and interaction between the surgical end effector jaw 101100 and the target object.
The plurality of central features 101120 can be substantially perpendicular to the chord of the arc of the jaw 101108. The plurality of central features 101120 are raised above the outer surface of the jaw 101108. In addition, the central features 101120 can be overlaid or overmolded with the lateral features 101132 that can be positioned along the jaw 101108. The lateral features 101132 can be comprised of a different material having a different rigidity and elasticity. For instance, the lateral features 101132 can be more elastic and/or have greater compliance than the central features 101120 which can allow the lateral features 101132 to have a greater ability to interact with a target, such as a patient's tissue. The plurality of central features 101120 can have a slight concavity with respect to the proximal portion 101106 of the end effector jaw 101100, for example. The plurality of peripheral features 101122 can include a convex shape with respect to the proximal portion 101106 of the end effector jaw 101100, for example. The convex-concave-convex pattern of the peripheral-central-peripheral feature combination can allow for greater interaction with a target, such as a patient's tissue.
Where the central features 101120 are aligned substantially perpendicular to the chord of the arc on the surgical end effector jaw 101100, the central features 101120 can facilitate a desired interaction with a patient's tissue. This configuration may allow the surgical end effector jaw 101100 to be drawn through the tissue plane and create a parting action of the tissue. Furthermore, where the patterns of the central features 101120 at the tip of the surgical instrument are aligned with the chord of the arc of the surgical end effector jaw 101100, this pattern facilitates the lateral movement of the surgical end effector jaw 101100 to create a tissue parting action.
The central, peripheral, and lateral features 101120, 101122, 101132 of the end effector jaw 101100 can include symmetrical or asymmetrical patterns that extend along the end effector jaw 101100. The patterns of the central, peripheral, and/or lateral features 101120, 101122, 101132 can be continuous or interlocking and become more interrupted and staggered as they extend towards the proximal portion 101106 and/or distal portion 101110 of the end effector jaw 101100. The various configurations of the central, peripheral, and lateral features 101120, 101122, 101132 can result in posts or standing pillars that can enhance the interaction of these features with the target object, such as a patient's tissue.
The central, peripheral, and lateral features 101120, 101122, 101132 can comprise overmolded plastic and/or polymers. The central, peripheral, and lateral features 101120, 101122, 101132 can comprise various polymers or plastics having different densities and/or properties. A first layer of plastic may be overmolded onto portions of the metallic core 101130 of the end effector jaw 101100. The first layer of plastic can have a first density, rigidity, and elasticity. A second layer of plastic may be overmolded onto portions of the first layer of overmolded plastic and/or onto portions of the metallic core 101130. The second layer of plastic can have a second density, rigidity, and elasticity. The first density, rigidity, and/or elasticity can be the same or different than the second density, rigidity and/or elasticity.
Various sections of the covering 101126 can comprise overmolded plastic and/or polymers. The various sections of the covering 101126 can comprise various polymers or plastics having different densities and/or properties. A first layer of plastics may be overmolded onto portions of the metallic core 101130 of the end effector jaw 101100. The first layer of plastic can have a first density, rigidity, and elasticity. A second layer of plastic may be overmolded onto portions of the first layer of overmolded plastic and/or onto portions of the metallic core 101130. The second layer of plastic can have a second density, rigidity, and elasticity. The first density, rigidity, and/or elasticity can be the same or different than the second density, rigidity and/or elasticity.
In one embodiment, the first layer can comprise a rigid layer that can provide a structural support or backbone to the end effector jaw 101100 along with the metallic core 101130. The second layer can comprise a more elastic and/or less rigid layer. The second layer can be more deformable to create a tissue interaction outer surface that allows for grasping and securing the tissue. The first layer that is more rigid can have a sharper profile and edges that can maintain its shape and actively shear tissue while the outer softer layer acts more like a bumper to prevent cutting tissue before the surgical end effector jaw 101100 is engaged with the desired location or section of tissue.
The inner surface 101118 of the end effector jaw 101100 comprises a plurality of teeth 101116 that extend between the proximal portion 101106 and the distal portion 101110 of the end effector jaw 101100. The plurality of teeth 101116 extend across the width of the inner surface 101118 and follow the tapered profile of the end effector jaw 101100. The central portion of the plurality of teeth 101116 comprises an exposed section of the metallic core 101130. The exposed section of the metallic core 101130 extends substantially uniformly down the central portion of the plurality of teeth 10116 between the proximal portion 101106 and the distal portion 101110. In the alternative, the metallic core 101130 can extend to the inner surface 101118 of the end effector jaw 101100, for example, in an asymmetrical pattern. The different exposed patterns of the metallic core 101130 can allow the end effector jaw 101100 to transmit electrosurgical energy to a patient's tissue in different ways, as described in greater detail below.
When a patient's tissue comes in contact with the metallic core 101130, a surgeon can apply electrosurgical energy to the targeted tissue through the metallic core 101130. The electrosurgical energy can cause ablation and/or cauterization of the targeted tissue.
The distal most portion of the inner surface 101118 comprises a distal bumper portion 101124 and a distal tip 101128. The distal bumper portion 101124 comprises an elastic and/or deformable material that can allow the end effector jaw 101100 to interact with a target object with less irritation to the object. The distal tip 101128 comprises the metallic core 101130 and is configured to deliver electrosurgical energy to a target object, such as a patient's tissue. The distal bumper portion 101124 being constructed of a more elastic and less rigid material can allow the user of the surgical end effector jaw 101100 to be more aggressive without increasing the irritation of the target object, such as a patient's tissue.
In addition, or in the alternative, the various polymers and/or plastics that comprise the surgical end effector jaw 101100 may comprise hydrophobic plastic or materials. The hydrophobic materials can repel liquid, such as body fluids and/or water to keep the dissection features free to dissect. In addition, by repelling fluids, the hydrophobic material may allow a user greater visibility of the interaction portions of the device when using the device in a minimally invasive procedure. The hydrophobic materials may also allow for a consistent dissection surface during the use of the surgical instrument by repelling and keeping away the fluids from the interaction site.
The frame 101202 of the surgical end effector jaw 101200 comprises a socket 101204. When the end effector jaw 101200 is used in a pair of jaws of a surgical instrument, the sockets 101204 of the two end effector jaws 101200 are aligned and a pin can be inserted through the sockets 101204. The pair of end effector jaws 101200 can be rotated about the pin between open and closed positions. The surgical instrument can also comprise an actuator that can move the end effector jaws 101200 between open and closed positions.
The surgical end effector jaw 101200 comprises a proximal portion 101206 and a distal portion 101210. The overall geometry of the end effector jaw 101200 is curved between the proximal portion 101206 and the distal portion 101210. In addition, the end effector jaw 101200 is tapered from the wider proximal portion 101206 to the narrower distal portion 101210. The tapered profile of the end effector jaw 101200 can permit a surgeon to target a specific location within a patient.
In addition, or in the alternative, the surgical end effector jaw 101200 can comprise other geometries, such as a symmetrical geometry and/or and a tapered geometry with a larger distal portion 101210 and a narrower proximal portion 101206, for example. When the surgical end effector jaw 101200 comprises a symmetrical profile, the surgical end effector jaw 101200 can grasp a patient's tissue evenly over the entire end effector jaw 101200. When the surgical end effector jaw 101200 comprises a tapered geometry with a larger distal portion 101210 and a narrower proximal portion 101206, the larger distal portion 101210 can allow the surgical end effector 101200 to grasp a larger portion of the patient's tissue.
The proximal portion 101206 of the outer surface 101208 comprises a substantially smooth surface. The substantially smooth surface can refer to a surface, for example, that is substantially free from projections or unevenness, generally flat or unruffled, and/or substantially of uniform consistency. The distal portion 101210 of the outer surface 101208 comprises a plurality of features. The plurality of features comprises central features 101220, peripheral features 101222, and lateral features 101232, and/or any other suitable features.
The central features 101220, peripheral features 101222, and lateral features 101232 comprise recesses or through holes, but could comprise any suitable configuration. The recesses or through holes expose the metallic core 101230 to the outer surface 101208 and patient tissue. The central features 101220, peripheral features 101122, and lateral features 101232 can comprise different diameters and/or depths, or the same diameters and/or depths. The central features 101220, peripheral features 101122, and lateral features 101232 can also comprise different patterns and/or orientations along the outer surface 101208 of the surgical end effector jaw 101200.
The central features 101220, peripheral features 101222, and lateral features 101232 allow a patient's tissue to come in contact with the metallic core 101230 of the surgical end effector jaw 101200. When a pair of end effector jaws 101200 is used to stretch out tissue, the mechanical forces used to stretch out the tissue can cause the tissue to flow into the central features 101220, peripheral features 101222, and/or lateral features 101232. Once the tissue is in contact with the metallic core 101230 within the central features 101220, peripheral features 101222, and/or lateral features 101232, a clinician can apply electrosurgical energy to the tissue. The combination of mechanical force and electrosurgical energy can allow for ablation of the tissue without tearing the tissue. In addition, or in the alternative, the electrosurgical energy can allow the end effector jaws 101200 to cauterize the tissue as the tissue is spread and/or torn. The combination of electrosurgical energy and mechanical forces can allow a surgeon to perform a surgical procedure with using less mechanical force as the effects of the electrosurgical energy and mechanical force are cumulative.
In various instances, less mechanical force, for example, is required to dissect tissue when more electrosurgical energy is applied. Correspondingly, more mechanical force is required to dissect tissue when less electrosurgical energy is applied. That said, the ratio of mechanical force to electrosurgical energy can be held constant throughout the opening stroke of the dissector jaws. In other instances, the ratio of mechanical force to electrosurgical energy can change throughout the opening stroke of the dissector jaws. In at lease one instance, the electrosurgical energy can increase as the dissector jaws are opened. Such an arrangement can apply the electrosurgical energy when tissue tearing and/or bleeding is most likely to occur. In other instances, the electrosurgical energy can decrease as the dissector jaws are opened. Such an arrangement can create or start an initial otomy that then is stretched open by the mechanical force.
The inner surface 101218 of the end effector jaw 101200 comprises a plurality of teeth 101216 that extend between the proximal portion 101206 and the distal portion 101210 of the end effector jaw 101200. The plurality of teeth 101216 extend across the width of the inner surface 101218 and follow the tapered profile of the end effector jaw 101200. The central portion of the plurality of teeth 101216 comprises an exposed section of the metallic core 101230. The exposed section of the metallic core 101230 extends substantially uniformly down the central portion of the plurality of teeth 10126 between the proximal portion 101206 and the distal portion 101210. In the alternative, the metallic core 101230 can extend to the inner surface 101218 of the end effector jaw 101200, for example, in an asymmetrical pattern. The different exposed patterns of the metallic core 101230 can allow the end effector jaw 101200 to transmit electrosurgical energy to a patient's tissue in different ways, as described in greater detail below.
When a patient's tissue comes in contact with the metallic core 101230, a surgeon can apply electrosurgical energy to the targeted tissue through the metallic core 101230. The electrosurgical energy can cause ablation and/or cauterization of the targeted tissue.
The distal most portion of the inner surface 101218 comprises a distal bumper portion 101224 and a distal tip 101228. The distal bumper portion 101224 comprises an elastic and/or deformable material that can allow the end effector jaw 101200 to interact with a target object with less irritation to the object. The distal tip 101228 comprises the metallic core 101230 and is configured to deliver electrosurgical energy to a target object, such as a patient's tissue. The distal bumper portion 101224 being constructed of a more elastic and less rigid material can allow the user of the surgical end effector jaw 101200 to be more aggressive without increasing the irritation of the target object, such as a patient's tissue.
Various sections of the covering 101226 can comprise overmolded plastic and/or polymers. The various sections of the covering 101226 can comprise various polymers or plastics having different densities and/or properties. A first layer of plastics may be overmolded onto portions of the metallic core 101230 of the end effector jaw 101200. The first layer of plastic can have a first density, rigidity, and elasticity. A second layer of plastic may be overmolded onto portions of the first layer of overmolded plastic and/or onto portions of the metallic core 101230. The second layer of plastic can have a second density, rigidity, and elasticity. The first density, rigidity, and/or elasticity can be the same or different than the second density, rigidity and/or elasticity.
In addition, or in the alternative, the various polymers and/or plastics that comprise the surgical end effector jaw 101200 may comprise hydrophobic plastic or materials. The hydrophobic materials can repel liquid, such as body fluids and/or water to keep the dissection features free to dissect. In addition, by repelling fluids, the hydrophobic material may allow a user greater visibility of the interaction portions of the device when using the device in a minimally invasive procedure. The hydrophobic materials may also allow for a consistent dissection surface during the use of the surgical instrument by repelling and keeping away the fluids from the interaction site.
The central distal feature 101336 and lateral distal features 101334 allow a patient's tissue to come in contact with the metallic core 101330 of the surgical end effector jaw 101300. When a surgeon pushes tissue with the nose of the surgical end effector jaw 101300, the mechanical forces used to push the jaw 101300 into the tissue to stretch out the tissue can cause the tissue to flow into the central distal feature 101336 and lateral distal features 101334. Once the tissue is in contact with the metallic core 101330 within the central distal feature 101336 and/or lateral distal features 101334, electrosurgical energy can be transmitted to the tissue. The combination of mechanical force and electrosurgical energy can allow for ablation of the tissue without tearing the tissue. In addition, or in the alternative, the electrosurgical energy can allow the end effector jaws 101300 to cauterize the tissue as the tissue is spread and/or torn. The combination of electrosurgical energy and mechanical forces can allow a surgeon to perform a surgical procedure with using less mechanical force as the effects of the electrosurgical energy and mechanical force are cumulative.
In various instances, less mechanical force, for example, is required to dissect tissue when more electrosurgical energy is applied. Correspondingly, more mechanical force is required to dissect tissue when less electrosurgical energy is applied. That said, the ratio of mechanical force to electrosurgical energy can be held constant throughout the opening stroke of the dissector jaws. In other instances, the ratio of mechanical force to electrosurgical energy can change throughout the opening stroke of the dissector jaws. In at lease one instance, the electrosurgical energy can increase as the dissector jaws are opened. Such an arrangement can apply the electrosurgical energy when tissue tearing and/or bleeding is most likely to occur. In other instances, the electrosurgical energy can decrease as the dissector jaws are opened. Such an arrangement can create or start an initial otomy that then is stretched open by the mechanical force.
The surgical end effector jaws may also have overmolded plastic bodies having fractal exterior geometries. The fractal exterior geometries can enable the distal tip of the end effector jaws to be more aggressive without creating undesired interaction with the tissue. In another embodiment, the metallic core of the end effector jaws can be positioned near the outer surface and at the distal tip as well as along the spine of the surgical end effector, as seen in
The various features and characteristics described with regard to the surgical instruments and end effectors illustrated in
In one embodiment, the first layer can comprise a rigid layer that can provide a structural support or backbone to the end effector. The second layer can comprise a more elastic and less rigid layer. The second layer can be more deformable to create a tissue interaction outer surface that allows for grasping and securing the tissue. The first layer that is more rigid can have a sharper profile and edges that can maintain its shape and actively shear tissue while the outer softer layer acts more like a bumper to prevent cutting tissue before the surgical end effector is engaged with the desired portion or section of tissue.
The surgical instruments illustrated in
As discussed above, with regard to
During the initial force loading condition 101412, the current delivered to the tissue 101402, the voltage to current ratio 101404, and the impedance of the tissue being treated 101406 initially increase. Over the initial force loading condition 101412, the current delivered to the tissue 101402 and the voltage to current ratio 101404 continue to increase while the impedance of the tissue being treated 101406 decreases and then levels out. The mechanical force being applied to the tissue 101408 also increases over the initial force loading condition 101412. As the mechanical force being applied to the tissue 101408 increase, the surgical end effector jaws begin to push layers of the tissue away.
Once the initial force loading condition 101412 is completed, the tissue spreading condition 101414 occurs. Over a first stage of the tissue spreading condition 101414, the current delivered to the tissue 101402 and the impedance of the tissue being treated 101406 remain relatively steady while the voltage to current ratio 101404 fluctuates. In addition, over the first stage of the tissue spreading condition 101414, the mechanical force being applied to the tissue 101408 increases and begins to exceed a higher reinforcement threshold. When the higher reinforcement threshold is exceeded, the current delivered to the tissue 101402 and the voltage to current ratio 101404 are increased to reinforce the tissue spreading, which in turn reduces the impedance of the tissue being treated 101406. The mechanical force being applied to the tissue 101408 by the end effector jaws drop due to the assistance of the electrosurgical energy, as such, the levels for the current delivered to the tissue 101402 and the voltage to current ratio 101404 are reduced. When the mechanical force being applied to the tissue 101408 falls below a lower reinforcement threshold, the current delivered to the tissue 101402 and the voltage to current ratio 101404 are reduced as the need for reinforcement assistance from the electrosurgical aspects of the surgical instrument are reduced. Once the mechanical force being applied to the tissue 101408 climbs above the lower reinforcement threshold, the current delivered to the tissue 101402 and the voltage to current ratio 101404 return to their previous levels.
After the tissue spreading condition 101414 occurs, the mechanical forces and electrosurgical energy being applied are reduced as represented by the unloading condition 101416. During the force unloading condition 101416, the current delivered to the tissue 101402, the voltage to current ratio 101404, the impedance of the tissue being treated 101406, and the mechanical force being applied to the tissue 101408 are all reduced to the initial unloaded condition. The combination of the mechanical force being applied to the tissue 101408 and electrosurgical energy allows the surgical instrument to perform the surgical procedure using less mechanical energy which can result in less tearing of the tissue. The application of the electrosurgical energy can also seal the tissue as it is being separated by the opening of the end effector jaws.
To detect the various threshold levels, discussed above, a surgical instrument may have sensors to monitor the pressures, currents, voltages, impedance of the tissue, and forces applied during a surgical procedure and modify the parameters to prevent any of the threshold from being exceeded. In addition, or in the alternative, a surgeon may be provided with tactical feedback regarding the parameters and manually control the various parameters.
A surgical system 128000 is illustrated in
Referring again to
Further to the above, the jaws of the end effector 128030 are driven by a jaw drive system including an electric motor. In use, a voltage potential is applied to the electric motor to rotate the drive shaft of the electric motor and drive the jaw drive system. The surgical system 128000 comprises a motor control system configured to apply the voltage potential to the electric motor. In at least one instance, the motor control system is configured to apply a constant DC voltage potential to the electric motor. In such instances, the electric motor will run at a constant speed, or an at least substantially constant speed. In various instances, the motor control system comprises a pulse width modulation (PWM) circuit and/or a frequency modulation (FM) circuit which can apply voltage pulses to the electric motor. The PWM and/or FM circuits can control the speed of the electric motor by controlling the frequency of the voltage pulses supplied to the electric motor, the duration of the voltage pulses supplied to the electric motor, and/or the duration between the voltage pulses supplied to the electric motor.
The motor control system is also configured to monitor the current drawn by the electric motor as a means for monitoring the force being applied by the jaws of the end effector 128030. When the current being drawn by the electric motor is low, the loading force on the jaws is low. Correspondingly, the loading force on the jaws is high when the current being drawn by the electric motor is high. In various instances, the voltage being applied to the electric motor is fixed, or held constant, and the motor current is permitted to fluctuate as a function of the force loading at the jaws. In certain instances, the motor control system is configured to limit the current drawn by the electric motor to limit the force that can be applied by the jaws. In at least one embodiment, the motor control system can include a current regulation circuit that holds constant, or at least substantially constant, the current drawn by the electric motor to maintain a constant loading force at the jaws.
The force generated between the jaws of the end effector 128030, and/or on the jaws of the end effector 128030, may be different depending on the task that the jaws are being used to perform. For instance, the force needed to hold a suture needle may be high as suture needles are typically small and it is possible that a suture needle may slip during use. As such, the jaws of the end effector 128030 are often used to generate large forces when the jaws are close together. On the other hand, the jaws of the end effector 128030 are often used to apply smaller forces when the jaws are positioned further apart to perform larger, or gross, tissue manipulation, for example.
Referring to the upper portion 128110 of the graph 128100 illustrated in
Referring again to
In addition to or in lieu of the above, the speed of the jaws 128040 and 128050 can be controlled and/or limited by the motor control system as a function of the mouth opening size between the jaws 128040 and 128050 and/or the direction the jaws are being moved. Referring to the middle portion 128120 and lower portion 128130 of the graph 128100 in
In various instances, further to the above, the handle of the surgical system 128000 comprises an actuator, the motion of which tracks, or is supposed to track, the motion of the jaws 128040 and 128050 of the end effector 128030. For instance, the actuator can comprise a scissors-grip configuration which is openable and closable to mimic the opening and closing of the end effector jaws 128040 and 128050. The control system of the surgical system 128000 can comprise one or more sensor systems configured to monitor the state of the end effector jaws 128040 and 128050 and the state of the handle actuator and, if there is a discrepancy between the two states, the control system can take a corrective action once the discrepancy exceeds a threshold and/or threshold range. In at least one instance, the control system can provide feedback, such as audio, tactile, and/or haptic feedback, for example, to the clinician that the discrepancy exists and/or provide the degree of discrepancy to the clinician. In such instances, the clinician can make mental compensations for this discrepancy. In addition to or in lieu of the above, the control system can adapt its control program of the jaws 128040 and 128050 to match the motion of the actuator. In at least one instance, the control system can monitor the loading force being applied to the jaws and align the closed position of the actuator with the position of the jaws when the jaws experience the peak force loading condition when grasping tissue. Similarly, the control system can align the open position of the actuator with the position of the jaws when the jaws experience the minimum force loading condition when grasping tissue. In various instances, the control system is configured to provide the clinician with a control to override these adjustments and allow the clinician to use their own discretion in using the surgical system 128000 in an appropriate manner.
A surgical system 128700 is illustrated in
As discussed above, the end effector 128730 comprises two scissor jaws 128740 and 128750 movable between an open position and a closed position to cut the tissue of a patient. The jaw 128740 comprises a sharp distal end 128741 and the jaw 128750 comprises a sharp distal end 128751 which are configured to snip the tissue of the patient at the mouth 128731 of the end effector 128730, for example. That said, other embodiments are envisioned in which the distal ends 128741 and 128751 are blunt and can be used to dissect tissue, for example. In any event, the jaws are driven by a jaw drive system including an electric drive motor, the speed of which is adjustable to adjust the closure rate and/or opening rate of the jaws. Referring to the graph 128400 of
The above-provided discussion with respect to the surgical system 128700 can provide mechanical energy or a mechanical cutting force to the tissue of a patient. That said, the surgical system 128700 is also configured to provide electrosurgical energy or an electrosurgical cutting force to the tissue of a patient. In various instances, the electrosurgical energy comprises RF energy, for example; however, electrosurgical energy could be supplied to the patient tissue at any suitable frequency. In addition to or in lieu of AC power, the surgical system 128700 can be configured to supply DC power to the patient tissue. The surgical system 128700 comprises a generator in electrical communication with one or more electrical pathways defined in the instrument shaft 128720 which can supply electrical power to the jaws 128740 and 128750 and also provide a return path for the current. In at least one instance, the jaw 128740 comprises an electrode 128742 in electrical communication with a first electrical pathway in the shaft 128720 and the jaw 128750 comprises an electrode 128752 in electrical communication with a second electrical pathway in the shaft 128720. The first and second electrical pathways are electrically insulated, or at least substantially insulated, from one another and the surrounding shaft structure such that the first and second electrical pathways, the electrodes 128742 and 128752, and the tissue positioned between the electrodes 128742 and 128752 forms a circuit. Such an arrangement provides a bipolar arrangement between the electrodes 128742 and 128752. That said, embodiments are envisioned in which a monopolar arrangement could be used. In such an arrangement, the return path for the current goes through the patient and into a return electrode positioned on or under the patient, for example.
As discussed above, the tissue of a patient can be cut by using a mechanical force and/or an electrical force. Such mechanical and electrical forces can be applied simultaneously and/or sequentially. For instance, both forces can be applied at the beginning of a tissue cutting actuation and then the mechanical force can be discontinued in favor of the electrosurgical force finishing the tissue cutting actuation. Such an approach can apply an energy-created hemostatic seal to the tissue after the mechanical cutting has been completed. In such arrangements, the electrosurgical force is applied throughout the duration of the tissue cutting actuation. In other instances, the mechanical cutting force, without the electrosurgical cutting force, can be used to start a tissue cutting actuation which is then followed by the electrosurgical cutting force after the mechanical cutting force has been stopped. In such arrangements, the mechanical and electrosurgical forces are not overlapping or co-extensive. In various instances, both the mechanical and electrosurgical forces are overlapping and co-extensive throughout the entire tissue cutting actuation. In at least one instance, both forces are overlapping and co-extensive throughout the entire tissue cutting actuation but in magnitudes or intensities that change during the tissue cutting actuation. The above being said, any suitable combination, pattern, and/or sequence of mechanical and electrosurgical cutting forces and energies could be used.
Further to the above, the surgical system 128700 comprises a control system configured to co-ordinate the application of the mechanical force and electrosurgical energy to the patient tissue. In various instances, the control system is in communication with the motor controller which drives the jaws 128740 and 128750 and, also, the electrical generator and comprises one or more sensing systems for monitoring the mechanical force and electrosurgical energy being applied to the tissue. Systems for monitoring the forces within a mechanical drive system are disclosed elsewhere herein. Systems for monitoring the electrosurgical energy being applied to the patient tissue include monitoring the impedance, or changes in the impedance, of the patient tissue via the electrical pathways of the electrosurgical circuit. In at least one instance, referring to the graph 128800 in
Further to the above, the control system and/or generator of the surgical system 128700 comprises one or more ammeter circuits and/or voltmeter circuits configured to monitor the electrosurgical current and/or voltage, respectively, being applied to the patient tissue. Referring again to
In various instances, the control system of the surgical system 128700 is configured to adaptively increase the electrosurgical energy applied to the patient tissue when the drive motor slows. The motor slowing can be a reaction to an increase in the tissue cutting load and/or an adaptation of the control system. Similarly, the control system of the surgical system 128700 is configured to adaptively increase the electrosurgical energy applied to the patient tissue when the drive motor stops. Again, the motor stopping can be a reaction to an increase in the tissue cutting load and/or an adaptation of the control system. Increasing the electrosurgical energy when the electric motor slows and/or stops can compensate for a reduction in mechanical cutting energy. In alternative embodiments, the electrosurgical energy can be reduced and/or stopped when the electric motor slows and/or stops. Such embodiments can afford the clinician to evaluate the situation in a low-energy environment.
In various instances, the control system of the surgical system 128700 is configured to adaptively decrease the electrosurgical energy applied to the patient tissue when the drive motor speeds up. The motor speeding up can be a reaction to a decrease in the cutting load and/or an adaptation of the control system. Decreasing the electrosurgical energy when the electric motor slows and/or stops can compensate for, or balance out, an increase in mechanical cutting energy. In alternative embodiments, the electrosurgical energy can be increased when the electric motor speeds up. Such embodiments can accelerate the closure of the jaws and provide a clean, quick cutting motion.
In various instances, the control system of the surgical system 128700 is configured to adaptively increase the speed of the drive motor when the electrosurgical energy applied to the patient tissue decreases. The electrosurgical energy decreasing can be a reaction to a change in tissue properties and/or an adaptation of the control system. Similarly, the control system of the surgical system 128700 is configured to adaptively increase the speed of the drive motor when electrosurgical energy applied to the patient tissue stops in response to an adaptation of the control system. Increasing the speed of the drive motor when the electrosurgical energy decreases or is stopped can compensate for a reduction in electrosurgical cutting energy. In alternative embodiments, the speed of the drive motor can be reduced and/or stopped when the electrosurgical energy decreases and/or is stopped. Such embodiments can afford the clinician to evaluate the situation in a low-energy and/or static environment.
In various instances, the control system of the surgical system 128700 is configured to adaptively decrease the speed of the electric motor when the electrosurgical energy applied to the patient tissue increases. The electrosurgical energy increasing can be a reaction to a change in tissue properties and/or an adaptation of the control system. Decreasing the drive motor speed when the electrosurgical energy increases can compensate for, or balance out, an increase in electrosurgical cutting energy. In alternative embodiments, the drive motor speed can be increased when the electrosurgical energy increases. Such embodiments can accelerate the closure of the jaws and provide a clean, quick cutting motion.
In various instances, the surgical system 128700 comprises controls, such as on the handle of the surgical system 128700, for example, that a clinician can use to control when the mechanical and/or electrosurgical forces are applied. In addition to or in lieu of manual controls, the control system of the surgical system 128700 is configured to monitor the mechanical force and electrical energy being applied to the tissue and adjust one or the other, if needed, to cut the tissue in a desirable manner according to one or more predetermined force-energy curves and/or matrices. In at least one instance, the control system can increase the electrical energy being delivered to the tissue once the mechanical force being applied reaches a threshold limit. Moreover, the control system is configured to consider other parameters, such as the impedance of the tissue being cut, when making adjustments to the mechanical force and/or electrical energy being applied to the tissue.
The surgical instrument systems described herein are motivated by an electric motor; however, the surgical instrument systems described herein can be motivated in any suitable manner. In certain instances, the motors disclosed herein may comprise a portion or portions of a robotically controlled system. U.S. patent application Ser. No. 13/118,241, entitled SURGICAL STAPLING INSTRUMENTS WITH ROTATABLE STAPLE DEPLOYMENT ARRANGEMENTS, now U.S. Pat. No. 9,072,535, for example, discloses several examples of a robotic surgical instrument system in greater detail, the entire disclosure of which is incorporated by reference herein.
The surgical instrument systems described herein can be used in connection with the deployment and deformation of staples. Various embodiments are envisioned which deploy fasteners other than staples, such as clamps or tacks, for example. Moreover, various embodiments are envisioned which utilize any suitable means for sealing tissue. For instance, an end effector in accordance with various embodiments can comprise electrodes configured to heat and seal the tissue. Also, for instance, an end effector in accordance with certain embodiments can apply vibrational energy to seal the tissue. In addition, various embodiments are envisioned which utilize a suitable cutting means to cut the tissue.
Example 1—A surgical end effector for use with a surgical instrument. The surgical end effector comprises a proximal connector configured to attach to a distal end of the surgical instrument. The proximal connector comprises an actuator. The surgical end effector further comprises a first jaw member. The first jaw member comprises a first portion comprising a first feature, and a second portion comprising a second feature. The surgical end effector further comprises a second jaw member. At least one of the first jaw member and the second jaw member is movable relative to the other one of the first jaw member and the second jaw member between an open configuration and a closed configuration. The second jaw member comprises a first portion comprising a first feature, and a second portion comprising a second feature. At least one of the first feature of the first jaw member and the first feature of the second jaw member is selected by a user in an additive manufacturing process.
Example 2—The surgical end effector of Example 1, wherein the additive manufacturing process comprises 3-D printing.
Example 3—The surgical end effector of Examples 1 or 2, wherein the first jaw member comprises an inner surface and an outer surface, wherein the second jaw member comprises an inner surface and an outer surface, and wherein the inner surface of the first jaw member and the inner surface of the second jaw member comprise a mating relationship when the surgical end effector is in the closed configuration.
Example 4—The surgical end effector of Examples 1, 2, or 3, wherein the first feature of the first jaw member comprises a tooth, wherein the first feature of the second jaw member comprises a void, and wherein, when the surgical end effector is in the closed configuration, the tooth is received in the void.
Example 5—The surgical end effector of Examples 1, 2, 3, or 4, wherein the first feature of the first jaw member comprises a first material, wherein the second feature of the first jaw member comprises a second material, and wherein the first material is different than the second material.
Example 6—The surgical end effector of Examples 1, 2, 3, or 4, wherein the first feature of the first jaw member comprises a first material, wherein the first feature of the second jaw member comprises a second material, and wherein the first material is different than the second material.
Example 7—The surgical end effector of Examples 1, 2, 3, 4, 5, or 6, wherein the first feature of the first jaw member comprises a first symmetrical pattern of protrusions, wherein the first feature of the second jaw member comprises a second symmetrical pattern of protrusions, and wherein the first symmetrical pattern of protrusions and the second symmetrical pattern of protrusions are complementary.
Example 8—The surgical end effector of Examples 1, 2, 3, 4, 5, or 6, wherein the first feature of the first jaw member comprises a first symmetrical pattern of protrusions, wherein the first feature of the second jaw member comprises a second symmetrical pattern of protrusions, and wherein the first symmetrical pattern of protrusions is different than the second symmetrical pattern of protrusions.
Example 9—The surgical end effector of Examples 1, 2, 3, 4, 5, or 6, wherein the first feature of the first jaw member comprises a first asymmetrical pattern of protrusions, wherein the first feature of the second jaw member comprises a second asymmetrical pattern of protrusions, and wherein the first asymmetrical pattern of protrusions and the second asymmetrical pattern of protrusions are complementary.
Example 10—The surgical end effector of Examples 1, 2, 3, 4, 5, or 6, wherein the first feature of the first jaw member comprises a first asymmetrical pattern of protrusions, wherein the first feature of the second jaw member comprises a second asymmetrical pattern of protrusions, and wherein the first asymmetrical pattern of protrusions is different than the second asymmetrical pattern of protrusions.
Example 11—The surgical end effector of Examples 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10, wherein the first portion of the first jaw member is proximal to the second portion of the first jaw member.
Example 12—The surgical end effector of Examples 1, 2, 3, 4, 5, 6, or 11, wherein the first feature of the first jaw member comprises a plurality of protrusions.
Example 13—The surgical end effector of Examples 1, 2, 3, 4, 5, 6, 11, or 12, wherein the second feature of the first jaw member comprises a plurality of protrusions.
Example 14—The surgical end effector of Examples 1, 2, 3, 4, 5, 6, 11, 12, or 13, wherein the first feature of the first jaw member comprises a plurality of protrusions, and wherein the second feature of the first jaw member comprises a substantially smooth surface.
Example 15—The surgical end effector of Examples 1 or 2, wherein the first jaw member comprises an inside surface and an outside surface, and wherein the first portion of the first jaw member is positioned along the inside surface of the first jaw member, and wherein the second portion of the first jaw member is positioned along the outside surface of the first jaw member.
Example 16—The surgical end effector of Examples 1, 2, or 15, wherein the first feature of the first jaw member comprises a plurality of protrusions, and wherein the second feature of the first jaw member comprises a substantially smooth surface.
Example 17—The surgical end effector of Examples 1, 2, or 15, wherein the first feature of the first jaw member comprises a substantially smooth surface, and wherein the second feature of the first jaw member comprises a plurality of protrusions.
Example 18—The surgical end effector of Examples 1, 2, or 15, wherein the first feature of the first jaw member comprises a plurality of first protrusions, and wherein the second feature of the first jaw member comprises a plurality of second protrusions.
Example 19—The surgical end effector of Example 18, wherein the plurality of first protrusions is different than the plurality of second protrusions.
Example 20—The surgical end effector of Examples 1, 2, or 15, wherein the first feature of the first jaw member comprises an asymmetrical profile, and wherein the second feature of the first jaw member comprises a symmetrical profile.
Example 21—The surgical end effector of Examples 1, 2, 15, or 20, wherein the first feature of the first jaw member comprises a low durometer surface.
Example 22—The surgical end effector of Examples 1, 2, 15, 20, or 21 wherein the second feature of the first jaw member comprises a low durometer surface.
Example 23—The surgical end effector of Examples 1, 2, or 15, wherein the first feature of the first jaw member comprises a curved profile.
Example 24—The surgical end effector of Examples 1, 2, or 15, wherein the second feature of the first jaw member comprises a curved profile.
Example 25—The surgical end effector of Examples 1, 2, 15, 16, 17, 18, 19, 20, 21, 22, 23, or 24, wherein the first feature of the first jaw member comprises a metallic material.
Example 26—The surgical end effector of Examples 1, 2, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, or 25, wherein the second feature of the first jaw member comprises a metallic material.
Example 27—A surgical end effector for use with a surgical instrument. The surgical end effector comprises a proximal connector configured to attach to a distal end of the surgical instrument. The proximal connector comprises an actuator. The surgical end effector further comprises a first jaw member. The first jaw member comprises a first portion comprising a first feature, and a second portion comprising a second feature. The surgical end effector further comprises a second jaw member. At least one of the first jaw member and the second jaw member is movable relative to the other one of the first jaw member and the second jaw member between an open configuration and a closed configuration. The second jaw member comprises a first portion comprising a first feature, and a second portion comprising a second feature. The surgical end effector further comprises means for selecting at least one of the first feature of the first jaw member and the first feature of the second jaw member by a user.
Example 28—The surgical end effector of Example 27, wherein the means comprises an additive manufacturing process.
Example 29—The surgical end effector of Examples 27 or 28, wherein the first jaw member comprises an inner surface and an outer surface, wherein the second jaw member comprises an inner surface and an outer surface, and wherein the inner surface of the first jaw member and the inner surface of the second jaw member comprise a mating relationship when the surgical end effector is in the closed configuration.
Example 30—The surgical end effector of Examples 27, 28, or 29, wherein the first feature of the first jaw member comprises a tooth, wherein the first feature of the second jaw member comprises a void, and wherein, when the surgical end effector is in the closed configuration, the tooth is received in the void.
Example 31—The surgical end effector of Examples 27, 28, 29, or 30, wherein the first feature of the first jaw member comprises a first material, wherein the second feature of the first jaw member comprises a second material, and wherein the first material is different than the second material.
Example 32—The surgical end effector of Examples 27, 28, 29, or 30, wherein the first feature of the first jaw member comprises a first material, wherein the first feature of the second jaw member comprises a second material, and wherein the first material is different than the second material.
Example 33—The surgical end effector of Examples 27, 28, 29, 30, 31, or 32, wherein the first feature of the first jaw member comprises a first symmetrical pattern of protrusions, wherein the first feature of the second jaw member comprises a second symmetrical pattern of protrusions, and wherein the first symmetrical pattern of protrusions and the second symmetrical pattern of protrusions are complementary.
Example 34—The surgical end effector of Examples 27, 28, 29, 30, 31, or 32, wherein the first feature of the first jaw member comprises a first symmetrical pattern of protrusions, wherein the first feature of the second jaw member comprises a second symmetrical pattern of protrusions, and wherein the first symmetrical pattern of protrusions is different than the second symmetrical pattern of protrusions.
Example 35—The surgical end effector of Examples 27, 28, 29, 30, 31, or 32, wherein the first feature of the first jaw member comprises a first asymmetrical pattern of protrusions, wherein the first feature of the second jaw member comprises a second asymmetrical pattern of protrusions, and wherein the first asymmetrical pattern of protrusions and the second asymmetrical pattern of protrusions are complementary.
Example 36—The surgical end effector of Examples 27, 28, 29, 30, 31, or 32, wherein the first feature of the first jaw member comprises a first asymmetrical pattern of protrusions, wherein the first feature of the second jaw member comprises a second asymmetrical pattern of protrusions, and wherein the first asymmetrical pattern of protrusions is different than the second asymmetrical pattern of protrusions.
Example 37—The surgical end effector of Examples 27, 28, 29, 30, 31, 32, 33, 34, 35, or 36, wherein the first portion of the first jaw member is proximal to the second portion of the first jaw member.
Example 38—The surgical end effector of Examples 27, 28, 29, 30, 31, 32, or 37, wherein the first feature of the first jaw member comprises a plurality of protrusion.
Example 39—The surgical end effector of Examples 27, 28, 29, 30, 31, 32, 37, or 38, wherein the second feature of the first jaw member comprises a plurality of protrusions.
Example 40—The surgical end effector of Examples 27, 28, 29, 30, 31, 32, 37, 38, or 39, wherein the first feature of the first jaw member comprises a plurality of protrusions, and wherein the second feature of the first jaw member comprises a substantially smooth surface.
Example 41—The surgical end effector of Examples 27 or 28, wherein the first jaw member comprises an inside surface and an outside surface, and where the first portion of the first jaw member is positioned along the inside surface of the first jaw member, and wherein the second portion of the first jaw member is positioned along the outside surface of the first jaw member.
Example 42—The surgical end effector of Examples 27, 28, or 41, wherein the first feature of the first jaw member comprises a plurality of protrusions, and wherein the second feature of the first jaw member comprises a substantially smooth surface.
Example 43—The surgical end effector of Examples 27, 28, or 41, wherein the first feature of the first jaw member comprises a substantially smooth surface, and wherein the second feature of the first jaw member comprises a plurality of protrusions.
Example 44—The surgical end effector of Examples 27, 28, or 43, wherein the first feature of the first jaw member comprises a plurality of first protrusions, and wherein the second feature of the first jaw member comprises a plurality of second protrusions.
Example 45—The surgical end effector of Example 44, wherein the plurality of first protrusions is different than the plurality of second protrusions.
Example 46—The surgical end effector of Examples 27, 28, or 41, wherein the first feature of the first jaw member comprises an asymmetrical profile, and wherein the second feature of the first jaw member comprises a symmetrical profile.
Example 47—The surgical end effector of Examples 27, 28, 41, or 46, wherein the first feature of the first jaw member comprises a low durometer surface.
Example 48—The surgical end effector of Examples 27, 28, 41, 46, or 47, wherein the second feature of the first jaw member comprises a low durometer surface.
Example 49—The surgical end effector of Examples 27, 28, or 41, wherein the first feature of the first jaw member comprises a curved profile.
Example 50—The surgical end effector of Examples 27, 28, or 41, wherein the second feature of the first jaw member comprises a curved profile.
Example 51—The surgical end effector of Examples 27, 28, 41, 42, 43, 44, 45, 46, 47, 48, 49, or 50, wherein the first feature of the first jaw member comprises a metallic material.
Example 52—The surgical end effector of Examples 27, 28, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, or 51 wherein the second feature of the first jaw member comprises a metallic material.
Example 53—A method for producing a customized end effector. The method comprises preparing an end effector connector for customization. The end effector connector comprises a proximal connector configured to attach to a distal end of a surgical instrument. The proximal connector comprises an actuator. The method further comprises determining through interaction with a patient a first desired characteristic of the end effector, determining through interaction with a patient a second desired characteristic of the end effector, and creating a first jaw member having the first desired characteristic. The first jaw member is attached to a distal portion of the end effector. The method further comprises creating a second jaw member having the second desired characteristic. The second jaw member is attached to a distal portion of the end effector.
Example 54—The method of Example 53, further comprising producing the first jaw member and the second jaw member using an additive manufacturing process.
Example 55—The method of Example 54, wherein the additive manufacturing process comprises 3-D printing.
Example 56—The method of Examples 53, 54, or 55, wherein the first characteristic of the first jaw member comprises a tooth, wherein the second characteristic of the second jaw member comprises a void.
Example 57—The method of Examples 53, 54, 55, or 56, wherein the first characteristic comprises a first material, wherein the second characteristic comprises a second material, and wherein the first material is different than the second material.
Example 58—The method of Examples 53, 54, 55, 56, or 57, wherein the first characteristic comprises a first symmetrical pattern of protrusions, wherein the second characteristic comprises a second symmetrical pattern of protrusions, and wherein the first symmetrical pattern of protrusions and the second symmetrical pattern of protrusions are complementary.
Example 59—The method of Examples 53, 54, 55, 56, or 57, wherein the first characteristic comprises a first symmetrical pattern of protrusions, wherein the second characteristic comprises a second symmetrical pattern of protrusions, and wherein the first symmetrical pattern of protrusions is different than the second symmetrical pattern of protrusions.
Example 60—The method of Examples 53, 54, 55, 56, or 57, wherein the first characteristic comprises a first asymmetrical pattern of protrusions, wherein the second characteristic comprises a second asymmetrical pattern of protrusions, and wherein the first asymmetrical pattern of protrusions and the second asymmetrical pattern of protrusions are complementary.
Example 61—The method of Examples 53, 54, 55, 56, or 57, wherein the first characteristic comprises a first asymmetrical pattern of protrusions, wherein the second characteristic comprises a second asymmetrical pattern of protrusions, and wherein the first asymmetrical pattern of protrusions is different than the second asymmetrical pattern of protrusions.
Example 62—The method of Example 53, further comprising creating a third desired characteristic on the first jaw member, and creating a fourth desired characteristic on the second jaw member.
Example 63—The method of Example 62, wherein the first characteristic comprises a plurality of protrusions.
Example 64—The method of Examples 62 or 63, wherein the third characteristic comprises a plurality of protrusions.
Example 65—The method of Examples 62 or 64, wherein the first characteristic comprises a plurality of protrusions, and wherein the third characteristic comprises a substantially smooth surface.
Example 66—The method of Examples 62, 63, 64, or 65, wherein the first jaw member comprises an inside surface and an outside surface, and where the first characteristic is positioned along the inside surface of the first jaw member, and wherein the third characteristic is positioned along the outside surface of the first jaw member.
Example 67—The method of Examples 62, 63, 64, 65, or 66, wherein the first characteristic comprises a plurality of protrusions, and wherein the third characteristic comprises a substantially smooth surface.
Example 68—The method of Examples 62, 63, 64, 65, or 66, wherein the first characteristic comprises a substantially smooth surface, and wherein the third characteristic comprises a plurality of protrusions.
Example 69—The method of Examples 62, 63, 64, 65, or 66, wherein the first characteristic comprises a plurality of first protrusions, and wherein the third characteristic comprises a plurality of second protrusions.
Example 70—The method of Example 69, wherein the plurality of first protrusions is different than the plurality of second protrusions.
Example 71—The method of Examples 62, 63, 64, 65, or 66, wherein the first characteristic comprises an asymmetrical profile, and wherein the third characteristic comprises a symmetrical profile.
Example 72—The method of Examples 62, 63, 64, 65, or 66, wherein the first characteristic comprises a low durometer surface.
Example 73—The method of Examples 62, 63, 64, 65, or 66, wherein the third characteristic comprises a low durometer surface.
Example 74—The method of Examples 62, 63, 64, 65, or 66, wherein the first characteristic comprises a curved profile.
Example 75—The method of Examples 62, 63, 64, 65, or 66, wherein the third characteristic comprises a curved profile.
Example 76—The method of Examples 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, or 75, wherein the first characteristic comprises a metallic material.
Example 77—The method of Examples 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, or 76, wherein the third characteristic comprises a metallic material.
Example 78—A surgical instrument comprising a composite dissector jaw. The composite dissector jaw comprises a first jaw. The first jaw comprises a proximal portion, a distal portion, a tissue contacting surface, a metallic core, and at least one layer of molded plastic on the metallic core. The at least one layer of molded plastic defines a pattern. The pattern defines at least a portion of the tissue contacting surface. The tissue contacting surface further comprises at least a portion of the metallic core. The composite dissector jaw further comprises a second jaw. At least one of the first jaw and the second jaw is rotatable with respect to the other one of the first jaw and the second jaw.
Example 79—The surgical instrument of Example 78, wherein the pattern comprises a first pattern on the proximal portion and a second pattern on the distal portion.
Example 80—The surgical instrument of Example 79, wherein the first pattern is different than the second pattern.
Example 81—The surgical instrument of Examples 79 or 80, wherein the first pattern comprises a first thickness of the at least one layer of molded plastic, wherein the second pattern comprises a second thickness of the at least one layer of molded plastic, and wherein the first thickness is different than the second thickness.
Example 82—The surgical instrument of Example 81, wherein the first thickness is greater than the second thickness.
Example 83—The surgical instrument of Example 81, wherein the first thickness is less than the second thickness.
Example 84—The surgical instrument of Examples 78, 79, 80, 81, 82, or 83, wherein the at least one layer of molded plastic comprises a first layer and a second layer.
Example 85—The surgical instrument of Example 84, wherein the first layer is different than the second layer.
Example 86—The surgical instrument of Examples 84 or 85, wherein the first layer comprises a first material, wherein the second layer comprises a second material, and wherein the first material is different than the second material.
Example 87—The surgical instrument of Examples 84, 85, or 86, wherein the first layer is in contact with the metallic core, and wherein the second layer is in contact with the first layer.
Example 88—The surgical instrument of Examples 84, 85, or 86, wherein the first layer is positioned on the proximal portion, and wherein the second layer is positioned on the distal portion.
Example 89—The surgical instrument of Examples 84, 85, 86, 87, or 88, wherein the first layer comprises a first rigidity, wherein the second layer comprises a second rigidity, wherein the first rigidity is different than the second rigidity.
Example 90—The surgical instrument of Example 89, wherein the first rigidity is greater than the second rigidity.
Example 91—The surgical instrument of Example 89, wherein the first rigidity is less than the second rigidity.
Example 92—The surgical instrument of Examples 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, or 91, wherein the first pattern comprises a plurality of recesses.
Example 93—The surgical instrument of Examples 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, or 92, wherein the first pattern comprises a plurality of ridges.
Example 94—The surgical instrument of Examples 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, or 93, wherein the first pattern is symmetrical.
Example 95—The surgical instrument of Examples 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, or 93, wherein the first pattern is asymmetrical.
Example 96—The surgical instrument of Examples 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, or 95, wherein the at least one layer of molded plastic on the metallic core comprises openings, and wherein the metallic core is exposed to tissue via the openings.
Example 97—The surgical instrument of Examples 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, or 96, wherein the first jaw and the second jaw are mechanically driven open to create an ostomy.
Example 98—A surgical dissector comprising a first jaw member. The first jaw member comprises a proximal end, a distal end, a first tissue contacting surface, a second tissue contacting surface, a metallic core, and a nonmetallic layer. The metallic core of the first jaw member is configured to transmit electrosurgical energy. The nonmetallic layer is disposed over at least a portion of the metallic core of the first jaw member. The surgical dissector further comprises a second jaw member. The second jaw member comprises a proximal end, a distal end, a first tissue contacting surface, a second tissue contacting surface, a metallic core, and a nonmetallic layer. The metallic core of the second jaw member is configured to transmit electrosurgical energy. The nonmetallic layer is disposed over at least a portion of the metallic core of the second jaw member. The surgical dissector further comprises a joint. The first jaw member and the second jaw member are rotatable about the joint between closed and open positions.
Example 99—The surgical dissector of Example 98, wherein the first tissue contacting surface of the first jaw member is positioned adjacent the first tissue contacting surface of the second jaw member when the first and the second jaw members are in the closed position.
Example 100—The surgical dissector of Examples 98 or 99, wherein the first tissue contacting surface of the first jaw member comprises a first pattern, and wherein the first tissue contacting surface of the second jaw member comprises a second pattern, and wherein the first pattern is different than the second pattern.
Example 101—The surgical dissector of Examples 98 or 99, wherein the first tissue contacting surface of the first jaw member comprises a first pattern, and wherein the first tissue contacting surface of the second jaw member comprises a second pattern, and wherein the first pattern is complementary to the second pattern.
Example 102—The surgical dissector of Examples 98 or 99, wherein the first tissue contacting surface of the first jaw member comprises a first pattern, and wherein the first tissue contacting surface of the second jaw member comprises a second pattern, wherein the first pattern comprises a plurality of first teeth, and wherein the second pattern comprises a plurality of second teeth.
Example 103—The surgical dissector of Examples 98 or 99, wherein the first tissue contacting surface of the first jaw member comprises a first pattern, and wherein the first tissue contacting surface of the second jaw member comprises a second pattern, wherein the first pattern comprises a plurality of first recesses, and wherein the second pattern comprises a plurality of second recesses.
Example 104—The surgical dissector of Examples 98, 99, 100, 101, 102, or 103, wherein the nonmetallic layer of the first jaw member comprises a first nonmetallic layer and a second nonmetallic layer.
Example 105—The surgical dissector of Example 104, wherein the first nonmetallic layer is different than the second nonmetallic layer.
Example 106—The surgical dissector of Examples 104 or 105, wherein the first nonmetallic layer comprises a first rigidity, wherein the second nonmetallic layer comprises a second rigidity, and wherein the first rigidity is different than the second rigidity.
Example 107—The surgical dissector of Example 98, wherein the first tissue contacting surface of the first jaw member comprises a first pattern, wherein the second tissue contacting surface of the first jaw member comprises a second pattern, and wherein the first pattern is different than the second pattern.
Example 108—The surgical dissector of Example 107, wherein the first pattern comprises a symmetrical pattern, and wherein the second pattern comprises an asymmetrical pattern.
Example 109—The surgical dissector of Examples 107 or 108, wherein the first pattern comprises a plurality of teeth, and wherein the second pattern comprises a plurality of cavities.
Example 110—The surgical dissector of Examples 107 or 108, wherein the first pattern comprises a plurality of first cavities, wherein the second pattern comprises a plurality of second cavities.
Example 111—The surgical dissector of Example 110, wherein the plurality of first cavities comprises a first depth, wherein the plurality of second cavities comprises a second depth, and wherein the first depth is different than the second depth.
Example 112—A surgical instrument comprising a jaw. The jaw comprises a metallic core and an outer skin. The outer skin comprises a plurality of first through holes exposing the metallic core to an outer surface of the jaw. The plurality of first through holes comprise a first through hole size. The outer skin further comprises a plurality of second through holes exposing the metallic core to the outer surface of the jaw. The plurality of second through holes comprise a second through hole size. The first through hole size is different than the second through hole size.
Example 113—The surgical instrument of Example 112, wherein the jaw further comprises a first region. The plurality of first through holes are positioned within the first region. The jaw further comprises a second region. The plurality of second through holes are positioned within the second region. The first region is different than the second region.
Example 114—The surgical instrument of Examples 112 or 113, wherein the jaw comprises a tip region, wherein the first through hole size is smaller than the second through hole size, and wherein the plurality of first through holes are positioned within the tip region.
Example 115—The surgical instrument of Examples 112 or 113, wherein the jaw comprises a tip region, wherein the first through hole size is larger than the second through hole size, and wherein the plurality of first through holes are positioned within the tip region.
Example 116—The surgical instrument of Examples 112, 113, 114, or 115, wherein the plurality of first through holes and the plurality of second through holes are intermixed along the outer skin.
Example 117—The surgical instrument of Examples 112, 113, 114, 115, or 116, wherein the plurality of first through holes are round, and wherein the plurality of second through holes are round.
Example 118—The surgical instrument of Examples 112, 113, 114, 115, or 116, wherein the plurality of first through holes are round, and wherein the plurality of second through holes are non-round.
Example 119—The surgical instrument of Examples 112, 113, 114, 115, or 116, wherein the plurality of first through holes are non-round, and wherein the plurality of second through holes are non-round.
Example 120—The surgical instrument of Examples 112, 113, 114, 115, 116, 117, 118, or 119, wherein the outer skin comprises an insulative plastic.
Example 121—The surgical instrument of Examples 112, 113, 114, 115, 116, 117, 118, or 119, wherein the outer skin comprises a semi-conductive plastic.
Example 122—The surgical instrument of Examples 112, 113, 114, 115, 116, 117, 118, or 119, wherein the outer skin is semi-conductive.
Example 123—The surgical instrument of Examples 112, 113, 114, 115, 116, 117, 118, or 119, wherein the outer skin comprises intrinsically conducting polymers.
Example 124—A surgical dissector comprising a first jaw member. The first jaw member comprises a first tissue contacting surface. The first tissue contacting surface comprises a first electrically conductive portion and a first electrically insulative portion. The surgical dissector further comprises a second jaw member. The second jaw member comprises a second tissue contacting surface. The second tissue contacting surface comprises a second electrically conductive portion and a second electrically insulative portion. The surgical dissector further comprises a pivot. The first jaw member and the second jaw member are rotatable about the pivot. The surgical dissector further comprises means for separating tissue. The means for separating tissue comprises means for applying a mechanical force to tissue of a patient through rotation of at least one of the first jaw member and the second jaw member, and means for applying electrosurgical force to the tissue through at least one of the first electrically conductive portion and the second electrically conductive portion.
Example 125—The surgical dissector of Example 124, wherein the means for separating tissue comprises applying the mechanical force in an amount less than the separation pressure needed to separate the tissue and applying electrosurgical force which supplements the mechanical force to separate the tissue.
The devices, systems, and methods disclosed in the Subject Application can be used with the devices, systems, and methods disclosed in U.S. Provisional Patent Application No. 62/659,900, entitled METHOD OF HUB COMMUNICATION, filed on Apr. 19, 2018, U.S. Provisional Patent Application No. 62/611,341, entitled INTERACTIVE SURGICAL PLATFORM, filed on Dec. 28, 2017, U.S. Provisional Patent Application No. 62/611,340, entitled CLOUD-BASED MEDICAL ANALYTICS, filed on Dec. 28, 2017, and U.S. Provisional Patent Application No. 62/611,339, entitled ROBOT ASSISTED SURGICAL PLATFORM, filed on Dec. 28, 2017, which are incorporated in their entireties herein. The devices, systems, and methods disclosed in the Subject Application can also be used with the devices, systems, and methods disclosed in U.S. patent application Ser. No. 15/908,021, entitled SURGICAL INSTRUMENT WITH REMOTE RELEASE, filed on Feb. 28, 2018, U.S. patent application Ser. No. 15/908,012, entitled SURGICAL INSTRUMENT HAVING DUAL ROTATABLE MEMBERS TO EFFECT DIFFERENT TYPES OF END EFFECTOR MOVEMENT, filed on Feb. 28, 2018, U.S. patent application Ser. No. 15/908,040, entitled SURGICAL INSTRUMENT WITH ROTARY DRIVE SELECTIVELY ACTUATING MULTIPLE END EFFECTOR FUNCTIONS, filed on Feb. 28, 2018, U.S. patent application Ser. No. 15/908,057, entitled SURGICAL INSTRUMENT WITH ROTARY DRIVE SELECTIVELY ACTUATING MULTIPLE END EFFECTOR FUNCTIONS, filed on Feb. 28, 2018, U.S. patent application Ser. No. 15/908,058, entitled SURGICAL INSTRUMENT WITH MODULAR POWER SOURCES, filed on Feb. 28, 2018, and U.S. patent application Ser. No. 15/908,143, entitled SURGICAL INSTRUMENT WITH SENSOR AND/OR CONTROL SYSTEMS, filed on Feb. 28, 2018, which are incorporated in their entireties herein. The devices, systems, and methods disclosed in the Subject Application can also be used with the devices, systems, and methods disclosed in U.S. patent application Ser. No. 14/226,133, now U.S. Patent Application Publication No. 2015/0272557, entitled MODULAR SURGICAL INSTRUMENT SYSTEM, filed on Mar. 26, 2014, which is incorporated in its entirety herein.
The entire disclosures of:
Although various devices have been described herein in connection with certain embodiments, modifications and variations to those embodiments may be implemented. Particular features, structures, or characteristics may be combined in any suitable manner in one or more embodiments. Thus, the particular features, structures, or characteristics illustrated or described in connection with one embodiment may be combined in whole or in part, with the features, structures or characteristics of one ore more other embodiments without limitation. Also, where materials are disclosed for certain components, other materials may be used. Furthermore, according to various embodiments, a single component may be replaced by multiple components, and multiple components may be replaced by a single component, to perform a given function or functions. The foregoing description and following claims are intended to cover all such modification and variations.
The devices disclosed herein can be designed to be disposed of after a single use, or they can be designed to be used multiple times. In either case, however, a device can be reconditioned for reuse after at least one use. Reconditioning can include any combination of the steps including, but not limited to, the disassembly of the device, followed by cleaning or replacement of particular pieces of the device, and subsequent reassembly of the device. In particular, a reconditioning facility and/or surgical team can disassemble a device and, after cleaning and/or replacing particular parts of the device, the device can be reassembled for subsequent use. Those skilled in the art will appreciate that reconditioning of a device can utilize a variety of techniques for disassembly, cleaning/replacement, and reassembly. Use of such techniques, and the resulting reconditioned device, are all within the scope of the present application.
The devices disclosed herein may be processed before surgery. First, a new or used instrument may be obtained and, when necessary, cleaned. The instrument may then be sterilized. In one sterilization technique, the instrument is placed in a closed and sealed container, such as a plastic or TYVEK bag. The container and instrument may then be placed in a field of radiation that can penetrate the container, such as gamma radiation, x-rays, and/or high-energy electrons. The radiation may kill bacteria on the instrument and in the container. The sterilized instrument may then be stored in the sterile container. The sealed container may keep the instrument sterile until it is opened in a medical facility. A device may also be sterilized using any other technique known in the art, including but not limited to beta radiation, gamma radiation, ethylene oxide, plasma peroxide, and/or steam.
While this invention has been described as having exemplary designs, the present invention may be further modified within the spirit and scope of the disclosure. This application is therefore intended to cover any variations, uses, or adaptations of the invention using its general principles.
Any patent, publication, or other disclosure material, in whole or in part, that is said to be incorporated by reference herein is incorporated herein only to the extent that the incorporated materials do not conflict with existing definitions, statements, or other disclosure material set forth in this disclosure. As such, and to the extent necessary, the disclosure as explicitly set forth herein supersedes any conflicting material incorporated herein by reference. Any material, or portion thereof, that is said to be incorporated by reference herein, but which conflicts with existing definitions, statements, or other disclosure material set forth herein will only be incorporated to the extent that no conflict arises between that incorporated material and the existing disclosure material.
This non-provisional application claims the benefit under 35 U.S.C. § 119(e) of U.S. Provisional Patent Application Ser. No. 62/578,793, entitled SURGICAL INSTRUMENT WITH REMOTE RELEASE, filed Oct. 30, 2017, of U.S. Provisional Patent Application Ser. No. 62/578,804, entitled SURGICAL INSTRUMENT HAVING DUAL ROTATABLE MEMBERS TO EFFECT DIFFERENT TYPES OF END EFFECTOR MOVEMENT, filed Oct. 30, 2017, of U.S. Provisional Patent Application Ser. No. 62/578,817, entitled SURGICAL INSTRUMENT WITH ROTARY DRIVE SELECTIVELY ACTUATING MULTIPLE END EFFECTOR FUNCTIONS, filed Oct. 30, 2017, of U.S. Provisional Patent Application Ser. No. 62/578,835, entitled SURGICAL INSTRUMENT WITH ROTARY DRIVE SELECTIVELY ACTUATING MULTIPLE END EFFECTOR FUNCTIONS, filed Oct. 30, 2017, of U.S. Provisional Patent Application Ser. No. 62/578,844, entitled SURGICAL INSTRUMENT WITH MODULAR POWER SOURCES, filed Oct. 30, 2017, and of U.S. Provisional Patent Application Ser. No. 62/578,855, entitled SURGICAL INSTRUMENT WITH SENSOR AND/OR CONTROL SYSTEMS, filed Oct. 30, 2017, the disclosures of which are incorporated by reference herein in their entirety. This non-provisional application claims the benefit under 35 U.S.C. § 119(e) of U.S. Provisional Patent Application Ser. No. 62/665,129, entitled SURGICAL SUTURING SYSTEMS, filed May 1, 2018, of U.S. Provisional Patent Application Ser. No. 62/665,139, entitled SURGICAL INSTRUMENTS COMPRISING CONTROL SYSTEMS, filed May 1, 2018, of U.S. Provisional Patent Application Ser. No. 62/665,177, entitled SURGICAL INSTRUMENTS COMPRISING HANDLE ARRANGEMENTS, filed May 1, 2018, of U.S. Provisional patent application Ser. No. 62/665,128, entitled MODULAR SURGICAL INSTRUMENTS, filed May 1, 2018, of U.S. Provisional Patent Application Ser. No. 62/665,192, entitled SURGICAL DISSECTORS, filed May 1, 2018, and of U.S. Provisional Patent Application Ser. No. 62/665,134, entitled SURGICAL CLIP APPLIER, filed May 1, 2018, the disclosures of which are incorporated by reference herein in their entirety.
Number | Name | Date | Kind |
---|---|---|---|
1853416 | Hall | Apr 1932 | A |
2222125 | Stehlik | Nov 1940 | A |
3082426 | Miles | Mar 1963 | A |
3503396 | Pierie et al. | Mar 1970 | A |
3584628 | Green | Jun 1971 | A |
3626457 | Duerr et al. | Dec 1971 | A |
3633584 | Farrell | Jan 1972 | A |
3759017 | Young | Sep 1973 | A |
3863118 | Lander et al. | Jan 1975 | A |
3898545 | Coppa et al. | Aug 1975 | A |
3912121 | Steffen | Oct 1975 | A |
3915271 | Harper | Oct 1975 | A |
3932812 | Milligan | Jan 1976 | A |
4041362 | Ichiyanagi | Aug 1977 | A |
4052649 | Greenwell et al. | Oct 1977 | A |
4087730 | Goles | May 1978 | A |
4157859 | Terry | Jun 1979 | A |
4171700 | Farin | Oct 1979 | A |
4202722 | Paquin | May 1980 | A |
4412539 | Jarvik | Nov 1983 | A |
4448193 | Ivanov | May 1984 | A |
4523695 | Braun et al. | Jun 1985 | A |
4608160 | Zoch | Aug 1986 | A |
4614366 | North et al. | Sep 1986 | A |
4633874 | Chow et al. | Jan 1987 | A |
4701193 | Robertson et al. | Oct 1987 | A |
4735603 | Goodson et al. | Apr 1988 | A |
4788977 | Farin et al. | Dec 1988 | A |
4849752 | Bryant | Jul 1989 | A |
D303787 | Messenger et al. | Oct 1989 | S |
4892244 | Fox et al. | Jan 1990 | A |
4976173 | Yang | Dec 1990 | A |
5010341 | Huntley et al. | Apr 1991 | A |
5026387 | Thomas | Jun 1991 | A |
5035692 | Lyon et al. | Jul 1991 | A |
5042460 | Sakurai et al. | Aug 1991 | A |
5047043 | Kubota et al. | Sep 1991 | A |
5084057 | Green et al. | Jan 1992 | A |
5100402 | Fan | Mar 1992 | A |
D327061 | Soren et al. | Jun 1992 | S |
5129570 | Schulze et al. | Jul 1992 | A |
5151102 | Kamiyama | Sep 1992 | A |
5156315 | Green et al. | Oct 1992 | A |
5158585 | Saho et al. | Oct 1992 | A |
5171247 | Hughett et al. | Dec 1992 | A |
5189277 | Boisvert et al. | Feb 1993 | A |
5197962 | Sansom et al. | Mar 1993 | A |
5204669 | Dorfe et al. | Apr 1993 | A |
5217003 | Wilk | Jun 1993 | A |
5242474 | Herbst et al. | Sep 1993 | A |
5253793 | Green et al. | Oct 1993 | A |
5271543 | Grant et al. | Dec 1993 | A |
RE34519 | Fox et al. | Jan 1994 | E |
5275323 | Schulze et al. | Jan 1994 | A |
5318516 | Cosmescu | Jun 1994 | A |
5318563 | Malis et al. | Jun 1994 | A |
5322055 | Davison et al. | Jun 1994 | A |
5342349 | Kaufman | Aug 1994 | A |
5364003 | Williamson, IV | Nov 1994 | A |
5383880 | Hooven | Jan 1995 | A |
5385544 | Edwards et al. | Jan 1995 | A |
5396900 | Slater | Mar 1995 | A |
5397046 | Savage et al. | Mar 1995 | A |
5403312 | Yates et al. | Apr 1995 | A |
5403327 | Thornton et al. | Apr 1995 | A |
5413267 | Solyntjes et al. | May 1995 | A |
5415335 | Knodell, Jr. | May 1995 | A |
5417699 | Klein et al. | May 1995 | A |
5439468 | Schulze et al. | Aug 1995 | A |
5445304 | Plyley et al. | Aug 1995 | A |
5462545 | Wang et al. | Oct 1995 | A |
5465895 | Knodel et al. | Nov 1995 | A |
5467911 | Tsuruta et al. | Nov 1995 | A |
5474566 | Alesi et al. | Dec 1995 | A |
5485947 | Olson et al. | Jan 1996 | A |
5496315 | Weaver et al. | Mar 1996 | A |
5496317 | Goble et al. | Mar 1996 | A |
5503320 | Webster et al. | Apr 1996 | A |
5529235 | Boiarski et al. | Jun 1996 | A |
5531743 | Nettekoven et al. | Jul 1996 | A |
5545148 | Wurster | Aug 1996 | A |
5552685 | Young et al. | Sep 1996 | A |
5560372 | Cory | Oct 1996 | A |
5584425 | Savage et al. | Dec 1996 | A |
5610379 | Muz et al. | Mar 1997 | A |
5610811 | Honda | Mar 1997 | A |
5613966 | Makower et al. | Mar 1997 | A |
5624452 | Yates | Apr 1997 | A |
D379346 | Mieki | May 1997 | S |
5626587 | Bishop et al. | May 1997 | A |
5643291 | Pier et al. | Jul 1997 | A |
5654750 | Weil et al. | Aug 1997 | A |
5673841 | Schulze et al. | Oct 1997 | A |
5673842 | Bittner et al. | Oct 1997 | A |
5675227 | Roos et al. | Oct 1997 | A |
5693042 | Boiarski et al. | Dec 1997 | A |
5693052 | Weaver | Dec 1997 | A |
5695502 | Pier et al. | Dec 1997 | A |
5697926 | Weaver | Dec 1997 | A |
5706998 | Plyley et al. | Jan 1998 | A |
5718359 | Palmer et al. | Feb 1998 | A |
5724468 | Leone et al. | Mar 1998 | A |
5725536 | Oberlin et al. | Mar 1998 | A |
5725542 | Yoon | Mar 1998 | A |
5735445 | Vidal et al. | Apr 1998 | A |
5735848 | Yates et al. | Apr 1998 | A |
5746209 | Yost et al. | May 1998 | A |
5749362 | Funda et al. | May 1998 | A |
5749893 | Vidal et al. | May 1998 | A |
5752644 | Bolanos et al. | May 1998 | A |
5762255 | Chrisman et al. | Jun 1998 | A |
5762458 | Wang et al. | Jun 1998 | A |
5766186 | Faraz et al. | Jun 1998 | A |
5769791 | Benaron et al. | Jun 1998 | A |
5775331 | Raymond et al. | Jul 1998 | A |
5797537 | Oberlin et al. | Aug 1998 | A |
5800350 | Coppleson et al. | Sep 1998 | A |
D399561 | Ellingson | Oct 1998 | S |
5817093 | Wlliamson, IV et al. | Oct 1998 | A |
5820009 | Melling et al. | Oct 1998 | A |
5833690 | Yates et al. | Nov 1998 | A |
5836849 | Mathiak et al. | Nov 1998 | A |
5836869 | Kudo et al. | Nov 1998 | A |
5836909 | Cosmescu | Nov 1998 | A |
5843080 | Fleenor et al. | Dec 1998 | A |
5846237 | Nettekoven | Dec 1998 | A |
5849022 | Sakashita et al. | Dec 1998 | A |
5873873 | Smith et al. | Feb 1999 | A |
5878938 | Bittner et al. | Mar 1999 | A |
5893849 | Weaver | Apr 1999 | A |
5906625 | Bito et al. | May 1999 | A |
5942333 | Arnett et al. | Aug 1999 | A |
5947996 | Logeman | Sep 1999 | A |
5968032 | Sleister | Oct 1999 | A |
5980510 | Tsonton et al. | Nov 1999 | A |
5987346 | Benaron et al. | Nov 1999 | A |
5997528 | Bisch et al. | Dec 1999 | A |
6004269 | Crowley et al. | Dec 1999 | A |
6010054 | Johnson et al. | Jan 2000 | A |
6030437 | Gourrier et al. | Feb 2000 | A |
6036637 | Kudo | Mar 2000 | A |
6039734 | Goble | Mar 2000 | A |
6039735 | Greep | Mar 2000 | A |
6059799 | Aranyi et al. | May 2000 | A |
6066137 | Greep | May 2000 | A |
6079606 | Milliman et al. | Jun 2000 | A |
6090107 | Borgmeier et al. | Jul 2000 | A |
6099537 | Sugai et al. | Aug 2000 | A |
6102907 | Smethers et al. | Aug 2000 | A |
6109500 | Alli et al. | Aug 2000 | A |
6113598 | Baker | Sep 2000 | A |
6126592 | Proch et al. | Oct 2000 | A |
6126658 | Baker | Oct 2000 | A |
6131789 | Schulze et al. | Oct 2000 | A |
6155473 | Tompkins et al. | Dec 2000 | A |
6214000 | Fleenor et al. | Apr 2001 | B1 |
6258105 | Hart et al. | Jul 2001 | B1 |
6269411 | Reasoner | Jul 2001 | B1 |
6273887 | Yamauchi et al. | Aug 2001 | B1 |
6283960 | Ashley | Sep 2001 | B1 |
6301495 | Gueziec et al. | Oct 2001 | B1 |
6302881 | Farin | Oct 2001 | B1 |
6308089 | von der Ruhr et al. | Oct 2001 | B1 |
6325808 | Bernard et al. | Dec 2001 | B1 |
6325811 | Messerly | Dec 2001 | B1 |
6331181 | Tierney et al. | Dec 2001 | B1 |
6341164 | Dilkie et al. | Jan 2002 | B1 |
6391102 | Sodden et al. | May 2002 | B1 |
6423057 | He et al. | Jul 2002 | B1 |
6434416 | Mizoguchi et al. | Aug 2002 | B1 |
6443973 | Whitman | Sep 2002 | B1 |
6451015 | Rittman, III et al. | Sep 2002 | B1 |
6454781 | Witt et al. | Sep 2002 | B1 |
6457625 | Tormala et al. | Oct 2002 | B1 |
6461352 | Morgan et al. | Oct 2002 | B2 |
6466817 | Kaula et al. | Oct 2002 | B1 |
6480796 | Wiener | Nov 2002 | B2 |
6482217 | Pintor et al. | Nov 2002 | B1 |
6524307 | Palmerton et al. | Feb 2003 | B1 |
6530933 | Yeung et al. | Mar 2003 | B1 |
6551243 | Bocionek et al. | Apr 2003 | B2 |
6569109 | Sakurai et al. | May 2003 | B2 |
6582424 | Fleenor et al. | Jun 2003 | B2 |
6584358 | Carter et al. | Jun 2003 | B2 |
6585791 | Garito et al. | Jul 2003 | B1 |
6611793 | Burnside et al. | Aug 2003 | B1 |
6618626 | West, Jr. et al. | Sep 2003 | B2 |
6633234 | Wiener et al. | Oct 2003 | B2 |
6648223 | Boukhny et al. | Nov 2003 | B2 |
6678552 | Pearlman | Jan 2004 | B2 |
6679899 | Wiener et al. | Jan 2004 | B2 |
6685704 | Greep | Feb 2004 | B2 |
6699187 | Webb et al. | Mar 2004 | B2 |
6731514 | Evans | May 2004 | B2 |
6742895 | Robin | Jun 2004 | B2 |
6752816 | Culp et al. | Jun 2004 | B2 |
6760616 | Hoey et al. | Jul 2004 | B2 |
6770072 | Truckai et al. | Aug 2004 | B1 |
6773444 | Messerly | Aug 2004 | B2 |
6775575 | Bommannan et al. | Aug 2004 | B2 |
6778846 | Martinez et al. | Aug 2004 | B1 |
6781683 | Kacyra et al. | Aug 2004 | B2 |
6783524 | Anderson et al. | Aug 2004 | B2 |
6783525 | Greep et al. | Aug 2004 | B2 |
6793652 | Whitman et al. | Sep 2004 | B1 |
6793663 | Kneifel et al. | Sep 2004 | B2 |
6824539 | Novak | Nov 2004 | B2 |
6846308 | Whitman et al. | Jan 2005 | B2 |
6849074 | Chen et al. | Feb 2005 | B2 |
6852219 | Hammond | Feb 2005 | B2 |
6863650 | Irion | Mar 2005 | B1 |
6869430 | Balbierz et al. | Mar 2005 | B2 |
6869435 | Blake, III | Mar 2005 | B2 |
6911033 | de Guillebon et al. | Jun 2005 | B2 |
6913471 | Smith | Jul 2005 | B2 |
6937892 | Leyde et al. | Aug 2005 | B2 |
6945981 | Donofrio et al. | Sep 2005 | B2 |
6951559 | Greep | Oct 2005 | B1 |
6962587 | Johnson et al. | Nov 2005 | B2 |
6978921 | Shelton, IV et al. | Dec 2005 | B2 |
6988649 | Shelton, IV et al. | Jan 2006 | B2 |
7000818 | Shelton, IV et al. | Feb 2006 | B2 |
7009511 | Mazar et al. | Mar 2006 | B2 |
7030146 | Baynes et al. | Apr 2006 | B2 |
7032798 | Whitman et al. | Apr 2006 | B2 |
7041941 | Faries, Jr. et al. | May 2006 | B2 |
7044352 | Shelton, IV et al. | May 2006 | B2 |
7044911 | Drinan et al. | May 2006 | B2 |
7044949 | Orszulak et al. | May 2006 | B2 |
7048775 | Jornitz et al. | May 2006 | B2 |
7053752 | Wang et al. | May 2006 | B2 |
7055730 | Ehrenfels et al. | Jun 2006 | B2 |
7073765 | Newkirk | Jul 2006 | B2 |
7077853 | Kramer et al. | Jul 2006 | B2 |
7077856 | Whitman | Jul 2006 | B2 |
7081096 | Brister et al. | Jul 2006 | B2 |
7097640 | Wang et al. | Aug 2006 | B2 |
7103688 | Strong | Sep 2006 | B2 |
7104949 | Anderson et al. | Sep 2006 | B2 |
7118564 | Ritchie et al. | Oct 2006 | B2 |
7121460 | Parsons et al. | Oct 2006 | B1 |
7137980 | Buysse et al. | Nov 2006 | B2 |
7140528 | Shelton, IV | Nov 2006 | B2 |
7143923 | Shelton, IV et al. | Dec 2006 | B2 |
7143925 | Shelton, IV et al. | Dec 2006 | B2 |
7147139 | Schwemberger et al. | Dec 2006 | B2 |
7155316 | Sutherland et al. | Dec 2006 | B2 |
7164940 | Hareyama et al. | Jan 2007 | B2 |
7169145 | Isaacson et al. | Jan 2007 | B2 |
7177533 | McFarlin et al. | Feb 2007 | B2 |
7182775 | de Guillebon et al. | Feb 2007 | B2 |
7207472 | Wukusick et al. | Apr 2007 | B2 |
7208005 | Frecker et al. | Apr 2007 | B2 |
7217269 | El-Galley et al. | May 2007 | B2 |
7230529 | Ketcherside, Jr. et al. | Jun 2007 | B2 |
7232447 | Gellman et al. | Jun 2007 | B2 |
7236817 | Papas et al. | Jun 2007 | B2 |
7246734 | Shelton, IV | Jul 2007 | B2 |
7252664 | Nasab et al. | Aug 2007 | B2 |
7278563 | Green | Oct 2007 | B1 |
7294106 | Birkenbach et al. | Nov 2007 | B2 |
7294116 | Ellman et al. | Nov 2007 | B1 |
7296724 | Green et al. | Nov 2007 | B2 |
7317955 | McGreevy | Jan 2008 | B2 |
7328828 | Ortiz et al. | Feb 2008 | B2 |
7334717 | Rethy et al. | Feb 2008 | B2 |
7343565 | Ying et al. | Mar 2008 | B2 |
7344532 | Goble et al. | Mar 2008 | B2 |
7353068 | Tanaka et al. | Apr 2008 | B2 |
7362228 | Nycz et al. | Apr 2008 | B2 |
7371227 | Zeiner | May 2008 | B2 |
7380695 | Doll et al. | Jun 2008 | B2 |
7383088 | Spinelli et al. | Jun 2008 | B2 |
7391173 | Schena | Jun 2008 | B2 |
7407074 | Ortiz et al. | Aug 2008 | B2 |
7408439 | Wang et al. | Aug 2008 | B2 |
7413541 | Konishi | Aug 2008 | B2 |
7422136 | Marczyk | Sep 2008 | B1 |
7422139 | Shelton, IV et al. | Sep 2008 | B2 |
7423972 | Shaham et al. | Sep 2008 | B2 |
D579876 | Novotney et al. | Nov 2008 | S |
7457804 | Uber, III et al. | Nov 2008 | B2 |
D583328 | Chiang | Dec 2008 | S |
7464847 | Viola et al. | Dec 2008 | B2 |
7464849 | Shelton, IV et al. | Dec 2008 | B2 |
7496418 | Kim et al. | Feb 2009 | B2 |
D589447 | Sasada et al. | Mar 2009 | S |
7515961 | Germanson et al. | Apr 2009 | B2 |
7518502 | Austin et al. | Apr 2009 | B2 |
7554343 | Bromfield | Jun 2009 | B2 |
7563259 | Takahashi | Jul 2009 | B2 |
7568604 | Ehrenfels et al. | Aug 2009 | B2 |
7575144 | Ortiz et al. | Aug 2009 | B2 |
7597731 | Palmerton et al. | Oct 2009 | B2 |
7617137 | Kreiner et al. | Nov 2009 | B2 |
7621192 | Conti et al. | Nov 2009 | B2 |
7621898 | Lalomia et al. | Nov 2009 | B2 |
7631793 | Rethy et al. | Dec 2009 | B2 |
7637410 | Marczyk | Dec 2009 | B2 |
7637907 | Blaha | Dec 2009 | B2 |
7641092 | Kruszynski et al. | Jan 2010 | B2 |
7644848 | Swayze et al. | Jan 2010 | B2 |
7667592 | Ohyama et al. | Feb 2010 | B2 |
7667839 | Bates | Feb 2010 | B2 |
7670334 | Hueil et al. | Mar 2010 | B2 |
7694865 | Scirica | Apr 2010 | B2 |
7699860 | Huitema et al. | Apr 2010 | B2 |
7720306 | Gardiner et al. | May 2010 | B2 |
7721934 | Shelton, IV et al. | May 2010 | B2 |
7721936 | Shalton, IV et al. | May 2010 | B2 |
7722603 | McPherson | May 2010 | B2 |
7736357 | Lee, Jr. et al. | Jun 2010 | B2 |
7742176 | Braunecker et al. | Jun 2010 | B2 |
7743960 | Whitman et al. | Jun 2010 | B2 |
7753245 | Boudreaux et al. | Jul 2010 | B2 |
7757028 | Druke et al. | Jul 2010 | B2 |
7766207 | Mather et al. | Aug 2010 | B2 |
7766905 | Paterson et al. | Aug 2010 | B2 |
7770773 | Whitman et al. | Aug 2010 | B2 |
7771429 | Ballard et al. | Aug 2010 | B2 |
7776037 | Odom | Aug 2010 | B2 |
7782789 | Stultz et al. | Aug 2010 | B2 |
7784663 | Shelton, IV | Aug 2010 | B2 |
7803151 | Whitman | Sep 2010 | B2 |
7810692 | Hall et al. | Oct 2010 | B2 |
7818041 | Kim et al. | Oct 2010 | B2 |
7819298 | Hall et al. | Oct 2010 | B2 |
7832612 | Baxter, III et al. | Nov 2010 | B2 |
7833219 | Tashiro et al. | Nov 2010 | B2 |
7836085 | Petakov et al. | Nov 2010 | B2 |
7837079 | Holsten et al. | Nov 2010 | B2 |
7837680 | Isaacson et al. | Nov 2010 | B2 |
7841980 | Minosawa et al. | Nov 2010 | B2 |
7845537 | Shelton, IV et al. | Dec 2010 | B2 |
7857185 | Swayze et al. | Dec 2010 | B2 |
D631252 | Leslie | Jan 2011 | S |
7862560 | Marlon | Jan 2011 | B2 |
7862579 | Ortiz et al. | Jan 2011 | B2 |
7865236 | Cory et al. | Jan 2011 | B2 |
7884735 | Newkirk | Feb 2011 | B2 |
7887530 | Zemlok et al. | Feb 2011 | B2 |
7892337 | Palmerton et al. | Feb 2011 | B2 |
7907166 | Lamprecht et al. | Mar 2011 | B2 |
7913891 | Doll et al. | Mar 2011 | B2 |
7918230 | Whitman et al. | Apr 2011 | B2 |
7918377 | Measamer et al. | Apr 2011 | B2 |
7920706 | Asokan et al. | Apr 2011 | B2 |
7927014 | Dehler | Apr 2011 | B2 |
7932826 | Fritchie et al. | Apr 2011 | B2 |
7942300 | Rethy et al. | May 2011 | B2 |
7945065 | Menzl et al. | May 2011 | B2 |
7945342 | Tsai et al. | May 2011 | B2 |
7951148 | McClurken | May 2011 | B2 |
7954682 | Giordano et al. | Jun 2011 | B2 |
7954687 | Zemlok et al. | Jun 2011 | B2 |
7955322 | Devengenzo et al. | Jun 2011 | B2 |
7956620 | Gilbert | Jun 2011 | B2 |
7963433 | Whitman et al. | Jun 2011 | B2 |
7966269 | Bauer et al. | Jun 2011 | B2 |
7967180 | Scirica | Jun 2011 | B2 |
7976553 | Shelton, IV et al. | Jul 2011 | B2 |
7979157 | Anvari | Jul 2011 | B2 |
7980443 | Scheib et al. | Jul 2011 | B2 |
7982776 | Dunki-Jacobs et al. | Jul 2011 | B2 |
7988028 | Farascioni et al. | Aug 2011 | B2 |
7993140 | Sakezles | Aug 2011 | B2 |
7993354 | Brecher et al. | Aug 2011 | B1 |
7995045 | Dunki-Jacobs | Aug 2011 | B2 |
8005947 | Morris et al. | Aug 2011 | B2 |
8007494 | Taylor et al. | Aug 2011 | B1 |
8007513 | Nalagatla et al. | Aug 2011 | B2 |
8010180 | Quaid et al. | Aug 2011 | B2 |
8012170 | Whitman et al. | Sep 2011 | B2 |
8015976 | Shah | Sep 2011 | B2 |
8016855 | Whitman et al. | Sep 2011 | B2 |
8019094 | Hsieh et al. | Sep 2011 | B2 |
8025199 | Whitman et al. | Sep 2011 | B2 |
8027710 | Dannan | Sep 2011 | B1 |
8035685 | Jensen | Oct 2011 | B2 |
8038686 | Huitema et al. | Oct 2011 | B2 |
8038693 | Allen | Oct 2011 | B2 |
8043560 | Okumoto et al. | Oct 2011 | B2 |
8054184 | Cline et al. | Nov 2011 | B2 |
8054752 | Druke et al. | Nov 2011 | B2 |
8062306 | Nobis et al. | Nov 2011 | B2 |
8062330 | Prommersberger et al. | Nov 2011 | B2 |
8066721 | Kortenbach et al. | Nov 2011 | B2 |
8074861 | Ehrenfels et al. | Dec 2011 | B2 |
8075571 | Vitali et al. | Dec 2011 | B2 |
8096459 | Ortiz et al. | Jan 2012 | B2 |
8118206 | Zand et al. | Feb 2012 | B2 |
8120301 | Goldberg et al. | Feb 2012 | B2 |
8123764 | Meade et al. | Feb 2012 | B2 |
D655678 | Kobayashi et al. | Mar 2012 | S |
8128625 | Odom | Mar 2012 | B2 |
8131565 | Dicks et al. | Mar 2012 | B2 |
8136712 | Zingman | Mar 2012 | B2 |
8146149 | Steinkogler et al. | Mar 2012 | B2 |
D657368 | Magee et al. | Apr 2012 | S |
8147486 | Honour et al. | Apr 2012 | B2 |
8155479 | Hoffman et al. | Apr 2012 | B2 |
8157145 | Shelton, IV et al. | Apr 2012 | B2 |
8157150 | Viola et al. | Apr 2012 | B2 |
8157151 | Ingmanson et al. | Apr 2012 | B2 |
8160098 | Yan et al. | Apr 2012 | B1 |
8160690 | Wilfley et al. | Apr 2012 | B2 |
8161977 | Shelton, IV et al. | Apr 2012 | B2 |
8170396 | Kuspa et al. | May 2012 | B2 |
8172836 | Ward | May 2012 | B2 |
8181839 | Beetel | May 2012 | B2 |
8185409 | Putnam et al. | May 2012 | B2 |
8206345 | Abboud et al. | Jun 2012 | B2 |
8208707 | Mendonca et al. | Jun 2012 | B2 |
8210411 | Yates et al. | Jul 2012 | B2 |
8214007 | Baker et al. | Jul 2012 | B2 |
8216849 | Petty | Jul 2012 | B2 |
8220688 | Laurent et al. | Jul 2012 | B2 |
8225643 | Abboud et al. | Jul 2012 | B2 |
8225979 | Farascioni et al. | Jul 2012 | B2 |
8229549 | Whitman et al. | Jul 2012 | B2 |
8231042 | Hessler et al. | Jul 2012 | B2 |
8239066 | Jennings et al. | Aug 2012 | B2 |
8241322 | Whitman et al. | Aug 2012 | B2 |
8255045 | Gharib et al. | Aug 2012 | B2 |
D667838 | Magee et al. | Sep 2012 | S |
8257387 | Cunningham | Sep 2012 | B2 |
8260016 | Maeda et al. | Sep 2012 | B2 |
8262560 | Whitman | Sep 2012 | B2 |
8292639 | Achammer et al. | Oct 2012 | B2 |
8292888 | Whitman | Oct 2012 | B2 |
8295902 | Salahieh et al. | Oct 2012 | B2 |
8308040 | Huang et al. | Nov 2012 | B2 |
8321581 | Katis et al. | Nov 2012 | B2 |
8322590 | Patel et al. | Dec 2012 | B2 |
8328065 | Shah | Dec 2012 | B2 |
8335590 | Costa et al. | Dec 2012 | B2 |
D675164 | Kobayashi et al. | Jan 2013 | S |
8343065 | Bartol et al. | Jan 2013 | B2 |
8346392 | Walser et al. | Jan 2013 | B2 |
8360299 | Zemlok et al. | Jan 2013 | B2 |
8364222 | Cook et al. | Jan 2013 | B2 |
D676392 | Gassauer | Feb 2013 | S |
8365975 | Manoux et al. | Feb 2013 | B1 |
D678196 | Miyauchi et al. | Mar 2013 | S |
D678304 | Yakoub et al. | Mar 2013 | S |
8388652 | Viola | Mar 2013 | B2 |
8393514 | Shelton, IV et al. | Mar 2013 | B2 |
8397972 | Kostrzewski | Mar 2013 | B2 |
8398541 | DiMaio et al. | Mar 2013 | B2 |
8403944 | Pain et al. | Mar 2013 | B2 |
8403945 | Whitfield et al. | Mar 2013 | B2 |
8403946 | Whitfield et al. | Mar 2013 | B2 |
8406859 | Zuzak et al. | Mar 2013 | B2 |
8411034 | Boillot et al. | Apr 2013 | B2 |
8413871 | Racenet et al. | Apr 2013 | B2 |
8422035 | Hinderling et al. | Apr 2013 | B2 |
8423182 | Robinson et al. | Apr 2013 | B2 |
8428722 | Verhoef et al. | Apr 2013 | B2 |
8429153 | Birdwell et al. | Apr 2013 | B2 |
8439910 | Greep et al. | May 2013 | B2 |
8444663 | Houser et al. | May 2013 | B2 |
8452615 | Abri | May 2013 | B2 |
8454506 | Rothman et al. | Jun 2013 | B2 |
8461744 | Wiener et al. | Jun 2013 | B2 |
8468030 | Stroup et al. | Jun 2013 | B2 |
8469973 | Meade et al. | Jun 2013 | B2 |
8472630 | Konrad et al. | Jun 2013 | B2 |
8473066 | Aghassian et al. | Jun 2013 | B2 |
D687146 | Juzkiw et al. | Jul 2013 | S |
8476227 | Kaplan et al. | Jul 2013 | B2 |
8478418 | Fahey | Jul 2013 | B2 |
8489235 | Moll et al. | Jul 2013 | B2 |
8499992 | Whitman et al. | Aug 2013 | B2 |
8500728 | Newton et al. | Aug 2013 | B2 |
8500756 | Papa et al. | Aug 2013 | B2 |
8503759 | Greer et al. | Aug 2013 | B2 |
8505801 | Ehrenfels et al. | Aug 2013 | B2 |
8506478 | Mizuyoshi | Aug 2013 | B2 |
8512325 | Mathonnet | Aug 2013 | B2 |
8512365 | Wiener et al. | Aug 2013 | B2 |
8515520 | Brunnett et al. | Aug 2013 | B2 |
8517239 | Scheib et al. | Aug 2013 | B2 |
8521331 | Itkowitz | Aug 2013 | B2 |
8523043 | Ullrich et al. | Sep 2013 | B2 |
8533475 | Frikart et al. | Sep 2013 | B2 |
8540709 | Allen | Sep 2013 | B2 |
8546996 | Messerly et al. | Oct 2013 | B2 |
8554697 | Claus et al. | Oct 2013 | B2 |
8560047 | Haider et al. | Oct 2013 | B2 |
8561870 | Baxter, III et al. | Oct 2013 | B2 |
8562598 | Falkenstein et al. | Oct 2013 | B2 |
8566115 | Moore | Oct 2013 | B2 |
8567393 | Hickle et al. | Oct 2013 | B2 |
8568411 | Falkenstein et al. | Oct 2013 | B2 |
8571598 | Valavi | Oct 2013 | B2 |
8573459 | Smith et al. | Nov 2013 | B2 |
8573465 | Shelton, IV | Nov 2013 | B2 |
8574229 | Eder et al. | Nov 2013 | B2 |
8585631 | Dacquay | Nov 2013 | B2 |
8585694 | Amoah et al. | Nov 2013 | B2 |
8590762 | Hess et al. | Nov 2013 | B2 |
8591536 | Robertson | Nov 2013 | B2 |
8595607 | Nekoomaram et al. | Nov 2013 | B2 |
8596513 | Olson et al. | Dec 2013 | B2 |
8596515 | Okoniewski | Dec 2013 | B2 |
8604709 | Jalbout et al. | Dec 2013 | B2 |
8608044 | Hueil et al. | Dec 2013 | B2 |
8608045 | Smith et al. | Dec 2013 | B2 |
8616431 | Timm et al. | Dec 2013 | B2 |
8617155 | Johnson et al. | Dec 2013 | B2 |
8620055 | Barratt et al. | Dec 2013 | B2 |
8620473 | Diolaiti et al. | Dec 2013 | B2 |
8622275 | Baxter, III et al. | Jan 2014 | B2 |
8623027 | Price et al. | Jan 2014 | B2 |
8627483 | Rachlin et al. | Jan 2014 | B2 |
8627993 | Smith et al. | Jan 2014 | B2 |
8627995 | Smith et al. | Jan 2014 | B2 |
8628518 | Blumenkranz et al. | Jan 2014 | B2 |
8628545 | Cabrera et al. | Jan 2014 | B2 |
8631987 | Shelton, IV et al. | Jan 2014 | B2 |
8632525 | Kerr et al. | Jan 2014 | B2 |
8636190 | Zemlok et al. | Jan 2014 | B2 |
8636736 | Yates et al. | Jan 2014 | B2 |
8641621 | Razzaque et al. | Feb 2014 | B2 |
8652086 | Gerg et al. | Feb 2014 | B2 |
8652121 | Quick et al. | Feb 2014 | B2 |
8652128 | Ward | Feb 2014 | B2 |
8657176 | Shelton, IV et al. | Feb 2014 | B2 |
8657177 | Scirica et al. | Feb 2014 | B2 |
8663220 | Wiener et al. | Mar 2014 | B2 |
8663222 | Anderson et al. | Mar 2014 | B2 |
8666544 | Moll et al. | Mar 2014 | B2 |
8679114 | Chapman | Mar 2014 | B2 |
8682049 | Zhao et al. | Mar 2014 | B2 |
8682489 | Itkowitz et al. | Mar 2014 | B2 |
8685056 | Evans et al. | Apr 2014 | B2 |
8688188 | Heller et al. | Apr 2014 | B2 |
8690864 | Hoarau | Apr 2014 | B2 |
8701962 | Kostrzewski | Apr 2014 | B2 |
D704839 | Juzkiw et al. | May 2014 | S |
8719061 | Birchall | May 2014 | B2 |
8720766 | Hess et al. | May 2014 | B2 |
8733613 | Huitema et al. | May 2014 | B2 |
8740840 | Foley et al. | Jun 2014 | B2 |
8740866 | Reasoner et al. | Jun 2014 | B2 |
8747238 | Shelton, IV et al. | Jun 2014 | B2 |
8752749 | Moore et al. | Jun 2014 | B2 |
8757465 | Woodard, Jr. et al. | Jun 2014 | B2 |
8761717 | Buchheit | Jun 2014 | B1 |
8763879 | Shelton, IV et al. | Jul 2014 | B2 |
8768251 | Claus et al. | Jul 2014 | B2 |
8771270 | Burbank | Jul 2014 | B2 |
8775196 | Simpson et al. | Jul 2014 | B2 |
8779648 | Giordano et al. | Jul 2014 | B2 |
8790253 | Sunagawa et al. | Jul 2014 | B2 |
8794497 | Zingman | Aug 2014 | B2 |
8795001 | Lam et al. | Aug 2014 | B1 |
8799008 | Johnson et al. | Aug 2014 | B2 |
8799009 | Mellin et al. | Aug 2014 | B2 |
8800838 | Shelton, IV | Aug 2014 | B2 |
8801703 | Gregg et al. | Aug 2014 | B2 |
8814996 | Giurgiutiu et al. | Aug 2014 | B2 |
8818556 | Sanchez et al. | Aug 2014 | B2 |
8819581 | Nakamura et al. | Aug 2014 | B2 |
8820603 | Shelton, IV et al. | Sep 2014 | B2 |
8820608 | Miyamoto | Sep 2014 | B2 |
8827134 | Viola et al. | Sep 2014 | B2 |
8827136 | Hessler | Sep 2014 | B2 |
8840003 | Morgan et al. | Sep 2014 | B2 |
D716333 | Chotin et al. | Oct 2014 | S |
8851354 | Swensgard et al. | Oct 2014 | B2 |
8852174 | Burbank | Oct 2014 | B2 |
8875973 | Whitman | Nov 2014 | B2 |
8876857 | Burbank | Nov 2014 | B2 |
8882662 | Charles | Nov 2014 | B2 |
8885032 | Igarashi et al. | Nov 2014 | B2 |
8886790 | Harrang et al. | Nov 2014 | B2 |
8893949 | Shelton, IV et al. | Nov 2014 | B2 |
8899479 | Cappuzzo et al. | Dec 2014 | B2 |
8905977 | Shelton et al. | Dec 2014 | B2 |
8912746 | Reid et al. | Dec 2014 | B2 |
8914098 | Brennan et al. | Dec 2014 | B2 |
8917513 | Hazzard | Dec 2014 | B1 |
8918207 | Prisco | Dec 2014 | B2 |
8920186 | Shishikura | Dec 2014 | B2 |
8920414 | Stone et al. | Dec 2014 | B2 |
8920433 | Barrier et al. | Dec 2014 | B2 |
8930203 | Kiaie et al. | Jan 2015 | B2 |
8930214 | Woolford | Jan 2015 | B2 |
8931679 | Kostrzewski | Jan 2015 | B2 |
8934684 | Mohamed | Jan 2015 | B2 |
8936614 | Allen, IV | Jan 2015 | B2 |
8945095 | Blumenkranz et al. | Feb 2015 | B2 |
8945163 | Voegele et al. | Feb 2015 | B2 |
8955732 | Zemlok et al. | Feb 2015 | B2 |
8956581 | Rosenbaum et al. | Feb 2015 | B2 |
8960519 | Whitman et al. | Feb 2015 | B2 |
8960520 | McCuen | Feb 2015 | B2 |
8962062 | Podhajsky et al. | Feb 2015 | B2 |
8967443 | McCuen | Mar 2015 | B2 |
8967455 | Zhou | Mar 2015 | B2 |
8968276 | Zemlok et al. | Mar 2015 | B2 |
8968296 | McPherson | Mar 2015 | B2 |
8968309 | Roy et al. | Mar 2015 | B2 |
8968312 | Marczyk et al. | Mar 2015 | B2 |
8968337 | Whitfield et al. | Mar 2015 | B2 |
8968358 | Reschke | Mar 2015 | B2 |
8974429 | Gordon et al. | Mar 2015 | B2 |
8979890 | Boudreaux | Mar 2015 | B2 |
8986288 | Konishi | Mar 2015 | B2 |
8986302 | Aldridge et al. | Mar 2015 | B2 |
8989903 | Weir et al. | Mar 2015 | B2 |
8991678 | Wellman et al. | Mar 2015 | B2 |
8992565 | Brisson et al. | Mar 2015 | B2 |
8998797 | Omori | Apr 2015 | B2 |
9002518 | Manzo et al. | Apr 2015 | B2 |
9010608 | Casasanta, Jr. et al. | Apr 2015 | B2 |
9010611 | Ross et al. | Apr 2015 | B2 |
9011366 | Dean et al. | Apr 2015 | B2 |
9011427 | Price et al. | Apr 2015 | B2 |
9016539 | Kostrzewski et al. | Apr 2015 | B2 |
9017326 | DiNardo et al. | Apr 2015 | B2 |
9020240 | Pettersson et al. | Apr 2015 | B2 |
D729267 | Yoo et al. | May 2015 | S |
9023032 | Robinson | May 2015 | B2 |
9023071 | Miller et al. | May 2015 | B2 |
9027431 | Tang et al. | May 2015 | B2 |
9028494 | Shelton, IV et al. | May 2015 | B2 |
9035568 | Ganton et al. | May 2015 | B2 |
9038882 | Racenet et al. | May 2015 | B2 |
9043027 | Durant et al. | May 2015 | B2 |
9044227 | Shelton, IV et al. | Jun 2015 | B2 |
9044244 | Ludwin et al. | Jun 2015 | B2 |
9044261 | Houser | Jun 2015 | B2 |
9050063 | Roe et al. | Jun 2015 | B2 |
9050083 | Yates et al. | Jun 2015 | B2 |
9050120 | Swarup et al. | Jun 2015 | B2 |
9052809 | Vesto | Jun 2015 | B2 |
9055035 | Porsch et al. | Jun 2015 | B2 |
9055870 | Meador et al. | Jun 2015 | B2 |
9060770 | Shelton, IV et al. | Jun 2015 | B2 |
9060775 | Wiener et al. | Jun 2015 | B2 |
9066650 | Sekiguchi | Jun 2015 | B2 |
9072523 | Houser et al. | Jul 2015 | B2 |
9072535 | Shelton, IV et al. | Jul 2015 | B2 |
9072536 | Shelton, IV et al. | Jul 2015 | B2 |
9078653 | Leimbach et al. | Jul 2015 | B2 |
9078727 | Miller | Jul 2015 | B2 |
9084606 | Greep | Jul 2015 | B2 |
9089360 | Messerly et al. | Jul 2015 | B2 |
9095362 | Dachs, II et al. | Aug 2015 | B2 |
9095367 | Olson et al. | Aug 2015 | B2 |
9099863 | Smith et al. | Aug 2015 | B2 |
9101358 | Kerr et al. | Aug 2015 | B2 |
9101359 | Smith et al. | Aug 2015 | B2 |
9101374 | Hoch et al. | Aug 2015 | B1 |
9106270 | Puterbaugh et al. | Aug 2015 | B2 |
9107573 | Birnkrant | Aug 2015 | B2 |
9107662 | Kostrzewski | Aug 2015 | B2 |
9107684 | Ma | Aug 2015 | B2 |
9107688 | Kimball et al. | Aug 2015 | B2 |
9107689 | Robertson et al. | Aug 2015 | B2 |
9107694 | Hendriks et al. | Aug 2015 | B2 |
9111548 | Nandy et al. | Aug 2015 | B2 |
9113880 | Zemlok et al. | Aug 2015 | B2 |
9114494 | Mah | Aug 2015 | B1 |
9116597 | Gulasky | Aug 2015 | B1 |
9119617 | Souls et al. | Sep 2015 | B2 |
9119655 | Bowling et al. | Sep 2015 | B2 |
9119657 | Shelton, IV et al. | Sep 2015 | B2 |
9123155 | Cunningham et al. | Sep 2015 | B2 |
9125644 | Lane et al. | Sep 2015 | B2 |
9129054 | Nawana et al. | Sep 2015 | B2 |
9137254 | Bilbrey et al. | Sep 2015 | B2 |
9138129 | Diolaiti | Sep 2015 | B2 |
9138225 | Huang et al. | Sep 2015 | B2 |
9149322 | Knowlton | Oct 2015 | B2 |
9155503 | Cadwell | Oct 2015 | B2 |
9160853 | Daddi et al. | Oct 2015 | B1 |
9161803 | Yates et al. | Oct 2015 | B2 |
9168054 | Turner et al. | Oct 2015 | B2 |
9168091 | Janssen et al. | Oct 2015 | B2 |
9168104 | Dein | Oct 2015 | B2 |
9179912 | Yates et al. | Nov 2015 | B2 |
9183723 | Sherman et al. | Nov 2015 | B2 |
9186143 | Timm et al. | Nov 2015 | B2 |
9192375 | Skinlo et al. | Nov 2015 | B2 |
9192447 | Choi et al. | Nov 2015 | B2 |
9192707 | Gerber et al. | Nov 2015 | B2 |
9198711 | Joseph | Dec 2015 | B2 |
9202078 | Abuelsaad et al. | Dec 2015 | B2 |
9204830 | Zand et al. | Dec 2015 | B2 |
9204879 | Shelton, IV | Dec 2015 | B2 |
9204995 | Scheller et al. | Dec 2015 | B2 |
9211120 | Scheib et al. | Dec 2015 | B2 |
9216062 | Duque et al. | Dec 2015 | B2 |
9218053 | Komuro et al. | Dec 2015 | B2 |
9220502 | Zemlok et al. | Dec 2015 | B2 |
9226689 | Jacobsen et al. | Jan 2016 | B2 |
9226751 | Shelton, IV et al. | Jan 2016 | B2 |
9226766 | Aldridge et al. | Jan 2016 | B2 |
9226767 | Stulen et al. | Jan 2016 | B2 |
9226791 | McCarthy et al. | Jan 2016 | B2 |
9232883 | Ozawa et al. | Jan 2016 | B2 |
9237891 | Shelton, IV | Jan 2016 | B2 |
9237921 | Messerly et al. | Jan 2016 | B2 |
9241728 | Price et al. | Jan 2016 | B2 |
9241730 | Babaev | Jan 2016 | B2 |
9241731 | Boudreaux et al. | Jan 2016 | B2 |
9247996 | Merana et al. | Feb 2016 | B1 |
9250172 | Harris et al. | Feb 2016 | B2 |
9255907 | Heanue et al. | Feb 2016 | B2 |
9259282 | Azizian et al. | Feb 2016 | B2 |
9265429 | St. Pierre et al. | Feb 2016 | B2 |
9265585 | Wingardner et al. | Feb 2016 | B2 |
9265959 | Drew et al. | Feb 2016 | B2 |
9272406 | Aronhalt et al. | Mar 2016 | B2 |
9277956 | Zhang | Mar 2016 | B2 |
9277961 | Panescu et al. | Mar 2016 | B2 |
9277969 | Brannan et al. | Mar 2016 | B2 |
9280884 | Schultz et al. | Mar 2016 | B1 |
9282962 | Schmid et al. | Mar 2016 | B2 |
9282974 | Shelton, IV | Mar 2016 | B2 |
9283045 | Rhee et al. | Mar 2016 | B2 |
9283054 | Morgan et al. | Mar 2016 | B2 |
9289211 | Williams et al. | Mar 2016 | B2 |
9289212 | Shelton, IV et al. | Mar 2016 | B2 |
9295514 | Shelton, IV et al. | Mar 2016 | B2 |
9301691 | Hufnagel et al. | Apr 2016 | B2 |
9301753 | Aldridge et al. | Apr 2016 | B2 |
9301755 | Shelton, IV et al. | Apr 2016 | B2 |
9301759 | Spivey et al. | Apr 2016 | B2 |
9301810 | Amiri et al. | Apr 2016 | B2 |
9302213 | Manahan et al. | Apr 2016 | B2 |
9307894 | von Grunberg et al. | Apr 2016 | B2 |
9307914 | Fahey | Apr 2016 | B2 |
9307986 | Hall et al. | Apr 2016 | B2 |
9314246 | Shelton, IV et al. | Apr 2016 | B2 |
9314308 | Parihar et al. | Apr 2016 | B2 |
9320563 | Brustad et al. | Apr 2016 | B2 |
9325732 | Stickle et al. | Apr 2016 | B1 |
9326767 | Koch et al. | May 2016 | B2 |
9326770 | Shelton, IV et al. | May 2016 | B2 |
9331422 | Nazzaro et al. | May 2016 | B2 |
9332987 | Leimbach et al. | May 2016 | B2 |
9333042 | Diolaiti et al. | May 2016 | B2 |
9336385 | Spencer et al. | May 2016 | B1 |
9341704 | Picard et al. | May 2016 | B2 |
9345481 | Hall et al. | May 2016 | B2 |
9345490 | Ippisch | May 2016 | B2 |
9345544 | Hourtash et al. | May 2016 | B2 |
9345546 | Toth et al. | May 2016 | B2 |
9345900 | Wu et al. | May 2016 | B2 |
9351726 | Leimbach et al. | May 2016 | B2 |
9351727 | Leimbach et al. | May 2016 | B2 |
9358003 | Hall et al. | Jun 2016 | B2 |
9358685 | Meier et al. | Jun 2016 | B2 |
9360449 | Durie | Jun 2016 | B2 |
9364230 | Shelton, IV et al. | Jun 2016 | B2 |
9364231 | Wenchell | Jun 2016 | B2 |
9364249 | Kimball et al. | Jun 2016 | B2 |
9364294 | Razzaque et al. | Jun 2016 | B2 |
9370400 | Parihar | Jun 2016 | B2 |
9375282 | Nau, Jr. et al. | Jun 2016 | B2 |
9375539 | Stearns et al. | Jun 2016 | B2 |
9381003 | Todor et al. | Jul 2016 | B2 |
9381058 | Houser et al. | Jul 2016 | B2 |
9386984 | Aronhalt et al. | Jul 2016 | B2 |
9386988 | Baxter, III et al. | Jul 2016 | B2 |
9387295 | Mastri et al. | Jul 2016 | B1 |
9393017 | Flanagan et al. | Jul 2016 | B2 |
9393037 | Olson et al. | Jul 2016 | B2 |
9398905 | Martin | Jul 2016 | B2 |
9398911 | Auld | Jul 2016 | B2 |
9402629 | Ehrenfels et al. | Aug 2016 | B2 |
9414776 | Sillay et al. | Aug 2016 | B2 |
9414940 | Stein et al. | Aug 2016 | B2 |
9419018 | Sasagawa et al. | Aug 2016 | B2 |
9421014 | Ingmanson et al. | Aug 2016 | B2 |
9433470 | Choi | Sep 2016 | B2 |
9439622 | Case et al. | Sep 2016 | B2 |
9439668 | Timm et al. | Sep 2016 | B2 |
9439736 | Olson | Sep 2016 | B2 |
9445764 | Gross et al. | Sep 2016 | B2 |
9445813 | Shelton, IV et al. | Sep 2016 | B2 |
9450701 | Do et al. | Sep 2016 | B2 |
9451949 | Gorek et al. | Sep 2016 | B2 |
9451958 | Shelton, IV et al. | Sep 2016 | B2 |
9463022 | Swayze et al. | Oct 2016 | B2 |
9463646 | Payne et al. | Oct 2016 | B2 |
9468438 | Baber et al. | Oct 2016 | B2 |
9474565 | Shikhman et al. | Oct 2016 | B2 |
D772252 | Myers et al. | Nov 2016 | S |
9480492 | Aranyi et al. | Nov 2016 | B2 |
9485475 | Speier et al. | Nov 2016 | B2 |
9486271 | Dunning | Nov 2016 | B2 |
9492146 | Kostrzewski et al. | Nov 2016 | B2 |
9492237 | Kang et al. | Nov 2016 | B2 |
9493807 | Little et al. | Nov 2016 | B2 |
9498182 | Case et al. | Nov 2016 | B2 |
9498215 | Duque et al. | Nov 2016 | B2 |
9498231 | Halder et al. | Nov 2016 | B2 |
9509566 | Chu et al. | Nov 2016 | B2 |
9516239 | Blanquart et al. | Dec 2016 | B2 |
9519753 | Gerdeman et al. | Dec 2016 | B1 |
9522003 | Weir et al. | Dec 2016 | B2 |
9526407 | Hoeg et al. | Dec 2016 | B2 |
9526499 | Kostrzewski et al. | Dec 2016 | B2 |
9526587 | Zhao et al. | Dec 2016 | B2 |
9532827 | Morgan et al. | Jan 2017 | B2 |
9532845 | Dossett et al. | Jan 2017 | B1 |
9539007 | Dhakad et al. | Jan 2017 | B2 |
9539020 | Conlon et al. | Jan 2017 | B2 |
9542481 | Halter et al. | Jan 2017 | B2 |
9546662 | Shener-Irmakoglu et al. | Jan 2017 | B2 |
9549781 | He et al. | Jan 2017 | B2 |
9554692 | Levy | Jan 2017 | B2 |
9554794 | Baber et al. | Jan 2017 | B2 |
9554854 | Yates et al. | Jan 2017 | B2 |
9561038 | Shelton, IV et al. | Feb 2017 | B2 |
9561045 | Hinman et al. | Feb 2017 | B2 |
9561082 | Yen et al. | Feb 2017 | B2 |
9561982 | Enicks et al. | Feb 2017 | B2 |
9566708 | Kurnianto | Feb 2017 | B2 |
9572592 | Price et al. | Feb 2017 | B2 |
9579099 | Penna et al. | Feb 2017 | B2 |
9579503 | McKinney et al. | Feb 2017 | B2 |
9585657 | Shelton, IV et al. | Mar 2017 | B2 |
9592095 | Panescu et al. | Mar 2017 | B2 |
9597081 | Swayze et al. | Mar 2017 | B2 |
9600031 | Kaneko et al. | Mar 2017 | B2 |
9600138 | Thomas et al. | Mar 2017 | B2 |
9603024 | Wang et al. | Mar 2017 | B2 |
9603277 | Morgan et al. | Mar 2017 | B2 |
9603609 | Kawashima et al. | Mar 2017 | B2 |
D783675 | Yagisawa et al. | Apr 2017 | S |
D784270 | Bhattacharya | Apr 2017 | S |
9610114 | Baxter, III et al. | Apr 2017 | B2 |
9610412 | Zemlok et al. | Apr 2017 | B2 |
9615877 | Tyrrell | Apr 2017 | B2 |
9622684 | Wybo | Apr 2017 | B2 |
9622808 | Beller et al. | Apr 2017 | B2 |
9628501 | Datta Ray et al. | Apr 2017 | B2 |
9629560 | Joseph | Apr 2017 | B2 |
9629623 | Lytle, IV et al. | Apr 2017 | B2 |
9629628 | Aranyi | Apr 2017 | B2 |
9629629 | Leimbach et al. | Apr 2017 | B2 |
9630318 | Ibarz Gabardos et al. | Apr 2017 | B2 |
9636096 | Heaton, II et al. | May 2017 | B1 |
9636112 | Penna et al. | May 2017 | B2 |
9636188 | Gattani et al. | May 2017 | B2 |
9636239 | Durand et al. | May 2017 | B2 |
9636825 | Penn et al. | May 2017 | B2 |
9641596 | Unagami et al. | May 2017 | B2 |
9641815 | Richardson et al. | May 2017 | B2 |
9642620 | Baxter, III et al. | May 2017 | B2 |
9643022 | Mashiach et al. | May 2017 | B2 |
9649110 | Parihar et al. | May 2017 | B2 |
9649111 | Shelton, IV et al. | May 2017 | B2 |
9649126 | Robertson et al. | May 2017 | B2 |
9649169 | Cinquin et al. | May 2017 | B2 |
9652655 | Satish et al. | May 2017 | B2 |
9655616 | Aranyi | May 2017 | B2 |
9656092 | Golden | May 2017 | B2 |
9662116 | Smith et al. | May 2017 | B2 |
9662177 | Weir et al. | May 2017 | B2 |
9668729 | Williams et al. | Jun 2017 | B2 |
9668732 | Patel et al. | Jun 2017 | B2 |
9668765 | Grace et al. | Jun 2017 | B2 |
9671860 | Ogawa et al. | Jun 2017 | B2 |
9675264 | Acquista et al. | Jun 2017 | B2 |
9675354 | Weir et al. | Jun 2017 | B2 |
9681870 | Baxter, III et al. | Jun 2017 | B2 |
9686306 | Chizeck et al. | Jun 2017 | B2 |
9687230 | Leimbach et al. | Jun 2017 | B2 |
9690362 | Leimbach et al. | Jun 2017 | B2 |
9700292 | Nawana et al. | Jul 2017 | B2 |
9700309 | Jaworek et al. | Jul 2017 | B2 |
9700312 | Kostrzewski et al. | Jul 2017 | B2 |
9700320 | Dinardo et al. | Jul 2017 | B2 |
9706993 | Hessler et al. | Jul 2017 | B2 |
9710214 | Lin et al. | Jul 2017 | B2 |
9710644 | Reybok et al. | Jul 2017 | B2 |
9713424 | Spaide | Jul 2017 | B2 |
9713503 | Goldschmidt | Jul 2017 | B2 |
9717141 | Tegg | Jul 2017 | B1 |
9717498 | Aranyi et al. | Aug 2017 | B2 |
9717525 | Ahluwalia et al. | Aug 2017 | B2 |
9717548 | Couture | Aug 2017 | B2 |
9724094 | Baber et al. | Aug 2017 | B2 |
9724100 | Scheib et al. | Aug 2017 | B2 |
9724118 | Schulte et al. | Aug 2017 | B2 |
9733663 | Leimbach et al. | Aug 2017 | B2 |
9737301 | Baber et al. | Aug 2017 | B2 |
9737310 | Whitfield et al. | Aug 2017 | B2 |
9737335 | Butler et al. | Aug 2017 | B2 |
9737355 | Yates et al. | Aug 2017 | B2 |
9737371 | Romo et al. | Aug 2017 | B2 |
9740826 | Raghavan et al. | Aug 2017 | B2 |
9743016 | Nestares et al. | Aug 2017 | B2 |
9743929 | Leimbach et al. | Aug 2017 | B2 |
9743946 | Faller et al. | Aug 2017 | B2 |
9743947 | Price et al. | Aug 2017 | B2 |
9750499 | Leimbach et al. | Sep 2017 | B2 |
9750500 | Malkowski | Sep 2017 | B2 |
9750522 | Scheib et al. | Sep 2017 | B2 |
9750523 | Tsubuku | Sep 2017 | B2 |
9750560 | Ballakur et al. | Sep 2017 | B2 |
9750563 | Shikhman et al. | Sep 2017 | B2 |
9753135 | Bosch | Sep 2017 | B2 |
9753568 | McMillen | Sep 2017 | B2 |
9757126 | Cappola | Sep 2017 | B2 |
9757128 | Baber et al. | Sep 2017 | B2 |
9757142 | Shimizu | Sep 2017 | B2 |
9757152 | Ogilvie et al. | Sep 2017 | B2 |
9763741 | Alvarez et al. | Sep 2017 | B2 |
9764164 | Wiener et al. | Sep 2017 | B2 |
9770541 | Carr et al. | Sep 2017 | B2 |
9775611 | Kostrzewski | Oct 2017 | B2 |
9777913 | Talbert et al. | Oct 2017 | B2 |
9782164 | Mumaw et al. | Oct 2017 | B2 |
9782169 | Kimsey et al. | Oct 2017 | B2 |
9782212 | Wham et al. | Oct 2017 | B2 |
9782214 | Houser et al. | Oct 2017 | B2 |
9788835 | Morgan et al. | Oct 2017 | B2 |
9788836 | Overmyer et al. | Oct 2017 | B2 |
9788851 | Dannaher et al. | Oct 2017 | B2 |
9788902 | Inoue et al. | Oct 2017 | B2 |
9788907 | Alvi et al. | Oct 2017 | B1 |
9795436 | Yates et al. | Oct 2017 | B2 |
9797486 | Zergiebel et al. | Oct 2017 | B2 |
9801531 | Morita et al. | Oct 2017 | B2 |
9801626 | Parihar et al. | Oct 2017 | B2 |
9801627 | Harris et al. | Oct 2017 | B2 |
9801679 | Trees et al. | Oct 2017 | B2 |
9802033 | Hibner et al. | Oct 2017 | B2 |
9804618 | Leimbach et al. | Oct 2017 | B2 |
9805472 | Chou et al. | Oct 2017 | B2 |
9808244 | Leimbach et al. | Nov 2017 | B2 |
9808245 | Richard et al. | Nov 2017 | B2 |
9808246 | Shelton, IV et al. | Nov 2017 | B2 |
9808248 | Hoffman | Nov 2017 | B2 |
9808249 | Shelton, IV | Nov 2017 | B2 |
9814457 | Martin et al. | Nov 2017 | B2 |
9814460 | Kimsey et al. | Nov 2017 | B2 |
9814462 | Woodard, Jr. et al. | Nov 2017 | B2 |
9814463 | Williams et al. | Nov 2017 | B2 |
9820699 | Bingley et al. | Nov 2017 | B2 |
9820738 | Lytle, IV et al. | Nov 2017 | B2 |
9820741 | Kostrzewski | Nov 2017 | B2 |
9820768 | Gee et al. | Nov 2017 | B2 |
9826976 | Parihar et al. | Nov 2017 | B2 |
9826977 | Leimbach et al. | Nov 2017 | B2 |
9827054 | Richmond et al. | Nov 2017 | B2 |
9827059 | Robinson et al. | Nov 2017 | B2 |
9830424 | Dixon et al. | Nov 2017 | B2 |
9833241 | Huitema et al. | Dec 2017 | B2 |
9833254 | Barral et al. | Dec 2017 | B1 |
9839419 | Deck et al. | Dec 2017 | B2 |
9839424 | Zergiebel et al. | Dec 2017 | B2 |
9839428 | Baxter, III et al. | Dec 2017 | B2 |
9839467 | Harper et al. | Dec 2017 | B2 |
9839470 | Gilbert et al. | Dec 2017 | B2 |
9839487 | Dachs, II | Dec 2017 | B2 |
9844321 | Ekvall et al. | Dec 2017 | B1 |
9844368 | Boudreaux et al. | Dec 2017 | B2 |
9844369 | Huitema et al. | Dec 2017 | B2 |
9844374 | Lytle, IV et al. | Dec 2017 | B2 |
9844375 | Overmyer et al. | Dec 2017 | B2 |
9844376 | Baxter, III et al. | Dec 2017 | B2 |
9844379 | Shelton, IV et al. | Dec 2017 | B2 |
9848058 | Johnson et al. | Dec 2017 | B2 |
9848877 | Shelton, IV et al. | Dec 2017 | B2 |
9861354 | Saliman et al. | Jan 2018 | B2 |
9861363 | Chen et al. | Jan 2018 | B2 |
9861428 | Trees et al. | Jan 2018 | B2 |
9864839 | Baym et al. | Jan 2018 | B2 |
9867612 | Parihar et al. | Jan 2018 | B2 |
9867651 | Wham | Jan 2018 | B2 |
9867670 | Brannan et al. | Jan 2018 | B2 |
9867914 | Bonano et al. | Jan 2018 | B2 |
9872609 | Levy | Jan 2018 | B2 |
9872683 | Hopkins et al. | Jan 2018 | B2 |
9877718 | Weir et al. | Jan 2018 | B2 |
9877721 | Schellin et al. | Jan 2018 | B2 |
9883860 | Leimbach | Feb 2018 | B2 |
9888864 | Rondon et al. | Feb 2018 | B2 |
9888914 | Martin et al. | Feb 2018 | B2 |
9888919 | Leimbach et al. | Feb 2018 | B2 |
9888921 | Williams et al. | Feb 2018 | B2 |
9888975 | Auld | Feb 2018 | B2 |
9895148 | Shelton, IV et al. | Feb 2018 | B2 |
9900787 | Ou | Feb 2018 | B2 |
9901342 | Shelton, IV et al. | Feb 2018 | B2 |
9901406 | State et al. | Feb 2018 | B2 |
9905000 | Chou et al. | Feb 2018 | B2 |
9907196 | Susini et al. | Feb 2018 | B2 |
9907550 | Sniffin et al. | Mar 2018 | B2 |
9913642 | Leimbach et al. | Mar 2018 | B2 |
9913645 | Zerkle et al. | Mar 2018 | B2 |
9918326 | Gilson et al. | Mar 2018 | B2 |
9918730 | Trees et al. | Mar 2018 | B2 |
9918778 | Walberg et al. | Mar 2018 | B2 |
9918788 | Paul et al. | Mar 2018 | B2 |
9922304 | DeBusk et al. | Mar 2018 | B2 |
9924941 | Burbank | Mar 2018 | B2 |
9924944 | Shelton, IV et al. | Mar 2018 | B2 |
9924961 | Shelton, IV et al. | Mar 2018 | B2 |
9931040 | Homyk et al. | Apr 2018 | B2 |
9931118 | Shelton, IV et al. | Apr 2018 | B2 |
9931124 | Gokharu | Apr 2018 | B2 |
9936863 | Tesar | Apr 2018 | B2 |
9936942 | Chin et al. | Apr 2018 | B2 |
9936955 | Miller et al. | Apr 2018 | B2 |
9936961 | Chien et al. | Apr 2018 | B2 |
9937012 | Hares et al. | Apr 2018 | B2 |
9937014 | Bowling et al. | Apr 2018 | B2 |
9937626 | Rockrohr | Apr 2018 | B2 |
9938972 | Walley | Apr 2018 | B2 |
9943230 | Kaku et al. | Apr 2018 | B2 |
9943309 | Shelton, IV et al. | Apr 2018 | B2 |
9943312 | Posada et al. | Apr 2018 | B2 |
9943377 | Yates et al. | Apr 2018 | B2 |
9943379 | Gregg, II et al. | Apr 2018 | B2 |
9943918 | Grogan et al. | Apr 2018 | B2 |
9943964 | Hares | Apr 2018 | B2 |
9949785 | Price et al. | Apr 2018 | B2 |
9962157 | Sapre | May 2018 | B2 |
9968355 | Shelton, IV et al. | May 2018 | B2 |
9974595 | Anderson et al. | May 2018 | B2 |
9980140 | Spencer et al. | May 2018 | B1 |
9980769 | Trees et al. | May 2018 | B2 |
9980778 | Ohline et al. | May 2018 | B2 |
9987000 | Shelton, IV et al. | Jun 2018 | B2 |
9987068 | Anderson et al. | Jun 2018 | B2 |
9987072 | McPherson | Jun 2018 | B2 |
9990856 | Kuchenbecker et al. | Jun 2018 | B2 |
9993248 | Shelton, IV et al. | Jun 2018 | B2 |
9993258 | Shelton, IV et al. | Jun 2018 | B2 |
9993305 | Andersson | Jun 2018 | B2 |
10004491 | Martin et al. | Jun 2018 | B2 |
10004497 | Overmyer et al. | Jun 2018 | B2 |
10004500 | Shelton, IV et al. | Jun 2018 | B2 |
10004501 | Shelton, IV et al. | Jun 2018 | B2 |
10004527 | Gee et al. | Jun 2018 | B2 |
10004557 | Gross | Jun 2018 | B2 |
D822206 | Shelton, IV et al. | Jul 2018 | S |
10010322 | Shelton, IV et al. | Jul 2018 | B2 |
10010324 | Huitema et al. | Jul 2018 | B2 |
10013049 | Leimbach et al. | Jul 2018 | B2 |
10016199 | Baber et al. | Jul 2018 | B2 |
10021318 | Hugosson et al. | Jul 2018 | B2 |
10022090 | Whitman | Jul 2018 | B2 |
10022120 | Martin et al. | Jul 2018 | B2 |
10022391 | Ruderman Chen et al. | Jul 2018 | B2 |
10022568 | Messerly et al. | Jul 2018 | B2 |
10028402 | Walker | Jul 2018 | B1 |
10028744 | Shelton, IV et al. | Jul 2018 | B2 |
10028761 | Leimbach et al. | Jul 2018 | B2 |
10028788 | Kang | Jul 2018 | B2 |
10034704 | Asher et al. | Jul 2018 | B2 |
10037641 | Hyde et al. | Jul 2018 | B2 |
10037715 | Toly et al. | Jul 2018 | B2 |
D826405 | Shelton, IV et al. | Aug 2018 | S |
10039546 | Williams et al. | Aug 2018 | B2 |
10039564 | Hibner et al. | Aug 2018 | B2 |
10039565 | Vezzu | Aug 2018 | B2 |
10039589 | Virshek et al. | Aug 2018 | B2 |
10041822 | Zemlok | Aug 2018 | B2 |
10044791 | Kamen et al. | Aug 2018 | B2 |
10045704 | Fagin et al. | Aug 2018 | B2 |
10045776 | Shelton, IV et al. | Aug 2018 | B2 |
10045779 | Savage et al. | Aug 2018 | B2 |
10045781 | Cropper et al. | Aug 2018 | B2 |
10045782 | Murthy Aravalli | Aug 2018 | B2 |
10045813 | Mueller | Aug 2018 | B2 |
10048379 | Markendorf et al. | Aug 2018 | B2 |
10052044 | Shelton, IV et al. | Aug 2018 | B2 |
10052102 | Baxter, III et al. | Aug 2018 | B2 |
10052104 | Shelton, IV et al. | Aug 2018 | B2 |
10054441 | Schorr et al. | Aug 2018 | B2 |
10058393 | Bonutti et al. | Aug 2018 | B2 |
10069633 | Gulati et al. | Sep 2018 | B2 |
10076326 | Yates et al. | Sep 2018 | B2 |
10080618 | Marshall et al. | Sep 2018 | B2 |
10084833 | McDonnell et al. | Sep 2018 | B2 |
D831209 | Huitema et al. | Oct 2018 | S |
10085748 | Morgan et al. | Oct 2018 | B2 |
10085749 | Cappola et al. | Oct 2018 | B2 |
10092355 | Hannaford et al. | Oct 2018 | B1 |
10095942 | Mentese et al. | Oct 2018 | B2 |
10097578 | Baldonado et al. | Oct 2018 | B2 |
10098527 | Weisenburgh, II et al. | Oct 2018 | B2 |
10098635 | Burbank | Oct 2018 | B2 |
10098642 | Baxter, III et al. | Oct 2018 | B2 |
10098705 | Brisson et al. | Oct 2018 | B2 |
10102926 | Leonardi | Oct 2018 | B1 |
10105140 | Malinouskas et al. | Oct 2018 | B2 |
10105142 | Baxter, III et al. | Oct 2018 | B2 |
10105470 | Reasoner et al. | Oct 2018 | B2 |
10111658 | Chowaniec et al. | Oct 2018 | B2 |
10111665 | Aranyi et al. | Oct 2018 | B2 |
10111679 | Baber et al. | Oct 2018 | B2 |
10111703 | Cosman, Jr. et al. | Oct 2018 | B2 |
D834541 | You et al. | Nov 2018 | S |
10117649 | Baxter et al. | Nov 2018 | B2 |
10117651 | Whitman et al. | Nov 2018 | B2 |
10117702 | Danziger et al. | Nov 2018 | B2 |
10118119 | Sappok et al. | Nov 2018 | B2 |
10130359 | Hess et al. | Nov 2018 | B2 |
10130360 | Olson et al. | Nov 2018 | B2 |
10130361 | Yates et al. | Nov 2018 | B2 |
10130367 | Cappola et al. | Nov 2018 | B2 |
10130432 | Auld et al. | Nov 2018 | B2 |
10133248 | Fitzsimmons et al. | Nov 2018 | B2 |
10135242 | Baber et al. | Nov 2018 | B2 |
10136246 | Yamada | Nov 2018 | B2 |
10136887 | Shelton, IV et al. | Nov 2018 | B2 |
10136891 | Shelton, IV et al. | Nov 2018 | B2 |
10136949 | Felder et al. | Nov 2018 | B2 |
10136954 | Johnson et al. | Nov 2018 | B2 |
10137245 | Melker et al. | Nov 2018 | B2 |
10143526 | Walker et al. | Dec 2018 | B2 |
10143948 | Bonifas et al. | Dec 2018 | B2 |
10147148 | Wu et al. | Dec 2018 | B2 |
10149680 | Parihar et al. | Dec 2018 | B2 |
10152789 | Carnes et al. | Dec 2018 | B2 |
10154841 | Weaner et al. | Dec 2018 | B2 |
10159044 | Hrabak | Dec 2018 | B2 |
10159481 | Whitman et al. | Dec 2018 | B2 |
10159483 | Beckman et al. | Dec 2018 | B2 |
10164466 | Calderoni | Dec 2018 | B2 |
10166025 | Leimbach et al. | Jan 2019 | B2 |
10166061 | Berry et al. | Jan 2019 | B2 |
10169862 | Andre et al. | Jan 2019 | B2 |
10172618 | Shelton, IV et al. | Jan 2019 | B2 |
10172687 | Garbus et al. | Jan 2019 | B2 |
10175096 | Dickerson | Jan 2019 | B2 |
10175127 | Collins et al. | Jan 2019 | B2 |
10178992 | Wise et al. | Jan 2019 | B2 |
10179413 | Rockrohr | Jan 2019 | B2 |
10180463 | Beckman et al. | Jan 2019 | B2 |
10182814 | Okonlewski | Jan 2019 | B2 |
10182816 | Shelton, IV et al. | Jan 2019 | B2 |
10182818 | Hensel et al. | Jan 2019 | B2 |
10188385 | Kerr et al. | Jan 2019 | B2 |
10189157 | Schlegel et al. | Jan 2019 | B2 |
10190888 | Hryb et al. | Jan 2019 | B2 |
10194891 | Jeong et al. | Feb 2019 | B2 |
10194907 | Marczyk et al. | Feb 2019 | B2 |
10194913 | Nalagatla et al. | Feb 2019 | B2 |
10194972 | Yates et al. | Feb 2019 | B2 |
10197803 | Badiali et al. | Feb 2019 | B2 |
10198965 | Hart | Feb 2019 | B2 |
10201311 | Chou et al. | Feb 2019 | B2 |
10201349 | Leimbach et al. | Feb 2019 | B2 |
10201364 | Leimbach et al. | Feb 2019 | B2 |
10201365 | Boudreaux et al. | Feb 2019 | B2 |
10205708 | Fletcher et al. | Feb 2019 | B1 |
10206605 | Shelton, IV et al. | Feb 2019 | B2 |
10206752 | Hares et al. | Feb 2019 | B2 |
10213201 | Shelton, IV et al. | Feb 2019 | B2 |
10213203 | Swayze et al. | Feb 2019 | B2 |
10213266 | Zemlok et al. | Feb 2019 | B2 |
10213268 | Dachs, II | Feb 2019 | B2 |
10219491 | Stiles, Jr. et al. | Mar 2019 | B2 |
10220522 | Rockrohr | Mar 2019 | B2 |
10222750 | Bang et al. | Mar 2019 | B2 |
10226249 | Jaworek et al. | Mar 2019 | B2 |
10226250 | Beckman et al. | Mar 2019 | B2 |
10226254 | Cabrera et al. | Mar 2019 | B2 |
10226302 | Lacal et al. | Mar 2019 | B2 |
10231634 | Zand et al. | Mar 2019 | B2 |
10231733 | Ehrenfels et al. | Mar 2019 | B2 |
10231775 | Shelton, IV et al. | Mar 2019 | B2 |
10238413 | Hibner et al. | Mar 2019 | B2 |
10245027 | Shelton, IV et al. | Apr 2019 | B2 |
10245028 | Shelton, IV et al. | Apr 2019 | B2 |
10245029 | Hunter et al. | Apr 2019 | B2 |
10245030 | Hunter et al. | Apr 2019 | B2 |
10245033 | Overmyer et al. | Apr 2019 | B2 |
10245037 | Conklin et al. | Apr 2019 | B2 |
10245038 | Hopkins et al. | Apr 2019 | B2 |
10245040 | Milliman | Apr 2019 | B2 |
10251661 | Collings et al. | Apr 2019 | B2 |
10251725 | Valentine et al. | Apr 2019 | B2 |
10258331 | Shelton, IV et al. | Apr 2019 | B2 |
10258359 | Kapadia | Apr 2019 | B2 |
10258362 | Conlon | Apr 2019 | B2 |
10258363 | Worrell et al. | Apr 2019 | B2 |
10258415 | Harrah et al. | Apr 2019 | B2 |
10258418 | Shelton, IV et al. | Apr 2019 | B2 |
10258425 | Mustufa et al. | Apr 2019 | B2 |
10263171 | Wiener et al. | Apr 2019 | B2 |
10265004 | Yamaguchi et al. | Apr 2019 | B2 |
10265035 | Fehre et al. | Apr 2019 | B2 |
10265066 | Measamer et al. | Apr 2019 | B2 |
10265068 | Harris et al. | Apr 2019 | B2 |
10265072 | Shelton, IV et al. | Apr 2019 | B2 |
10265090 | Ingmanson et al. | Apr 2019 | B2 |
10265130 | Hess et al. | Apr 2019 | B2 |
10271840 | Sapre | Apr 2019 | B2 |
10271844 | Valentine et al. | Apr 2019 | B2 |
10271850 | Wiliams | Apr 2019 | B2 |
10271851 | Shelton, IV et al. | Apr 2019 | B2 |
D847989 | Shelton, IV et al. | May 2019 | S |
10278698 | Racenet | May 2019 | B2 |
10278778 | State et al. | May 2019 | B2 |
10283220 | Azizian et al. | May 2019 | B2 |
10285694 | Viola et al. | May 2019 | B2 |
10285698 | Cappola et al. | May 2019 | B2 |
10285700 | Scheib | May 2019 | B2 |
10285705 | Shelton, IV et al. | May 2019 | B2 |
10292610 | Srivastava | May 2019 | B2 |
10292704 | Harris et al. | May 2019 | B2 |
10292707 | Shelton, IV et al. | May 2019 | B2 |
10292758 | Boudreaux et al. | May 2019 | B2 |
10292769 | Yu | May 2019 | B1 |
10292771 | Wood et al. | May 2019 | B2 |
10293129 | Fox et al. | May 2019 | B2 |
10299792 | Huitema et al. | May 2019 | B2 |
10299870 | Connolly et al. | May 2019 | B2 |
10305926 | Mihan et al. | May 2019 | B2 |
D850617 | Shelton, IV et al. | Jun 2019 | S |
10307159 | Harris et al. | Jun 2019 | B2 |
10307170 | Parfett et al. | Jun 2019 | B2 |
10307199 | Farritor et al. | Jun 2019 | B2 |
10311036 | Hussam et al. | Jun 2019 | B1 |
10313137 | Aarnio et al. | Jun 2019 | B2 |
10314577 | Laurent et al. | Jun 2019 | B2 |
10314582 | Shelton, IV et al. | Jun 2019 | B2 |
10321907 | Shelton, IV et al. | Jun 2019 | B2 |
10321964 | Grover et al. | Jun 2019 | B2 |
10327764 | Harris et al. | Jun 2019 | B2 |
10327779 | Richard et al. | Jun 2019 | B2 |
10335147 | Rector et al. | Jul 2019 | B2 |
10335149 | Baxter, III et al. | Jul 2019 | B2 |
10335180 | Johnson et al. | Jul 2019 | B2 |
10335227 | Heard | Jul 2019 | B2 |
10339496 | Matson et al. | Jul 2019 | B2 |
10342543 | Shelton, IV et al. | Jul 2019 | B2 |
10342602 | Strobl et al. | Jul 2019 | B2 |
10342623 | Huelman et al. | Jul 2019 | B2 |
10343102 | Reasoner et al. | Jul 2019 | B2 |
10349824 | Claude et al. | Jul 2019 | B2 |
10349939 | Shelton, IV et al. | Jul 2019 | B2 |
10349941 | Marczyk et al. | Jul 2019 | B2 |
10350016 | Burbank et al. | Jul 2019 | B2 |
10357184 | Crawford et al. | Jul 2019 | B2 |
10357246 | Shelton, IV et al. | Jul 2019 | B2 |
10357247 | Shelton, IV et al. | Jul 2019 | B2 |
10362179 | Harris | Jul 2019 | B2 |
10363032 | Scheib et al. | Jul 2019 | B2 |
10363037 | Aronhalt et al. | Jul 2019 | B2 |
10368861 | Baxter, III et al. | Aug 2019 | B2 |
10368865 | Harris et al. | Aug 2019 | B2 |
10368867 | Harris et al. | Aug 2019 | B2 |
10368876 | Bhatnagar et al. | Aug 2019 | B2 |
10368894 | Madan et al. | Aug 2019 | B2 |
10368903 | Morales et al. | Aug 2019 | B2 |
10376263 | Morgan et al. | Aug 2019 | B2 |
10376305 | Yates et al. | Aug 2019 | B2 |
10376337 | Kilroy et al. | Aug 2019 | B2 |
10376338 | Taylor et al. | Aug 2019 | B2 |
10378893 | Mankovskii | Aug 2019 | B2 |
10383518 | Abu-Tarif et al. | Aug 2019 | B2 |
10383699 | Kilroy et al. | Aug 2019 | B2 |
10384021 | Koeth et al. | Aug 2019 | B2 |
10386990 | Shikhman et al. | Aug 2019 | B2 |
10390718 | Chen et al. | Aug 2019 | B2 |
10390794 | Kuroiwa et al. | Aug 2019 | B2 |
10390825 | Shelton, IV et al. | Aug 2019 | B2 |
10390831 | Holsten et al. | Aug 2019 | B2 |
10390895 | Henderson et al. | Aug 2019 | B2 |
10398348 | Osadchy et al. | Sep 2019 | B2 |
10398434 | Shelton, IV et al. | Sep 2019 | B2 |
10398517 | Eckert et al. | Sep 2019 | B2 |
10398521 | Itkowitz et al. | Sep 2019 | B2 |
10404521 | McChord et al. | Sep 2019 | B2 |
10404801 | Martch | Sep 2019 | B2 |
10405857 | Shelton, IV et al. | Sep 2019 | B2 |
10405859 | Harris et al. | Sep 2019 | B2 |
10405863 | Wise et al. | Sep 2019 | B2 |
10413291 | Worthington et al. | Sep 2019 | B2 |
10413293 | Shelton, IV et al. | Sep 2019 | B2 |
10413297 | Harris et al. | Sep 2019 | B2 |
10417446 | Takeyama | Sep 2019 | B2 |
10420552 | Shelton, IV et al. | Sep 2019 | B2 |
10420558 | Nalagatla et al. | Sep 2019 | B2 |
10420559 | Marczyk et al. | Sep 2019 | B2 |
10420620 | Rockrohr | Sep 2019 | B2 |
10420865 | Reasoner et al. | Sep 2019 | B2 |
10422727 | Pliskin | Sep 2019 | B2 |
10426466 | Contini et al. | Oct 2019 | B2 |
10426467 | Miller et al. | Oct 2019 | B2 |
10426468 | Contini et al. | Oct 2019 | B2 |
10426471 | Shelton, IV et al. | Oct 2019 | B2 |
10426481 | Aronhalt et al. | Oct 2019 | B2 |
10433837 | Worthington et al. | Oct 2019 | B2 |
10433844 | Shelton, IV et al. | Oct 2019 | B2 |
10433849 | Shelton, IV et al. | Oct 2019 | B2 |
10433918 | Shelton, IV et al. | Oct 2019 | B2 |
10441279 | Shelton, IV et al. | Oct 2019 | B2 |
10441345 | Aldridge et al. | Oct 2019 | B2 |
10448948 | Shelton, IV et al. | Oct 2019 | B2 |
10448950 | Shelton, IV et al. | Oct 2019 | B2 |
10456137 | Vendely et al. | Oct 2019 | B2 |
10456140 | Shelton, IV et al. | Oct 2019 | B2 |
10456193 | Yates et al. | Oct 2019 | B2 |
10463365 | Williams | Nov 2019 | B2 |
10463367 | Kostrzewski et al. | Nov 2019 | B2 |
10463371 | Kostrzewski | Nov 2019 | B2 |
10463436 | Jackson et al. | Nov 2019 | B2 |
10470762 | Leimbach et al. | Nov 2019 | B2 |
10470764 | Baxter, III et al. | Nov 2019 | B2 |
10470768 | Harris et al. | Nov 2019 | B2 |
10470791 | Houser | Nov 2019 | B2 |
10471254 | Sano et al. | Nov 2019 | B2 |
10478181 | Shelton, IV et al. | Nov 2019 | B2 |
10478182 | Taylor | Nov 2019 | B2 |
10478185 | Nicholas | Nov 2019 | B2 |
10478189 | Bear et al. | Nov 2019 | B2 |
10478190 | Miller et al. | Nov 2019 | B2 |
10478544 | Friederichs et al. | Nov 2019 | B2 |
10485450 | Gupta et al. | Nov 2019 | B2 |
10485542 | Shelton, IV et al. | Nov 2019 | B2 |
10485543 | Shelton, IV et al. | Nov 2019 | B2 |
10492783 | Shelton, IV et al. | Dec 2019 | B2 |
10492784 | Beardsley et al. | Dec 2019 | B2 |
10492785 | Overmyer et al. | Dec 2019 | B2 |
10496788 | Amarasingham et al. | Dec 2019 | B2 |
10498269 | Zemlok et al. | Dec 2019 | B2 |
10499847 | Latimer et al. | Dec 2019 | B2 |
10499891 | Chaplin et al. | Dec 2019 | B2 |
10499914 | Huang et al. | Dec 2019 | B2 |
10499915 | Aranyi | Dec 2019 | B2 |
10499994 | Luks et al. | Dec 2019 | B2 |
10507068 | Kopp et al. | Dec 2019 | B2 |
10510267 | Jarc et al. | Dec 2019 | B2 |
10512413 | Schepis et al. | Dec 2019 | B2 |
10512461 | Gupta et al. | Dec 2019 | B2 |
10512499 | McHenry et al. | Dec 2019 | B2 |
10512509 | Bowling et al. | Dec 2019 | B2 |
10512514 | Nowlin et al. | Dec 2019 | B2 |
10517588 | Gupta et al. | Dec 2019 | B2 |
10517595 | Hunter et al. | Dec 2019 | B2 |
10517596 | Hunter et al. | Dec 2019 | B2 |
10517686 | Vokrot et al. | Dec 2019 | B2 |
10524789 | Swayze et al. | Jan 2020 | B2 |
10531579 | Hsiao et al. | Jan 2020 | B2 |
10531874 | Morgan et al. | Jan 2020 | B2 |
10531929 | Widenhouse et al. | Jan 2020 | B2 |
10532330 | Diallo et al. | Jan 2020 | B2 |
10536617 | Liang et al. | Jan 2020 | B2 |
10537324 | Shelton, IV et al. | Jan 2020 | B2 |
10537325 | Bakos et al. | Jan 2020 | B2 |
10537351 | Shelton, IV et al. | Jan 2020 | B2 |
10542978 | Chowaniec et al. | Jan 2020 | B2 |
10542979 | Shelton, IV et al. | Jan 2020 | B2 |
10542982 | Beckman et al. | Jan 2020 | B2 |
10542991 | Shelton, IV et al. | Jan 2020 | B2 |
D876466 | Kobayashi et al. | Feb 2020 | S |
10548504 | Shelton, IV et al. | Feb 2020 | B2 |
10548612 | Martinez et al. | Feb 2020 | B2 |
10548673 | Harris et al. | Feb 2020 | B2 |
10552574 | Sweeney | Feb 2020 | B2 |
10555675 | Satish et al. | Feb 2020 | B2 |
10555748 | Yates et al. | Feb 2020 | B2 |
10555750 | Conlon et al. | Feb 2020 | B2 |
10555769 | Worrell et al. | Feb 2020 | B2 |
10561349 | Wedekind et al. | Feb 2020 | B2 |
10561422 | Schellin et al. | Feb 2020 | B2 |
10561470 | Hourtash et al. | Feb 2020 | B2 |
10561471 | Nichogi | Feb 2020 | B2 |
10561560 | Boutoussov et al. | Feb 2020 | B2 |
10561753 | Thompson et al. | Feb 2020 | B2 |
10568625 | Harris et al. | Feb 2020 | B2 |
10568626 | Shelton, IV et al. | Feb 2020 | B2 |
10568632 | Miller et al. | Feb 2020 | B2 |
10568704 | Savaii et al. | Feb 2020 | B2 |
10575868 | Hall et al. | Mar 2020 | B2 |
10582928 | Hunter et al. | Mar 2020 | B2 |
10582931 | Mujawar | Mar 2020 | B2 |
10582964 | Weinberg et al. | Mar 2020 | B2 |
10586074 | Rose et al. | Mar 2020 | B2 |
10588623 | Schmid et al. | Mar 2020 | B2 |
10588625 | Weaner et al. | Mar 2020 | B2 |
10588629 | Malinouskas et al. | Mar 2020 | B2 |
10588630 | Shelton, IV et al. | Mar 2020 | B2 |
10588631 | Shelton, IV et al. | Mar 2020 | B2 |
10588632 | Shelton, IV et al. | Mar 2020 | B2 |
10588711 | DiCarlo et al. | Mar 2020 | B2 |
10592067 | Merdan et al. | Mar 2020 | B2 |
10595844 | Nawana et al. | Mar 2020 | B2 |
10595882 | Parfett et al. | Mar 2020 | B2 |
10595887 | Shelton, IV et al. | Mar 2020 | B2 |
10595930 | Scheib et al. | Mar 2020 | B2 |
10595952 | Forrest et al. | Mar 2020 | B2 |
10602007 | Takano | Mar 2020 | B2 |
10602848 | Magana | Mar 2020 | B2 |
10603036 | Hunter et al. | Mar 2020 | B2 |
10603128 | Zergiebel et al. | Mar 2020 | B2 |
10610223 | Wellman et al. | Apr 2020 | B2 |
10610224 | Shelton, IV et al. | Apr 2020 | B2 |
10610286 | Wiener et al. | Apr 2020 | B2 |
10610313 | Bailey et al. | Apr 2020 | B2 |
10617412 | Shelton, IV et al. | Apr 2020 | B2 |
10617414 | Shelton, IV et al. | Apr 2020 | B2 |
10617482 | Houser et al. | Apr 2020 | B2 |
10617484 | Kilroy et al. | Apr 2020 | B2 |
10624635 | Harris et al. | Apr 2020 | B2 |
10624667 | Faller et al. | Apr 2020 | B2 |
10624691 | Wiener et al. | Apr 2020 | B2 |
10631423 | Collins et al. | Apr 2020 | B2 |
10631858 | Burbank | Apr 2020 | B2 |
10631912 | McFarlin et al. | Apr 2020 | B2 |
10631916 | Horner et al. | Apr 2020 | B2 |
10631917 | Ineson | Apr 2020 | B2 |
10631939 | Dachs, II et al. | Apr 2020 | B2 |
10639027 | Shelton, IV et al. | May 2020 | B2 |
10639034 | Harris et al. | May 2020 | B2 |
10639035 | Shelton, IV et al. | May 2020 | B2 |
10639036 | Yates et al. | May 2020 | B2 |
10639037 | Shelton, IV et al. | May 2020 | B2 |
10639039 | Vendely et al. | May 2020 | B2 |
10639098 | Cosman et al. | May 2020 | B2 |
10639111 | Kopp | May 2020 | B2 |
10639185 | Agrawal et al. | May 2020 | B2 |
10653413 | Worthington et al. | May 2020 | B2 |
10653476 | Ross | May 2020 | B2 |
10653489 | Kopp | May 2020 | B2 |
10656720 | Holz | May 2020 | B1 |
10660705 | Piron et al. | May 2020 | B2 |
10667809 | Bakos et al. | Jun 2020 | B2 |
10667810 | Shelton, IV et al. | Jun 2020 | B2 |
10667811 | Harris et al. | Jun 2020 | B2 |
10667877 | Kapadia | Jun 2020 | B2 |
10674897 | Levy | Jun 2020 | B2 |
10675021 | Harris et al. | Jun 2020 | B2 |
10675023 | Cappola | Jun 2020 | B2 |
10675024 | Shelton, IV et al. | Jun 2020 | B2 |
10675025 | Swayze et al. | Jun 2020 | B2 |
10675026 | Harris et al. | Jun 2020 | B2 |
10675035 | Zingman | Jun 2020 | B2 |
10675100 | Frushour | Jun 2020 | B2 |
10675104 | Kapadia | Jun 2020 | B2 |
10677764 | Ross et al. | Jun 2020 | B2 |
10679758 | Fox et al. | Jun 2020 | B2 |
10682136 | Harris et al. | Jun 2020 | B2 |
10682138 | Shelton, IV et al. | Jun 2020 | B2 |
10686805 | Reybok, Jr. et al. | Jun 2020 | B2 |
10687806 | Shelton, IV et al. | Jun 2020 | B2 |
10687809 | Shelton, IV et al. | Jun 2020 | B2 |
10687810 | Shelton, IV et al. | Jun 2020 | B2 |
10687884 | Wiener et al. | Jun 2020 | B2 |
10687905 | Kostrzewski | Jun 2020 | B2 |
10695055 | Shelton, IV et al. | Jun 2020 | B2 |
10695081 | Shelton, IV et al. | Jun 2020 | B2 |
10695134 | Barral et al. | Jun 2020 | B2 |
10702270 | Shelton, IV et al. | Jul 2020 | B2 |
10702271 | Aranyi et al. | Jul 2020 | B2 |
10709446 | Harris et al. | Jul 2020 | B2 |
10716489 | Kalvoy et al. | Jul 2020 | B2 |
10716615 | Shelton, IV et al. | Jul 2020 | B2 |
10716639 | Kapadia et al. | Jul 2020 | B2 |
10717194 | Griffiths et al. | Jul 2020 | B2 |
10722222 | Aranyi | Jul 2020 | B2 |
10722233 | Wellman | Jul 2020 | B2 |
10722292 | Arya et al. | Jul 2020 | B2 |
D893717 | Messerly et al. | Aug 2020 | S |
10729458 | Stoddard et al. | Aug 2020 | B2 |
10729509 | Shelton, IV et al. | Aug 2020 | B2 |
10733267 | Pedersen | Aug 2020 | B2 |
10736219 | Seow et al. | Aug 2020 | B2 |
10736616 | Scheib et al. | Aug 2020 | B2 |
10736628 | Yates et al. | Aug 2020 | B2 |
10736629 | Shelton, IV et al. | Aug 2020 | B2 |
10736636 | Baxter, III et al. | Aug 2020 | B2 |
10736705 | Scheib et al. | Aug 2020 | B2 |
10743872 | Leimbach et al. | Aug 2020 | B2 |
10748115 | Laster et al. | Aug 2020 | B2 |
10751052 | Stokes et al. | Aug 2020 | B2 |
10751136 | Farritor et al. | Aug 2020 | B2 |
10751768 | Hersey et al. | Aug 2020 | B2 |
10755813 | Shelton, IV et al. | Aug 2020 | B2 |
D896379 | Shelton, IV et al. | Sep 2020 | S |
10758229 | Shelton, IV et al. | Sep 2020 | B2 |
10758230 | Shelton, IV et al. | Sep 2020 | B2 |
10758294 | Jones | Sep 2020 | B2 |
10758310 | Shelton, IV et al. | Sep 2020 | B2 |
10765376 | Brown, III et al. | Sep 2020 | B2 |
10765424 | Baxter, III et al. | Sep 2020 | B2 |
10765427 | Shelton, IV et al. | Sep 2020 | B2 |
10765470 | Yates et al. | Sep 2020 | B2 |
10772630 | Wixey | Sep 2020 | B2 |
10772651 | Shelton, IV et al. | Sep 2020 | B2 |
10772673 | Allen, IV et al. | Sep 2020 | B2 |
10772688 | Peine et al. | Sep 2020 | B2 |
10779818 | Zemlok et al. | Sep 2020 | B2 |
10779821 | Harris et al. | Sep 2020 | B2 |
10779823 | Shelton, IV et al. | Sep 2020 | B2 |
10779897 | Rockrohr | Sep 2020 | B2 |
10779900 | Pedros et al. | Sep 2020 | B2 |
10783634 | Nye et al. | Sep 2020 | B2 |
10786298 | Johnson | Sep 2020 | B2 |
10786317 | Zhou et al. | Sep 2020 | B2 |
10786327 | Anderson et al. | Sep 2020 | B2 |
10792038 | Becerra et al. | Oct 2020 | B2 |
10792118 | Prpa et al. | Oct 2020 | B2 |
10792422 | Douglas et al. | Oct 2020 | B2 |
10799304 | Kapadia et al. | Oct 2020 | B2 |
10803977 | Sanmugalingham | Oct 2020 | B2 |
10806445 | Penna et al. | Oct 2020 | B2 |
10806453 | Chen et al. | Oct 2020 | B2 |
10806454 | Kopp | Oct 2020 | B2 |
10806499 | Castaneda et al. | Oct 2020 | B2 |
10806506 | Gaspredes et al. | Oct 2020 | B2 |
10806532 | Grubbs et al. | Oct 2020 | B2 |
10813638 | Shelton, IV et al. | Oct 2020 | B2 |
10813703 | Swayze et al. | Oct 2020 | B2 |
10818383 | Sedeh et al. | Oct 2020 | B2 |
10828028 | Harris et al. | Nov 2020 | B2 |
10828030 | Weir et al. | Nov 2020 | B2 |
10835206 | Bell et al. | Nov 2020 | B2 |
10835245 | Swayze et al. | Nov 2020 | B2 |
10835246 | Shelton, IV et al. | Nov 2020 | B2 |
10835247 | Shelton, IV et al. | Nov 2020 | B2 |
10842473 | Scheib et al. | Nov 2020 | B2 |
10842490 | DiNardo et al. | Nov 2020 | B2 |
10842492 | Shelton, IV et al. | Nov 2020 | B2 |
10842522 | Messerly et al. | Nov 2020 | B2 |
10842523 | Shelton, IV et al. | Nov 2020 | B2 |
10842575 | Panescu et al. | Nov 2020 | B2 |
10842897 | Schwartz et al. | Nov 2020 | B2 |
D904612 | Wynn et al. | Dec 2020 | S |
10849697 | Yates et al. | Dec 2020 | B2 |
10849700 | Kopp et al. | Dec 2020 | B2 |
10856768 | Osadchy et al. | Dec 2020 | B2 |
10856867 | Shelton, IV et al. | Dec 2020 | B2 |
10856868 | Shelton, IV et al. | Dec 2020 | B2 |
10856870 | Harris et al. | Dec 2020 | B2 |
10863984 | Shelton, IV et al. | Dec 2020 | B2 |
10864037 | Mun et al. | Dec 2020 | B2 |
10864050 | Tabandeh et al. | Dec 2020 | B2 |
10872684 | McNutt et al. | Dec 2020 | B2 |
10881399 | Shelton, IV et al. | Jan 2021 | B2 |
10881401 | Baber et al. | Jan 2021 | B2 |
10881446 | Strobl | Jan 2021 | B2 |
10881464 | Odermatt et al. | Jan 2021 | B2 |
10888321 | Shelton, IV et al. | Jan 2021 | B2 |
10888322 | Morgan et al. | Jan 2021 | B2 |
10892899 | Shelton, IV et al. | Jan 2021 | B2 |
10892995 | Shelton, IV et al. | Jan 2021 | B2 |
10893863 | Shelton, IV et al. | Jan 2021 | B2 |
10893864 | Harris et al. | Jan 2021 | B2 |
10893884 | Stoddard et al. | Jan 2021 | B2 |
10898183 | Shelton, IV et al. | Jan 2021 | B2 |
10898186 | Bakos et al. | Jan 2021 | B2 |
10898189 | McDonald, II | Jan 2021 | B2 |
10898256 | Yates et al. | Jan 2021 | B2 |
10898280 | Kopp | Jan 2021 | B2 |
10898622 | Shelton, IV et al. | Jan 2021 | B2 |
10902944 | Casey et al. | Jan 2021 | B1 |
10903685 | Yates et al. | Jan 2021 | B2 |
10905415 | DiNardo et al. | Feb 2021 | B2 |
10905418 | Shelton, IV et al. | Feb 2021 | B2 |
10905420 | Jasemian et al. | Feb 2021 | B2 |
10912559 | Harris et al. | Feb 2021 | B2 |
10912567 | Shelton, IV et al. | Feb 2021 | B2 |
10912580 | Green et al. | Feb 2021 | B2 |
10912619 | Jarc et al. | Feb 2021 | B2 |
10916415 | Karancsi et al. | Feb 2021 | B2 |
D914878 | Shelton, IV et al. | Mar 2021 | S |
10932784 | Mozdzierz et al. | Mar 2021 | B2 |
10950982 | Regnier et al. | Mar 2021 | B2 |
10952732 | Binmoeller et al. | Mar 2021 | B2 |
10966590 | Takahashi et al. | Apr 2021 | B2 |
10980595 | Wham | Apr 2021 | B2 |
11000276 | Shelton, IV et al. | May 2021 | B2 |
11051817 | Shelton, IV et al. | Jul 2021 | B2 |
11051902 | Kruecker et al. | Jul 2021 | B2 |
11058501 | Tokarchuk et al. | Jul 2021 | B2 |
11071595 | Johnson et al. | Jul 2021 | B2 |
11141213 | Yates et al. | Oct 2021 | B2 |
11185325 | Shelton, IV et al. | Nov 2021 | B2 |
11273290 | Kowshik | Mar 2022 | B2 |
D950728 | Bakos et al. | May 2022 | S |
D952144 | Boudreaux | May 2022 | S |
11382715 | Arai et al. | Jul 2022 | B2 |
D964564 | Boudreaux | Sep 2022 | S |
20010056237 | Cane et al. | Dec 2001 | A1 |
20020049551 | Friedman et al. | Apr 2002 | A1 |
20020052616 | Wiener et al. | May 2002 | A1 |
20020072746 | Lingenfelder | Jun 2002 | A1 |
20020138642 | Miyazawa et al. | Sep 2002 | A1 |
20020169584 | Fu et al. | Nov 2002 | A1 |
20030009111 | Cory et al. | Jan 2003 | A1 |
20030009154 | Whitman | Jan 2003 | A1 |
20030018329 | Hooven | Jan 2003 | A1 |
20030046109 | Uchikubo | Mar 2003 | A1 |
20030069573 | Kadhiresan et al. | Apr 2003 | A1 |
20030093503 | Yamaki et al. | May 2003 | A1 |
20030114851 | Truckai et al. | Jun 2003 | A1 |
20030130711 | Pearson et al. | Jul 2003 | A1 |
20030210812 | Khamene et al. | Nov 2003 | A1 |
20030223877 | Anstine et al. | Dec 2003 | A1 |
20040015053 | Bieger et al. | Jan 2004 | A1 |
20040078236 | Stoodley et al. | Apr 2004 | A1 |
20040108825 | Lee et al. | Jun 2004 | A1 |
20040199180 | Knodel et al. | Oct 2004 | A1 |
20040199659 | Ishikawa et al. | Oct 2004 | A1 |
20040206365 | Knowlton | Oct 2004 | A1 |
20040229496 | Robinson et al. | Nov 2004 | A1 |
20040243147 | Lipow | Dec 2004 | A1 |
20040243148 | Wasielewski | Dec 2004 | A1 |
20040243435 | Williams | Dec 2004 | A1 |
20050020909 | Moctezuma de la Barrera et al. | Jan 2005 | A1 |
20050020918 | Wilk et al. | Jan 2005 | A1 |
20050021027 | Shields et al. | Jan 2005 | A1 |
20050023324 | Doll et al. | Feb 2005 | A1 |
20050063575 | Ma et al. | Mar 2005 | A1 |
20050065438 | Miller | Mar 2005 | A1 |
20050070800 | Takahashi | Mar 2005 | A1 |
20050100867 | Hilscher et al. | May 2005 | A1 |
20050131390 | Heinrich et al. | Jun 2005 | A1 |
20050139629 | Schwemberger et al. | Jun 2005 | A1 |
20050143759 | Kelly | Jun 2005 | A1 |
20050148854 | Ito et al. | Jul 2005 | A1 |
20050149001 | Uchikubo et al. | Jul 2005 | A1 |
20050149356 | Cyr et al. | Jul 2005 | A1 |
20050165390 | Mauti et al. | Jul 2005 | A1 |
20050182655 | Merzlak et al. | Aug 2005 | A1 |
20050192633 | Montpetit | Sep 2005 | A1 |
20050203380 | Sauer et al. | Sep 2005 | A1 |
20050203384 | Sati et al. | Sep 2005 | A1 |
20050203504 | Wham et al. | Sep 2005 | A1 |
20050213832 | Schofield et al. | Sep 2005 | A1 |
20050222631 | Dalal et al. | Oct 2005 | A1 |
20050228246 | Lee et al. | Oct 2005 | A1 |
20050228425 | Boukhny et al. | Oct 2005 | A1 |
20050236474 | Onuma et al. | Oct 2005 | A1 |
20050251233 | Kanzius | Nov 2005 | A1 |
20050277913 | McCary | Dec 2005 | A1 |
20060020272 | Gildenberg | Jan 2006 | A1 |
20060025816 | Shelton | Feb 2006 | A1 |
20060059018 | Shiobara et al. | Mar 2006 | A1 |
20060069388 | Truckai | Mar 2006 | A1 |
20060079872 | Eggleston | Apr 2006 | A1 |
20060079874 | Faller et al. | Apr 2006 | A1 |
20060116908 | Dew et al. | Jun 2006 | A1 |
20060136622 | Rouvelin et al. | Jun 2006 | A1 |
20060142739 | DiSilestro et al. | Jun 2006 | A1 |
20060184160 | Ozaki et al. | Aug 2006 | A1 |
20060241399 | Fabian | Oct 2006 | A1 |
20060282009 | Oberg et al. | Dec 2006 | A1 |
20060287645 | Tashiro et al. | Dec 2006 | A1 |
20070010838 | Shelton et al. | Jan 2007 | A1 |
20070016235 | Tanaka et al. | Jan 2007 | A1 |
20070016979 | Damaj et al. | Jan 2007 | A1 |
20070027459 | Horvath et al. | Feb 2007 | A1 |
20070038080 | Salisbury et al. | Feb 2007 | A1 |
20070049947 | Menn et al. | Mar 2007 | A1 |
20070066970 | Ineson | Mar 2007 | A1 |
20070078678 | DiSilvestro et al. | Apr 2007 | A1 |
20070084896 | Doll et al. | Apr 2007 | A1 |
20070085528 | Govari et al. | Apr 2007 | A1 |
20070156019 | Larkin et al. | Jul 2007 | A1 |
20070167702 | Hasser et al. | Jul 2007 | A1 |
20070168461 | Moore | Jul 2007 | A1 |
20070173803 | Wham et al. | Jul 2007 | A1 |
20070175955 | Shelton et al. | Aug 2007 | A1 |
20070179482 | Anderson | Aug 2007 | A1 |
20070179508 | Arndt | Aug 2007 | A1 |
20070191713 | Eichmann et al. | Aug 2007 | A1 |
20070192139 | Cookson et al. | Aug 2007 | A1 |
20070203744 | Scholl | Aug 2007 | A1 |
20070225556 | Ortiz et al. | Sep 2007 | A1 |
20070225690 | Sekiguchi et al. | Sep 2007 | A1 |
20070239028 | Houser et al. | Oct 2007 | A1 |
20070244478 | Bahney | Oct 2007 | A1 |
20070249990 | Cosmescu | Oct 2007 | A1 |
20070270660 | Caylor et al. | Nov 2007 | A1 |
20070282195 | Masini et al. | Dec 2007 | A1 |
20070282321 | Shah et al. | Dec 2007 | A1 |
20070282333 | Fortson et al. | Dec 2007 | A1 |
20070293218 | Meylan et al. | Dec 2007 | A1 |
20080013460 | Allen et al. | Jan 2008 | A1 |
20080015664 | Podhajsky | Jan 2008 | A1 |
20080015912 | Rosenthal et al. | Jan 2008 | A1 |
20080019393 | Yamaki | Jan 2008 | A1 |
20080033404 | Romoda et al. | Feb 2008 | A1 |
20080039742 | Hashimshony et al. | Feb 2008 | A1 |
20080040151 | Moore | Feb 2008 | A1 |
20080058593 | Gu et al. | Mar 2008 | A1 |
20080059658 | Williams | Mar 2008 | A1 |
20080077158 | Haider et al. | Mar 2008 | A1 |
20080083414 | Messerges | Apr 2008 | A1 |
20080091071 | Kumar et al. | Apr 2008 | A1 |
20080114212 | Messerges | May 2008 | A1 |
20080114350 | Park et al. | May 2008 | A1 |
20080129465 | Rao | Jun 2008 | A1 |
20080140090 | Aranyi et al. | Jun 2008 | A1 |
20080167644 | Shelton et al. | Jul 2008 | A1 |
20080177258 | Govari et al. | Jul 2008 | A1 |
20080177362 | Phillips et al. | Jul 2008 | A1 |
20080200940 | Eichmann et al. | Aug 2008 | A1 |
20080223904 | Marczyk | Sep 2008 | A1 |
20080234708 | Houser et al. | Sep 2008 | A1 |
20080235052 | Node-Langlois et al. | Sep 2008 | A1 |
20080255413 | Zemlok et al. | Oct 2008 | A1 |
20080262654 | Omori et al. | Oct 2008 | A1 |
20080272172 | Zemlok et al. | Nov 2008 | A1 |
20080281301 | DeBoer et al. | Nov 2008 | A1 |
20080281678 | Keuls et al. | Nov 2008 | A1 |
20080296346 | Shelton, IV et al. | Dec 2008 | A1 |
20080306759 | Ilkin et al. | Dec 2008 | A1 |
20080312953 | Claus | Dec 2008 | A1 |
20090017910 | Rofougaran et al. | Jan 2009 | A1 |
20090030437 | Houser et al. | Jan 2009 | A1 |
20090036750 | Weinstein et al. | Feb 2009 | A1 |
20090036794 | Stubhaug et al. | Feb 2009 | A1 |
20090043253 | Podaima | Feb 2009 | A1 |
20090046146 | Hoyt | Feb 2009 | A1 |
20090048589 | Takashino et al. | Feb 2009 | A1 |
20090048611 | Funda et al. | Feb 2009 | A1 |
20090076409 | Wu et al. | Mar 2009 | A1 |
20090090763 | Zemlok et al. | Apr 2009 | A1 |
20090099866 | Newman | Apr 2009 | A1 |
20090114699 | Viola | May 2009 | A1 |
20090128084 | Johnson et al. | May 2009 | A1 |
20090182577 | Squilla et al. | Jul 2009 | A1 |
20090206131 | Weisenburgh, II et al. | Aug 2009 | A1 |
20090217932 | Voegele | Sep 2009 | A1 |
20090234352 | Behnke et al. | Sep 2009 | A1 |
20090259149 | Tahara et al. | Oct 2009 | A1 |
20090259221 | Tahara et al. | Oct 2009 | A1 |
20090259489 | Kimura et al. | Oct 2009 | A1 |
20090270678 | Scott et al. | Oct 2009 | A1 |
20090299214 | Wu et al. | Dec 2009 | A1 |
20090306581 | Claus | Dec 2009 | A1 |
20090307681 | Armado et al. | Dec 2009 | A1 |
20090326321 | Jacobsen et al. | Dec 2009 | A1 |
20090326336 | Lemke et al. | Dec 2009 | A1 |
20100036374 | Ward | Feb 2010 | A1 |
20100036405 | Giordano et al. | Feb 2010 | A1 |
20100038403 | D'Arcangelo | Feb 2010 | A1 |
20100057106 | Sorrentino et al. | Mar 2010 | A1 |
20100065604 | Weng | Mar 2010 | A1 |
20100069939 | Konishi | Mar 2010 | A1 |
20100069942 | Shelton, IV | Mar 2010 | A1 |
20100070417 | Flynn et al. | Mar 2010 | A1 |
20100120266 | Rimborg | May 2010 | A1 |
20100132334 | Duclos et al. | Jun 2010 | A1 |
20100137845 | Ramstein et al. | Jun 2010 | A1 |
20100137886 | Zergiebel et al. | Jun 2010 | A1 |
20100168561 | Anderson | Jul 2010 | A1 |
20100179831 | Brown et al. | Jul 2010 | A1 |
20100191100 | Anderson et al. | Jul 2010 | A1 |
20100198200 | Horvath | Aug 2010 | A1 |
20100198248 | Vakharia | Aug 2010 | A1 |
20100204717 | Knodel | Aug 2010 | A1 |
20100217991 | Choi | Aug 2010 | A1 |
20100234996 | Schreiber et al. | Sep 2010 | A1 |
20100235689 | Tian et al. | Sep 2010 | A1 |
20100250571 | Pierce et al. | Sep 2010 | A1 |
20100258327 | Esenwein et al. | Oct 2010 | A1 |
20100292535 | Paskar | Nov 2010 | A1 |
20100292684 | Cybulski et al. | Nov 2010 | A1 |
20100301095 | Shelton, IV et al. | Dec 2010 | A1 |
20110022032 | Zemlok et al. | Jan 2011 | A1 |
20110036890 | Ma | Feb 2011 | A1 |
20110043612 | Keller et al. | Feb 2011 | A1 |
20110046618 | Minar et al. | Feb 2011 | A1 |
20110071530 | Carson | Mar 2011 | A1 |
20110077512 | Boswell | Mar 2011 | A1 |
20110087238 | Wang et al. | Apr 2011 | A1 |
20110087502 | Yelton et al. | Apr 2011 | A1 |
20110105277 | Shauli | May 2011 | A1 |
20110105895 | Kornblau et al. | May 2011 | A1 |
20110112569 | Friedman | May 2011 | A1 |
20110118708 | Burbank et al. | May 2011 | A1 |
20110119075 | Dhoble | May 2011 | A1 |
20110125149 | El-Galley et al. | May 2011 | A1 |
20110152712 | Cao et al. | Jun 2011 | A1 |
20110163147 | Laurent et al. | Jul 2011 | A1 |
20110166883 | Palmer et al. | Jul 2011 | A1 |
20110196398 | Robertson et al. | Aug 2011 | A1 |
20110237883 | Chun | Sep 2011 | A1 |
20110251612 | Faller et al. | Oct 2011 | A1 |
20110264000 | Paul et al. | Oct 2011 | A1 |
20110264078 | Lipow et al. | Oct 2011 | A1 |
20110265311 | Kondo et al. | Nov 2011 | A1 |
20110273465 | Konishi et al. | Nov 2011 | A1 |
20110278343 | Knodel et al. | Nov 2011 | A1 |
20110290024 | Lefler | Dec 2011 | A1 |
20110295270 | Giordano et al. | Dec 2011 | A1 |
20110306840 | Allen et al. | Dec 2011 | A1 |
20120012638 | Huang et al. | Jan 2012 | A1 |
20120021684 | Schultz et al. | Jan 2012 | A1 |
20120022519 | Huang et al. | Jan 2012 | A1 |
20120029354 | Mark et al. | Feb 2012 | A1 |
20120046662 | Gilbert | Feb 2012 | A1 |
20120059684 | Hampapur et al. | Mar 2012 | A1 |
20120078247 | Worrell | Mar 2012 | A1 |
20120080336 | Shelton, IV et al. | Apr 2012 | A1 |
20120083786 | Artale et al. | Apr 2012 | A1 |
20120100517 | Bowditch et al. | Apr 2012 | A1 |
20120101488 | Aldridge et al. | Apr 2012 | A1 |
20120116265 | Houser et al. | May 2012 | A1 |
20120116381 | Houser et al. | May 2012 | A1 |
20120116394 | Timm et al. | May 2012 | A1 |
20120130217 | Kauphusman et al. | May 2012 | A1 |
20120145714 | Farascioni et al. | Jun 2012 | A1 |
20120172696 | Kallback et al. | Jul 2012 | A1 |
20120190981 | Harris et al. | Jul 2012 | A1 |
20120191091 | Allen | Jul 2012 | A1 |
20120191162 | Villa | Jul 2012 | A1 |
20120197619 | Namer Yelin et al. | Aug 2012 | A1 |
20120203067 | Higgins et al. | Aug 2012 | A1 |
20120203785 | Awada | Aug 2012 | A1 |
20120211542 | Racenet | Aug 2012 | A1 |
20120226150 | Balicki et al. | Sep 2012 | A1 |
20120245958 | Lawrence et al. | Sep 2012 | A1 |
20120253329 | Zemlok et al. | Oct 2012 | A1 |
20120253847 | Dell'Anno et al. | Oct 2012 | A1 |
20120265555 | Cappuzzo et al. | Oct 2012 | A1 |
20120292367 | Morgan et al. | Nov 2012 | A1 |
20120319859 | Taub et al. | Dec 2012 | A1 |
20130001121 | Metzger | Jan 2013 | A1 |
20130006241 | Takashino | Jan 2013 | A1 |
20130008677 | Huifu | Jan 2013 | A1 |
20130024213 | Poon | Jan 2013 | A1 |
20130046182 | Hegg et al. | Feb 2013 | A1 |
20130046279 | Niklewski et al. | Feb 2013 | A1 |
20130046295 | Kerr et al. | Feb 2013 | A1 |
20130066647 | Andrie et al. | Mar 2013 | A1 |
20130090526 | Suzuki et al. | Apr 2013 | A1 |
20130090755 | Kiryu et al. | Apr 2013 | A1 |
20130093829 | Rosenblatt et al. | Apr 2013 | A1 |
20130096597 | Anand et al. | Apr 2013 | A1 |
20130116218 | Kaplan et al. | May 2013 | A1 |
20130131845 | Guilleminot | May 2013 | A1 |
20130144284 | Behnke, II et al. | Jun 2013 | A1 |
20130153635 | Hodgkinson | Jun 2013 | A1 |
20130165776 | Blomqvist | Jun 2013 | A1 |
20130178853 | Hyink et al. | Jul 2013 | A1 |
20130191647 | Ferrara, Jr. et al. | Jul 2013 | A1 |
20130193188 | Shelton, IV et al. | Aug 2013 | A1 |
20130197531 | Boukhny et al. | Aug 2013 | A1 |
20130201356 | Kennedy et al. | Aug 2013 | A1 |
20130206813 | Nalagatla | Aug 2013 | A1 |
20130214025 | Zemlok et al. | Aug 2013 | A1 |
20130253480 | Kimball et al. | Sep 2013 | A1 |
20130256373 | Schmid et al. | Oct 2013 | A1 |
20130267874 | Marcotte et al. | Oct 2013 | A1 |
20130268283 | Vann et al. | Oct 2013 | A1 |
20130277410 | Fernandez et al. | Oct 2013 | A1 |
20130317837 | Ballantyne et al. | Nov 2013 | A1 |
20130321425 | Greene et al. | Dec 2013 | A1 |
20130325809 | Kim et al. | Dec 2013 | A1 |
20130331873 | Ross et al. | Dec 2013 | A1 |
20130331875 | Ross et al. | Dec 2013 | A1 |
20140001231 | Shelton, IV et al. | Jan 2014 | A1 |
20140001234 | Shelton, IV et al. | Jan 2014 | A1 |
20140005640 | Shelton, IV et al. | Jan 2014 | A1 |
20140006132 | Barker | Jan 2014 | A1 |
20140006943 | Robbins et al. | Jan 2014 | A1 |
20140009894 | Yu | Jan 2014 | A1 |
20140013565 | MacDonald et al. | Jan 2014 | A1 |
20140018788 | Engelman et al. | Jan 2014 | A1 |
20140029411 | Nayak et al. | Jan 2014 | A1 |
20140033926 | Fassel et al. | Feb 2014 | A1 |
20140035762 | Shelton, IV et al. | Feb 2014 | A1 |
20140066700 | Wilson et al. | Mar 2014 | A1 |
20140073893 | Bencini | Mar 2014 | A1 |
20140074076 | Gertner | Mar 2014 | A1 |
20140081255 | Johnson et al. | Mar 2014 | A1 |
20140081659 | Nawana et al. | Mar 2014 | A1 |
20140084949 | Smith et al. | Mar 2014 | A1 |
20140087999 | Kaplan et al. | Mar 2014 | A1 |
20140092089 | Kasuya et al. | Apr 2014 | A1 |
20140107697 | Patani et al. | Apr 2014 | A1 |
20140108035 | Akbay et al. | Apr 2014 | A1 |
20140108983 | William R. et al. | Apr 2014 | A1 |
20140117256 | Mueller et al. | May 2014 | A1 |
20140121669 | Claus | May 2014 | A1 |
20140148729 | Schmitz et al. | May 2014 | A1 |
20140148803 | Taylor | May 2014 | A1 |
20140163359 | Sholev et al. | Jun 2014 | A1 |
20140166724 | Schellin et al. | Jun 2014 | A1 |
20140171778 | Tsusaka et al. | Jun 2014 | A1 |
20140176576 | Spencer | Jun 2014 | A1 |
20140187856 | Holoien et al. | Jul 2014 | A1 |
20140188440 | Donhowe et al. | Jul 2014 | A1 |
20140194864 | Martin et al. | Jul 2014 | A1 |
20140195052 | Tsusaka et al. | Jul 2014 | A1 |
20140204190 | Rosenblatt, III et al. | Jul 2014 | A1 |
20140226572 | Thota et al. | Aug 2014 | A1 |
20140243799 | Parihar | Aug 2014 | A1 |
20140243809 | Gelfand et al. | Aug 2014 | A1 |
20140243811 | Reschke et al. | Aug 2014 | A1 |
20140246475 | Hall et al. | Sep 2014 | A1 |
20140249557 | Koch et al. | Sep 2014 | A1 |
20140252064 | Mozdzierz et al. | Sep 2014 | A1 |
20140263541 | Leimbach et al. | Sep 2014 | A1 |
20140263552 | Hall et al. | Sep 2014 | A1 |
20140275760 | Lee et al. | Sep 2014 | A1 |
20140276749 | Johnson | Sep 2014 | A1 |
20140287393 | Kumar et al. | Sep 2014 | A1 |
20140296694 | Jaworski | Oct 2014 | A1 |
20140303660 | Boyden et al. | Oct 2014 | A1 |
20140303990 | Schoenefeld et al. | Oct 2014 | A1 |
20140336943 | Pellini et al. | Nov 2014 | A1 |
20140337052 | Pellini et al. | Nov 2014 | A1 |
20140364691 | Krivopisk et al. | Dec 2014 | A1 |
20150006201 | Pait et al. | Jan 2015 | A1 |
20150025549 | Kilroy et al. | Jan 2015 | A1 |
20150032150 | Ishida et al. | Jan 2015 | A1 |
20150051452 | Ciaccio | Feb 2015 | A1 |
20150051598 | Orszulak et al. | Feb 2015 | A1 |
20150051617 | Takemura et al. | Feb 2015 | A1 |
20150053737 | Leimbach et al. | Feb 2015 | A1 |
20150053743 | Yates et al. | Feb 2015 | A1 |
20150057675 | Akeel et al. | Feb 2015 | A1 |
20150062316 | Haraguchi et al. | Mar 2015 | A1 |
20150066000 | An et al. | Mar 2015 | A1 |
20150070187 | Wiesner et al. | Mar 2015 | A1 |
20150073400 | Sverdlik et al. | Mar 2015 | A1 |
20150077528 | Awdeh | Mar 2015 | A1 |
20150083774 | Measamer et al. | Mar 2015 | A1 |
20150108198 | Estrella | Apr 2015 | A1 |
20150133945 | Dushyant et al. | May 2015 | A1 |
20150136833 | Shelton, IV et al. | May 2015 | A1 |
20150140982 | Postrel | May 2015 | A1 |
20150145682 | Harris | May 2015 | A1 |
20150148830 | Stulen et al. | May 2015 | A1 |
20150157354 | Bales, Jr. et al. | Jun 2015 | A1 |
20150173673 | Toth et al. | Jun 2015 | A1 |
20150173756 | Baxter, III et al. | Jun 2015 | A1 |
20150182220 | Yates et al. | Jul 2015 | A1 |
20150196295 | Shelton, IV et al. | Jul 2015 | A1 |
20150199109 | Lee | Jul 2015 | A1 |
20150201918 | Kumar et al. | Jul 2015 | A1 |
20150202014 | Kim et al. | Jul 2015 | A1 |
20150208934 | Sztrubel et al. | Jul 2015 | A1 |
20150223725 | Engel et al. | Aug 2015 | A1 |
20150223868 | Brandt et al. | Aug 2015 | A1 |
20150237502 | Schmidt et al. | Aug 2015 | A1 |
20150238355 | Vezzu et al. | Aug 2015 | A1 |
20150272557 | Overmyer et al. | Oct 2015 | A1 |
20150272571 | Leimbach et al. | Oct 2015 | A1 |
20150272580 | Leimbach et al. | Oct 2015 | A1 |
20150272582 | Leimbach et al. | Oct 2015 | A1 |
20150272694 | Charles | Oct 2015 | A1 |
20150282821 | Look et al. | Oct 2015 | A1 |
20150296042 | Aoyama | Oct 2015 | A1 |
20150297200 | Fitzsimmons et al. | Oct 2015 | A1 |
20150297222 | Huitema et al. | Oct 2015 | A1 |
20150297228 | Huitema et al. | Oct 2015 | A1 |
20150297233 | Huitema et al. | Oct 2015 | A1 |
20150297311 | Tesar | Oct 2015 | A1 |
20150302157 | Collar et al. | Oct 2015 | A1 |
20150310174 | Coudert et al. | Oct 2015 | A1 |
20150313538 | Bechtel et al. | Nov 2015 | A1 |
20150317899 | Dumbauld et al. | Nov 2015 | A1 |
20150320423 | Aranyi | Nov 2015 | A1 |
20150324114 | Hurley et al. | Nov 2015 | A1 |
20150328474 | Flyash et al. | Nov 2015 | A1 |
20150332003 | Stamm et al. | Nov 2015 | A1 |
20150332196 | Stiller et al. | Nov 2015 | A1 |
20150335344 | Aljuri et al. | Nov 2015 | A1 |
20150374259 | Garbey et al. | Dec 2015 | A1 |
20160000437 | Giordano et al. | Jan 2016 | A1 |
20160001411 | Alberti | Jan 2016 | A1 |
20160015471 | Piron et al. | Jan 2016 | A1 |
20160022374 | Haider et al. | Jan 2016 | A1 |
20160034648 | Mohlenbrock et al. | Feb 2016 | A1 |
20160038224 | Couture et al. | Feb 2016 | A1 |
20160038253 | Piron et al. | Feb 2016 | A1 |
20160048780 | Sethumadhavan et al. | Feb 2016 | A1 |
20160058439 | Shelton, IV et al. | Mar 2016 | A1 |
20160066913 | Swayze et al. | Mar 2016 | A1 |
20160078190 | Greene et al. | Mar 2016 | A1 |
20160100837 | Huang et al. | Apr 2016 | A1 |
20160106516 | Mesallum | Apr 2016 | A1 |
20160106934 | Hiraga et al. | Apr 2016 | A1 |
20160121143 | Mumaw et al. | May 2016 | A1 |
20160157717 | Gaster | Jun 2016 | A1 |
20160158468 | Tang et al. | Jun 2016 | A1 |
20160166336 | Razzaque et al. | Jun 2016 | A1 |
20160174998 | Lal et al. | Jun 2016 | A1 |
20160175025 | Strobl | Jun 2016 | A1 |
20160180045 | Syed | Jun 2016 | A1 |
20160182637 | Adriaens et al. | Jun 2016 | A1 |
20160184054 | Lowe | Jun 2016 | A1 |
20160192960 | Bueno et al. | Jul 2016 | A1 |
20160203599 | Gillies et al. | Jul 2016 | A1 |
20160206202 | Frangioni | Jul 2016 | A1 |
20160206362 | Mehta et al. | Jul 2016 | A1 |
20160224760 | Petak et al. | Aug 2016 | A1 |
20160225551 | Shedletsky | Aug 2016 | A1 |
20160228061 | Kallback et al. | Aug 2016 | A1 |
20160228204 | Quaid et al. | Aug 2016 | A1 |
20160235303 | Fleming et al. | Aug 2016 | A1 |
20160242836 | Eggers et al. | Aug 2016 | A1 |
20160249910 | Shelton, IV et al. | Sep 2016 | A1 |
20160249920 | Gupta et al. | Sep 2016 | A1 |
20160270861 | Guru et al. | Sep 2016 | A1 |
20160275259 | Nolan et al. | Sep 2016 | A1 |
20160278841 | Panescu et al. | Sep 2016 | A1 |
20160287312 | Tegg et al. | Oct 2016 | A1 |
20160287316 | Worrell et al. | Oct 2016 | A1 |
20160287912 | Warnking | Oct 2016 | A1 |
20160292456 | Dubey et al. | Oct 2016 | A1 |
20160296246 | Schaller | Oct 2016 | A1 |
20160302210 | Thornton et al. | Oct 2016 | A1 |
20160310055 | Zand et al. | Oct 2016 | A1 |
20160310204 | Mchenry et al. | Oct 2016 | A1 |
20160314716 | Grubbs | Oct 2016 | A1 |
20160314717 | Grubbs | Oct 2016 | A1 |
20160321400 | Durrant et al. | Nov 2016 | A1 |
20160323283 | Kang et al. | Nov 2016 | A1 |
20160331460 | Cheatham, III et al. | Nov 2016 | A1 |
20160342753 | Feazell | Nov 2016 | A1 |
20160342916 | Arceneaux et al. | Nov 2016 | A1 |
20160345857 | Jensrud et al. | Dec 2016 | A1 |
20160345976 | Gonzalez et al. | Dec 2016 | A1 |
20160350490 | Martinez et al. | Dec 2016 | A1 |
20160354160 | Crowley et al. | Dec 2016 | A1 |
20160354162 | Yen et al. | Dec 2016 | A1 |
20160361070 | Ardel et al. | Dec 2016 | A1 |
20160367305 | Hareland | Dec 2016 | A1 |
20160367401 | Claus | Dec 2016 | A1 |
20160374710 | Sinelnikov et al. | Dec 2016 | A1 |
20160374723 | Frankhouser et al. | Dec 2016 | A1 |
20160374762 | Case et al. | Dec 2016 | A1 |
20160379504 | Bailey et al. | Dec 2016 | A1 |
20170000516 | Stulen et al. | Jan 2017 | A1 |
20170000553 | Wiener et al. | Jan 2017 | A1 |
20170005911 | Kasargod et al. | Jan 2017 | A1 |
20170007247 | Shelton, IV et al. | Jan 2017 | A1 |
20170027603 | Pandey | Feb 2017 | A1 |
20170042604 | McFarland et al. | Feb 2017 | A1 |
20170068792 | Reiner | Mar 2017 | A1 |
20170079530 | DiMaio et al. | Mar 2017 | A1 |
20170079730 | Azizian et al. | Mar 2017 | A1 |
20170086829 | Vendely et al. | Mar 2017 | A1 |
20170086930 | Thompson et al. | Mar 2017 | A1 |
20170105754 | Boudreaux et al. | Apr 2017 | A1 |
20170105787 | Witt et al. | Apr 2017 | A1 |
20170116873 | Lendvay et al. | Apr 2017 | A1 |
20170127499 | Unoson et al. | May 2017 | A1 |
20170132374 | Lee et al. | May 2017 | A1 |
20170132385 | Hunter et al. | May 2017 | A1 |
20170132785 | Wshah et al. | May 2017 | A1 |
20170143284 | Sehnert et al. | May 2017 | A1 |
20170143442 | Tesar et al. | May 2017 | A1 |
20170156076 | Eom et al. | Jun 2017 | A1 |
20170164997 | Johnson et al. | Jun 2017 | A1 |
20170165008 | Finley | Jun 2017 | A1 |
20170165012 | Chaplin et al. | Jun 2017 | A1 |
20170172550 | Mukherjee et al. | Jun 2017 | A1 |
20170172565 | Heneveld | Jun 2017 | A1 |
20170172614 | Scheib et al. | Jun 2017 | A1 |
20170172674 | Hanuschik et al. | Jun 2017 | A1 |
20170172676 | Itkowitz et al. | Jun 2017 | A1 |
20170173262 | Veltz | Jun 2017 | A1 |
20170177807 | Fabian | Jun 2017 | A1 |
20170178069 | Paterra et al. | Jun 2017 | A1 |
20170185732 | Niklewski et al. | Jun 2017 | A1 |
20170196583 | Sugiyama | Jul 2017 | A1 |
20170196637 | Shelton, IV et al. | Jul 2017 | A1 |
20170202591 | Shelton, IV et al. | Jul 2017 | A1 |
20170202595 | Shelton, IV | Jul 2017 | A1 |
20170202607 | Shelton, IV et al. | Jul 2017 | A1 |
20170202608 | Shelton, IV et al. | Jul 2017 | A1 |
20170209145 | Swayze et al. | Jul 2017 | A1 |
20170215944 | Keffeler | Aug 2017 | A1 |
20170224332 | Hunter et al. | Aug 2017 | A1 |
20170224334 | Worthington et al. | Aug 2017 | A1 |
20170224428 | Kopp | Aug 2017 | A1 |
20170231553 | Igarashi et al. | Aug 2017 | A1 |
20170231627 | Shelton, IV et al. | Aug 2017 | A1 |
20170231628 | Shelton, IV et al. | Aug 2017 | A1 |
20170245809 | Ma et al. | Aug 2017 | A1 |
20170249431 | Shelton, IV et al. | Aug 2017 | A1 |
20170249432 | Grantcharov | Aug 2017 | A1 |
20170262604 | Francois | Sep 2017 | A1 |
20170265864 | Hessler et al. | Sep 2017 | A1 |
20170265943 | Sela et al. | Sep 2017 | A1 |
20170273715 | Piron et al. | Sep 2017 | A1 |
20170281171 | Shelton, IV et al. | Oct 2017 | A1 |
20170281173 | Shelton, IV et al. | Oct 2017 | A1 |
20170281186 | Shelton, IV et al. | Oct 2017 | A1 |
20170281189 | Nalagatla et al. | Oct 2017 | A1 |
20170290585 | Shelton, IV et al. | Oct 2017 | A1 |
20170296169 | Yates et al. | Oct 2017 | A1 |
20170296173 | Shelton, IV et al. | Oct 2017 | A1 |
20170296185 | Swensgard et al. | Oct 2017 | A1 |
20170296213 | Swensgard et al. | Oct 2017 | A1 |
20170303984 | Malackowskl | Oct 2017 | A1 |
20170304007 | Piron et al. | Oct 2017 | A1 |
20170304020 | Ng et al. | Oct 2017 | A1 |
20170311777 | Hirayama et al. | Nov 2017 | A1 |
20170312456 | Phillips | Nov 2017 | A1 |
20170325876 | Nakadate et al. | Nov 2017 | A1 |
20170325878 | Messerly et al. | Nov 2017 | A1 |
20170333152 | Wade | Nov 2017 | A1 |
20170337043 | Brincat et al. | Nov 2017 | A1 |
20170360358 | Amiot et al. | Dec 2017 | A1 |
20170360499 | Greep et al. | Dec 2017 | A1 |
20170367583 | Black et al. | Dec 2017 | A1 |
20170367695 | Shelton, IV et al. | Dec 2017 | A1 |
20170367754 | Narisawa | Dec 2017 | A1 |
20170367771 | Tako et al. | Dec 2017 | A1 |
20170367772 | Gunn et al. | Dec 2017 | A1 |
20170370710 | Chen et al. | Dec 2017 | A1 |
20180008359 | Randle | Jan 2018 | A1 |
20180011983 | Zuhars et al. | Jan 2018 | A1 |
20180021058 | Meglan | Jan 2018 | A1 |
20180042659 | Rupp et al. | Feb 2018 | A1 |
20180050196 | Pawsey et al. | Feb 2018 | A1 |
20180052971 | Hanina et al. | Feb 2018 | A1 |
20180055529 | Messerly et al. | Mar 2018 | A1 |
20180065248 | Barral et al. | Mar 2018 | A1 |
20180078170 | Panescu et al. | Mar 2018 | A1 |
20180098049 | Sugano et al. | Apr 2018 | A1 |
20180098816 | Govari et al. | Apr 2018 | A1 |
20180108438 | Ryan et al. | Apr 2018 | A1 |
20180110523 | Shelton, IV | Apr 2018 | A1 |
20180116662 | Shelton, IV et al. | May 2018 | A1 |
20180116735 | Tierney et al. | May 2018 | A1 |
20180122506 | Grantcharov et al. | May 2018 | A1 |
20180125590 | Giordano et al. | May 2018 | A1 |
20180132895 | Silver | May 2018 | A1 |
20180144243 | Hsieh et al. | May 2018 | A1 |
20180153436 | Olson | Jun 2018 | A1 |
20180153574 | Faller et al. | Jun 2018 | A1 |
20180153628 | Grover et al. | Jun 2018 | A1 |
20180153632 | Tokarchuk et al. | Jun 2018 | A1 |
20180154297 | Maletich et al. | Jun 2018 | A1 |
20180161062 | Kaga et al. | Jun 2018 | A1 |
20180161716 | Li et al. | Jun 2018 | A1 |
20180165780 | Romeo | Jun 2018 | A1 |
20180168574 | Robinson et al. | Jun 2018 | A1 |
20180168575 | Simms et al. | Jun 2018 | A1 |
20180168577 | Aronhalt et al. | Jun 2018 | A1 |
20180168578 | Aronhalt et al. | Jun 2018 | A1 |
20180168579 | Aronhalt et al. | Jun 2018 | A1 |
20180168584 | Harris et al. | Jun 2018 | A1 |
20180168586 | Shelton, IV et al. | Jun 2018 | A1 |
20180168590 | Overmyer et al. | Jun 2018 | A1 |
20180168592 | Overmyer et al. | Jun 2018 | A1 |
20180168593 | Overmyer et al. | Jun 2018 | A1 |
20180168597 | Fanelli et al. | Jun 2018 | A1 |
20180168598 | Shelton, IV et al. | Jun 2018 | A1 |
20180168608 | Shelton, IV et al. | Jun 2018 | A1 |
20180168609 | Fanelli et al. | Jun 2018 | A1 |
20180168610 | Shelton, IV et al. | Jun 2018 | A1 |
20180168614 | Shelton, IV et al. | Jun 2018 | A1 |
20180168615 | Shelton, IV et al. | Jun 2018 | A1 |
20180168617 | Shelton, IV et al. | Jun 2018 | A1 |
20180168618 | Scott et al. | Jun 2018 | A1 |
20180168619 | Scott et al. | Jun 2018 | A1 |
20180168623 | Simms et al. | Jun 2018 | A1 |
20180168625 | Posada et al. | Jun 2018 | A1 |
20180168627 | Weaner et al. | Jun 2018 | A1 |
20180168628 | Hunter et al. | Jun 2018 | A1 |
20180168633 | Shelton, IV et al. | Jun 2018 | A1 |
20180168647 | Shelton, IV et al. | Jun 2018 | A1 |
20180168648 | Shelton, IV et al. | Jun 2018 | A1 |
20180168649 | Shelton, IV et al. | Jun 2018 | A1 |
20180168650 | Shelton, IV et al. | Jun 2018 | A1 |
20180168651 | Shelton, IV et al. | Jun 2018 | A1 |
20180172420 | Hein et al. | Jun 2018 | A1 |
20180177383 | Noonan et al. | Jun 2018 | A1 |
20180182475 | Cossler et al. | Jun 2018 | A1 |
20180183684 | Jacobson et al. | Jun 2018 | A1 |
20180193579 | Hanrahan et al. | Jul 2018 | A1 |
20180206884 | Beaupre | Jul 2018 | A1 |
20180206905 | Batchelor et al. | Jul 2018 | A1 |
20180211726 | Courtemanche et al. | Jul 2018 | A1 |
20180214025 | Homyk et al. | Aug 2018 | A1 |
20180221005 | Hamel et al. | Aug 2018 | A1 |
20180221598 | Silver | Aug 2018 | A1 |
20180228557 | Darisse et al. | Aug 2018 | A1 |
20180233222 | Daley et al. | Aug 2018 | A1 |
20180235719 | Jarc | Aug 2018 | A1 |
20180235722 | Baghdadi et al. | Aug 2018 | A1 |
20180242967 | Meade | Aug 2018 | A1 |
20180247128 | Alvi et al. | Aug 2018 | A1 |
20180247711 | Terry | Aug 2018 | A1 |
20180250086 | Grubbs | Sep 2018 | A1 |
20180250825 | Hashimoto et al. | Sep 2018 | A1 |
20180263699 | Murphy et al. | Sep 2018 | A1 |
20180263710 | Sakaguchi et al. | Sep 2018 | A1 |
20180268320 | Shekhar | Sep 2018 | A1 |
20180271520 | Shelton, IV et al. | Sep 2018 | A1 |
20180271603 | Nir et al. | Sep 2018 | A1 |
20180289427 | Griffiths et al. | Oct 2018 | A1 |
20180294060 | Kassab | Oct 2018 | A1 |
20180296286 | Peine et al. | Oct 2018 | A1 |
20180296289 | Rodriguez-Navarro et al. | Oct 2018 | A1 |
20180303552 | Ryan et al. | Oct 2018 | A1 |
20180304471 | Tokuchi | Oct 2018 | A1 |
20180310935 | Wixey | Nov 2018 | A1 |
20180310986 | Batchelor et al. | Nov 2018 | A1 |
20180315492 | Bishop et al. | Nov 2018 | A1 |
20180317826 | Muhsin et al. | Nov 2018 | A1 |
20180317916 | Wixey | Nov 2018 | A1 |
20180333188 | Nott et al. | Nov 2018 | A1 |
20180333207 | Moctezuma De La Barrera | Nov 2018 | A1 |
20180333209 | Frushour et al. | Nov 2018 | A1 |
20180351987 | Patel et al. | Dec 2018 | A1 |
20180353186 | Mozdzierz et al. | Dec 2018 | A1 |
20180357383 | Allen et al. | Dec 2018 | A1 |
20180360454 | Shelton, IV et al. | Dec 2018 | A1 |
20180360456 | Shelton, IV et al. | Dec 2018 | A1 |
20180366213 | Fidone et al. | Dec 2018 | A1 |
20180368930 | Esterberg et al. | Dec 2018 | A1 |
20180369511 | Zerglebel et al. | Dec 2018 | A1 |
20190000446 | Shelton, IV et al. | Jan 2019 | A1 |
20190000478 | Messerly et al. | Jan 2019 | A1 |
20190000565 | Shelton, IV et al. | Jan 2019 | A1 |
20190000569 | Crawford et al. | Jan 2019 | A1 |
20190001079 | Zergiebel et al. | Jan 2019 | A1 |
20190005641 | Yamamoto | Jan 2019 | A1 |
20190006047 | Gorek et al. | Jan 2019 | A1 |
20190025040 | Andreason et al. | Jan 2019 | A1 |
20190036688 | Wasily et al. | Jan 2019 | A1 |
20190038335 | Mohr et al. | Feb 2019 | A1 |
20190038364 | Enoki | Feb 2019 | A1 |
20190045515 | Kwasnick et al. | Feb 2019 | A1 |
20190046198 | Stokes et al. | Feb 2019 | A1 |
20190053801 | Wixey et al. | Feb 2019 | A1 |
20190053866 | Seow et al. | Feb 2019 | A1 |
20190059986 | Shelton, IV et al. | Feb 2019 | A1 |
20190069949 | Vrba et al. | Mar 2019 | A1 |
20190069964 | Hagn | Mar 2019 | A1 |
20190069966 | Petersen et al. | Mar 2019 | A1 |
20190070550 | Lalomia et al. | Mar 2019 | A1 |
20190070731 | Bowling et al. | Mar 2019 | A1 |
20190083190 | Graves et al. | Mar 2019 | A1 |
20190087544 | Peterson | Mar 2019 | A1 |
20190099221 | Schmidt et al. | Apr 2019 | A1 |
20190104919 | Shelton, IV et al. | Apr 2019 | A1 |
20190110828 | Despatie | Apr 2019 | A1 |
20190110855 | Barral et al. | Apr 2019 | A1 |
20190115108 | Hegedus et al. | Apr 2019 | A1 |
20190122330 | Saget et al. | Apr 2019 | A1 |
20190125320 | Shelton, IV et al. | May 2019 | A1 |
20190125321 | Shelton, IV et al. | May 2019 | A1 |
20190125324 | Scheib et al. | May 2019 | A1 |
20190125335 | Shelton, IV et al. | May 2019 | A1 |
20190125336 | Deck et al. | May 2019 | A1 |
20190125337 | Shelton, IV et al. | May 2019 | A1 |
20190125338 | Shelton, IV et al. | May 2019 | A1 |
20190125339 | Shelton, IV et al. | May 2019 | A1 |
20190125347 | Stokes et al. | May 2019 | A1 |
20190125348 | Shelton, IV et al. | May 2019 | A1 |
20190125352 | Shelton, IV et al. | May 2019 | A1 |
20190125353 | Shelton, IV et al. | May 2019 | A1 |
20190125354 | Deck et al. | May 2019 | A1 |
20190125355 | Shelton, IV et al. | May 2019 | A1 |
20190125356 | Shelton, IV et al. | May 2019 | A1 |
20190125357 | Shelton, IV et al. | May 2019 | A1 |
20190125358 | Shelton, IV et al. | May 2019 | A1 |
20190125359 | Shelton, IV et al. | May 2019 | A1 |
20190125360 | Shelton, IV et al. | May 2019 | A1 |
20190125361 | Shelton, IV et al. | May 2019 | A1 |
20190125377 | Shelton, IV | May 2019 | A1 |
20190125378 | Shelton, IV et al. | May 2019 | A1 |
20190125379 | Shelton, IV et al. | May 2019 | A1 |
20190125380 | Hunter et al. | May 2019 | A1 |
20190125383 | Scheib et al. | May 2019 | A1 |
20190125384 | Scheib et al. | May 2019 | A1 |
20190125385 | Scheib et al. | May 2019 | A1 |
20190125386 | Shelton, IV et al. | May 2019 | A1 |
20190125387 | Parihar et al. | May 2019 | A1 |
20190125388 | Shelton, IV et al. | May 2019 | A1 |
20190125389 | Shelton, IV et al. | May 2019 | A1 |
20190125431 | Shelton, IV et al. | May 2019 | A1 |
20190125432 | Shelton, IV et al. | May 2019 | A1 |
20190125454 | Stokes et al. | May 2019 | A1 |
20190125455 | Shelton, IV et al. | May 2019 | A1 |
20190125456 | Shelton, IV et al. | May 2019 | A1 |
20190125457 | Parihar et al. | May 2019 | A1 |
20190125458 | Shelton, IV et al. | May 2019 | A1 |
20190125459 | Shelton, IV et al. | May 2019 | A1 |
20190125476 | Shelton, IV et al. | May 2019 | A1 |
20190133703 | Seow et al. | May 2019 | A1 |
20190142449 | Shelton, IV et al. | May 2019 | A1 |
20190142535 | Seow et al. | May 2019 | A1 |
20190145942 | Dutriez et al. | May 2019 | A1 |
20190150975 | Kawasaki et al. | May 2019 | A1 |
20190159777 | Ehrenfels et al. | May 2019 | A1 |
20190159778 | Shelton, IV et al. | May 2019 | A1 |
20190162179 | O'Shea et al. | May 2019 | A1 |
20190163875 | Allen et al. | May 2019 | A1 |
20190167296 | Tsubuku et al. | Jun 2019 | A1 |
20190192044 | Ravi et al. | Jun 2019 | A1 |
20190192157 | Scott et al. | Jun 2019 | A1 |
20190192236 | Shelton, IV et al. | Jun 2019 | A1 |
20190200844 | Shelton, IV et al. | Jul 2019 | A1 |
20190200863 | Shelton, IV et al. | Jul 2019 | A1 |
20190200905 | Shelton, IV et al. | Jul 2019 | A1 |
20190200906 | Shelton, IV et al. | Jul 2019 | A1 |
20190200977 | Shelton, IV et al. | Jul 2019 | A1 |
20190200980 | Shelton, IV et al. | Jul 2019 | A1 |
20190200981 | Harris et al. | Jul 2019 | A1 |
20190200984 | Shelton, IV et al. | Jul 2019 | A1 |
20190200985 | Shelton, IV et al. | Jul 2019 | A1 |
20190200986 | Shelton, IV et al. | Jul 2019 | A1 |
20190200987 | Shelton, IV et al. | Jul 2019 | A1 |
20190200988 | Shelton, IV | Jul 2019 | A1 |
20190200996 | Shelton, IV et al. | Jul 2019 | A1 |
20190200997 | Shelton, IV et al. | Jul 2019 | A1 |
20190200998 | Shelton, IV et al. | Jul 2019 | A1 |
20190201020 | Shelton, IV et al. | Jul 2019 | A1 |
20190201021 | Shelton, IV et al. | Jul 2019 | A1 |
20190201023 | Shelton, IV et al. | Jul 2019 | A1 |
20190201024 | Shelton, IV et al. | Jul 2019 | A1 |
20190201025 | Shelton, IV et al. | Jul 2019 | A1 |
20190201026 | Shelton, IV et al. | Jul 2019 | A1 |
20190201027 | Shelton, IV et al. | Jul 2019 | A1 |
20190201028 | Shelton, IV et al. | Jul 2019 | A1 |
20190201029 | Shelton, IV et al. | Jul 2019 | A1 |
20190201030 | Shelton, IV et al. | Jul 2019 | A1 |
20190201033 | Yates et al. | Jul 2019 | A1 |
20190201034 | Shelton, IV et al. | Jul 2019 | A1 |
20190201036 | Nott et al. | Jul 2019 | A1 |
20190201037 | Houser et al. | Jul 2019 | A1 |
20190201038 | Yates et al. | Jul 2019 | A1 |
20190201039 | Widenhouse et al. | Jul 2019 | A1 |
20190201040 | Messerly et al. | Jul 2019 | A1 |
20190201041 | Kimball et al. | Jul 2019 | A1 |
20190201042 | Nott et al. | Jul 2019 | A1 |
20190201043 | Shelton, IV et al. | Jul 2019 | A1 |
20190201044 | Shelton, IV et al. | Jul 2019 | A1 |
20190201045 | Yates et al. | Jul 2019 | A1 |
20190201046 | Shelton, IV et al. | Jul 2019 | A1 |
20190201047 | Yates et al. | Jul 2019 | A1 |
20190201073 | Nott et al. | Jul 2019 | A1 |
20190201074 | Yates et al. | Jul 2019 | A1 |
20190201075 | Shelton, IV et al. | Jul 2019 | A1 |
20190201076 | Honda et al. | Jul 2019 | A1 |
20190201077 | Yates et al. | Jul 2019 | A1 |
20190201079 | Shelton, IV et al. | Jul 2019 | A1 |
20190201080 | Messerly et al. | Jul 2019 | A1 |
20190201081 | Shelton, IV et al. | Jul 2019 | A1 |
20190201082 | Shelton, IV et al. | Jul 2019 | A1 |
20190201083 | Shelton, IV et al. | Jul 2019 | A1 |
20190201084 | Shelton, IV et al. | Jul 2019 | A1 |
20190201085 | Shelton, IV et al. | Jul 2019 | A1 |
20190201086 | Shelton, IV et al. | Jul 2019 | A1 |
20190201087 | Shelton, IV et al. | Jul 2019 | A1 |
20190201090 | Shelton, IV et al. | Jul 2019 | A1 |
20190201091 | Yates et al. | Jul 2019 | A1 |
20190201092 | Yates et al. | Jul 2019 | A1 |
20190201102 | Shelton, IV et al. | Jul 2019 | A1 |
20190201104 | Shelton, IV et al. | Jul 2019 | A1 |
20190201105 | Shelton, IV et al. | Jul 2019 | A1 |
20190201111 | Shelton, IV et al. | Jul 2019 | A1 |
20190201112 | Wiener et al. | Jul 2019 | A1 |
20190201113 | Shelton, IV et al. | Jul 2019 | A1 |
20190201114 | Shelton, IV et al. | Jul 2019 | A1 |
20190201115 | Shelton, IV et al. | Jul 2019 | A1 |
20190201116 | Shelton, IV et al. | Jul 2019 | A1 |
20190201118 | Shelton, IV et al. | Jul 2019 | A1 |
20190201119 | Harris et al. | Jul 2019 | A1 |
20190201120 | Shelton, IV et al. | Jul 2019 | A1 |
20190201123 | Shelton, IV et al. | Jul 2019 | A1 |
20190201124 | Shelton, IV et al. | Jul 2019 | A1 |
20190201125 | Shelton, IV et al. | Jul 2019 | A1 |
20190201126 | Shelton, IV et al. | Jul 2019 | A1 |
20190201127 | Shelton, IV et al. | Jul 2019 | A1 |
20190201128 | Yates et al. | Jul 2019 | A1 |
20190201129 | Shelton, IV et al. | Jul 2019 | A1 |
20190201130 | Shelton, IV et al. | Jul 2019 | A1 |
20190201135 | Shelton, IV et al. | Jul 2019 | A1 |
20190201136 | Shelton, IV et al. | Jul 2019 | A1 |
20190201137 | Shelton, IV et al. | Jul 2019 | A1 |
20190201138 | Yates et al. | Jul 2019 | A1 |
20190201139 | Shelton, IV et al. | Jul 2019 | A1 |
20190201140 | Yates et al. | Jul 2019 | A1 |
20190201141 | Shelton, IV et al. | Jul 2019 | A1 |
20190201142 | Shelton, IV et al. | Jul 2019 | A1 |
20190201143 | Shelton, IV et al. | Jul 2019 | A1 |
20190201144 | Shelton, IV et al. | Jul 2019 | A1 |
20190201145 | Shelton, IV et al. | Jul 2019 | A1 |
20190201146 | Shelton, IV et al. | Jul 2019 | A1 |
20190201158 | Shelton, IV et al. | Jul 2019 | A1 |
20190201159 | Shelton, IV et al. | Jul 2019 | A1 |
20190201594 | Shelton, IV et al. | Jul 2019 | A1 |
20190201597 | Shelton, IV et al. | Jul 2019 | A1 |
20190204201 | Shelton, IV et al. | Jul 2019 | A1 |
20190205001 | Messerly et al. | Jul 2019 | A1 |
20190205441 | Shelton, IV et al. | Jul 2019 | A1 |
20190205566 | Shelton, IV et al. | Jul 2019 | A1 |
20190205567 | Shelton, IV et al. | Jul 2019 | A1 |
20190206003 | Harris et al. | Jul 2019 | A1 |
20190206004 | Shelton, IV et al. | Jul 2019 | A1 |
20190206050 | Yates et al. | Jul 2019 | A1 |
20190206216 | Shelton, IV et al. | Jul 2019 | A1 |
20190206542 | Shelton, IV et al. | Jul 2019 | A1 |
20190206551 | Yates et al. | Jul 2019 | A1 |
20190206555 | Morgan et al. | Jul 2019 | A1 |
20190206556 | Shelton, IV et al. | Jul 2019 | A1 |
20190206561 | Shelton, IV et al. | Jul 2019 | A1 |
20190206562 | Shelton, IV et al. | Jul 2019 | A1 |
20190206563 | Shelton, IV et al. | Jul 2019 | A1 |
20190206564 | Shelton, IV et al. | Jul 2019 | A1 |
20190206565 | Shelton, IV | Jul 2019 | A1 |
20190206569 | Shelton, IV et al. | Jul 2019 | A1 |
20190206576 | Shelton, IV et al. | Jul 2019 | A1 |
20190207911 | Wiener et al. | Jul 2019 | A1 |
20190208641 | Yates et al. | Jul 2019 | A1 |
20190224434 | Silver et al. | Jul 2019 | A1 |
20190254759 | Azizian | Aug 2019 | A1 |
20190261984 | Nelson et al. | Aug 2019 | A1 |
20190269476 | Bowling et al. | Sep 2019 | A1 |
20190272917 | Couture et al. | Sep 2019 | A1 |
20190274662 | Rockman et al. | Sep 2019 | A1 |
20190274705 | Sawhney et al. | Sep 2019 | A1 |
20190274706 | Nott et al. | Sep 2019 | A1 |
20190274707 | Sawhney et al. | Sep 2019 | A1 |
20190274708 | Boudreaux | Sep 2019 | A1 |
20190274709 | Scoggins | Sep 2019 | A1 |
20190274710 | Black | Sep 2019 | A1 |
20190274711 | Scoggins et al. | Sep 2019 | A1 |
20190274712 | Faller et al. | Sep 2019 | A1 |
20190274713 | Scoggins et al. | Sep 2019 | A1 |
20190274714 | Cut et al. | Sep 2019 | A1 |
20190274716 | Nott et al. | Sep 2019 | A1 |
20190274717 | Nott et al. | Sep 2019 | A1 |
20190274718 | Denzinger et al. | Sep 2019 | A1 |
20190274719 | Stulen | Sep 2019 | A1 |
20190274720 | Gee et al. | Sep 2019 | A1 |
20190274749 | Brady et al. | Sep 2019 | A1 |
20190274750 | Jayme et al. | Sep 2019 | A1 |
20190274752 | Denzinger et al. | Sep 2019 | A1 |
20190278262 | Taylor et al. | Sep 2019 | A1 |
20190282311 | Nowlin et al. | Sep 2019 | A1 |
20190290389 | Kopp | Sep 2019 | A1 |
20190298340 | Shelton, IV et al. | Oct 2019 | A1 |
20190298341 | Shelton, IV et al. | Oct 2019 | A1 |
20190298342 | Shelton, IV et al. | Oct 2019 | A1 |
20190298343 | Shelton, IV et al. | Oct 2019 | A1 |
20190298346 | Shelton, IV et al. | Oct 2019 | A1 |
20190298347 | Shelton, IV et al. | Oct 2019 | A1 |
20190298350 | Shelton, IV et al. | Oct 2019 | A1 |
20190298351 | Shelton, IV et al. | Oct 2019 | A1 |
20190298352 | Shelton, IV et al. | Oct 2019 | A1 |
20190298353 | Shelton, IV et al. | Oct 2019 | A1 |
20190298354 | Shelton, IV et al. | Oct 2019 | A1 |
20190298355 | Shelton, IV et al. | Oct 2019 | A1 |
20190298356 | Shelton, IV et al. | Oct 2019 | A1 |
20190298357 | Shelton, IV et al. | Oct 2019 | A1 |
20190298464 | Abbott | Oct 2019 | A1 |
20190298481 | Rosenberg et al. | Oct 2019 | A1 |
20190307520 | Peine et al. | Oct 2019 | A1 |
20190311802 | Kokubo et al. | Oct 2019 | A1 |
20190314015 | Shelton, IV et al. | Oct 2019 | A1 |
20190314016 | Huitema et al. | Oct 2019 | A1 |
20190314081 | Brogna | Oct 2019 | A1 |
20190320929 | Spencer et al. | Oct 2019 | A1 |
20190321117 | Itkowitz et al. | Oct 2019 | A1 |
20190333626 | Mansi et al. | Oct 2019 | A1 |
20190343594 | Garcia Kilroy et al. | Nov 2019 | A1 |
20190374140 | Tucker et al. | Dec 2019 | A1 |
20190374292 | Barral et al. | Dec 2019 | A1 |
20190378610 | Barral et al. | Dec 2019 | A1 |
20200000470 | Du et al. | Jan 2020 | A1 |
20200000509 | Hayashida et al. | Jan 2020 | A1 |
20200038120 | Ziraknejad et al. | Feb 2020 | A1 |
20200046353 | Deck et al. | Feb 2020 | A1 |
20200054317 | Pisarnwongs et al. | Feb 2020 | A1 |
20200054320 | Harris et al. | Feb 2020 | A1 |
20200054321 | Harris et al. | Feb 2020 | A1 |
20200054322 | Harris et al. | Feb 2020 | A1 |
20200054323 | Harris et al. | Feb 2020 | A1 |
20200054326 | Harris et al. | Feb 2020 | A1 |
20200054328 | Harris et al. | Feb 2020 | A1 |
20200054330 | Harris et al. | Feb 2020 | A1 |
20200078070 | Henderson et al. | Mar 2020 | A1 |
20200078071 | Asher | Mar 2020 | A1 |
20200078076 | Henderson et al. | Mar 2020 | A1 |
20200078077 | Henderson et al. | Mar 2020 | A1 |
20200078078 | Henderson et al. | Mar 2020 | A1 |
20200078079 | Morgan et al. | Mar 2020 | A1 |
20200078080 | Henderson et al. | Mar 2020 | A1 |
20200078081 | Jayme et al. | Mar 2020 | A1 |
20200078082 | Henderson et al. | Mar 2020 | A1 |
20200078089 | Henderson et al. | Mar 2020 | A1 |
20200078096 | Barbagli et al. | Mar 2020 | A1 |
20200078106 | Henderson et al. | Mar 2020 | A1 |
20200078110 | Henderson et al. | Mar 2020 | A1 |
20200078111 | Oberkircher et al. | Mar 2020 | A1 |
20200078112 | Henderson et al. | Mar 2020 | A1 |
20200078113 | Sawhney et al. | Mar 2020 | A1 |
20200078114 | Asher et al. | Mar 2020 | A1 |
20200078115 | Asher et al. | Mar 2020 | A1 |
20200078116 | Oberkircher et al. | Mar 2020 | A1 |
20200078117 | Henderson et al. | Mar 2020 | A1 |
20200078118 | Henderson et al. | Mar 2020 | A1 |
20200078119 | Henderson et al. | Mar 2020 | A1 |
20200078120 | Aldridge et al. | Mar 2020 | A1 |
20200081585 | Petre et al. | Mar 2020 | A1 |
20200090808 | Carroll et al. | Mar 2020 | A1 |
20200100825 | Henderson et al. | Apr 2020 | A1 |
20200100830 | Henderson et al. | Apr 2020 | A1 |
20200106220 | Henderson et al. | Apr 2020 | A1 |
20200162896 | Su et al. | May 2020 | A1 |
20200168323 | Bullington et al. | May 2020 | A1 |
20200178760 | Kashima et al. | Jun 2020 | A1 |
20200178971 | Harris et al. | Jun 2020 | A1 |
20200193600 | Shameli et al. | Jun 2020 | A1 |
20200197027 | Hershberger et al. | Jun 2020 | A1 |
20200203004 | Shanbhag et al. | Jun 2020 | A1 |
20200214699 | Shelton, IV et al. | Jul 2020 | A1 |
20200226751 | Jin et al. | Jul 2020 | A1 |
20200230803 | Yamashita et al. | Jul 2020 | A1 |
20200237372 | Park | Jul 2020 | A1 |
20200261075 | Boudreaux et al. | Aug 2020 | A1 |
20200261076 | Boudreaux et al. | Aug 2020 | A1 |
20200261077 | Shelton, IV et al. | Aug 2020 | A1 |
20200261078 | Bakos et al. | Aug 2020 | A1 |
20200261080 | Bakos et al. | Aug 2020 | A1 |
20200261081 | Boudreaux et al. | Aug 2020 | A1 |
20200261082 | Boudreaux et al. | Aug 2020 | A1 |
20200261083 | Bakos et al. | Aug 2020 | A1 |
20200261084 | Bakos et al. | Aug 2020 | A1 |
20200261085 | Boudreaux et al. | Aug 2020 | A1 |
20200261086 | Zeiner et al. | Aug 2020 | A1 |
20200261087 | Timm et al. | Aug 2020 | A1 |
20200261088 | Harris et al. | Aug 2020 | A1 |
20200261089 | Shelton, IV et al. | Aug 2020 | A1 |
20200275928 | Shelton, IV et al. | Sep 2020 | A1 |
20200275930 | Harris et al. | Sep 2020 | A1 |
20200281665 | Kopp | Sep 2020 | A1 |
20200305924 | Carroll | Oct 2020 | A1 |
20200305945 | Morgan et al. | Oct 2020 | A1 |
20200314569 | Morgan et al. | Oct 2020 | A1 |
20200348662 | Cella et al. | Nov 2020 | A1 |
20200405304 | Mozdzierz et al. | Dec 2020 | A1 |
20200405375 | Shelton, IV et al. | Dec 2020 | A1 |
20210000555 | Shelton, IV et al. | Jan 2021 | A1 |
20210007760 | Reisin | Jan 2021 | A1 |
20210015568 | Liao et al. | Jan 2021 | A1 |
20210022731 | Eisinger | Jan 2021 | A1 |
20210022738 | Weir et al. | Jan 2021 | A1 |
20210022809 | Crawford et al. | Jan 2021 | A1 |
20210059674 | Shelton, IV et al. | Mar 2021 | A1 |
20210068834 | Shelton, IV et al. | Mar 2021 | A1 |
20210076966 | Grantcharov et al. | Mar 2021 | A1 |
20210128149 | Whitfield et al. | May 2021 | A1 |
20210153889 | Nott et al. | May 2021 | A1 |
20210169516 | Houser et al. | Jun 2021 | A1 |
20210176179 | Shelton, IV | Jun 2021 | A1 |
20210177452 | Nott et al. | Jun 2021 | A1 |
20210177489 | Yates et al. | Jun 2021 | A1 |
20210186454 | Behzadi et al. | Jun 2021 | A1 |
20210192914 | Shelton, IV et al. | Jun 2021 | A1 |
20210201646 | Shelton, IV et al. | Jul 2021 | A1 |
20210205020 | Shelton, IV et al. | Jul 2021 | A1 |
20210205021 | Shelton, IV et al. | Jul 2021 | A1 |
20210205028 | Shelton, IV et al. | Jul 2021 | A1 |
20210205029 | Wiener et al. | Jul 2021 | A1 |
20210205030 | Shelton, IV et al. | Jul 2021 | A1 |
20210205031 | Shelton, IV et al. | Jul 2021 | A1 |
20210212602 | Shelton, IV et al. | Jul 2021 | A1 |
20210212694 | Shelton, IV et al. | Jul 2021 | A1 |
20210212717 | Yates et al. | Jul 2021 | A1 |
20210212719 | Houser et al. | Jul 2021 | A1 |
20210212770 | Messerly et al. | Jul 2021 | A1 |
20210212771 | Shelton, IV et al. | Jul 2021 | A1 |
20210212774 | Shelton, IV et al. | Jul 2021 | A1 |
20210212775 | Shelton, IV et al. | Jul 2021 | A1 |
20210212782 | Shelton, IV et al. | Jul 2021 | A1 |
20210219976 | DiNardo et al. | Jul 2021 | A1 |
20210220058 | Messerly et al. | Jul 2021 | A1 |
20210240852 | Shelton, IV et al. | Aug 2021 | A1 |
20210241898 | Shelton, IV et al. | Aug 2021 | A1 |
20210249125 | Morgan et al. | Aug 2021 | A1 |
20210251487 | Shelton, IV et al. | Aug 2021 | A1 |
20210259687 | Gonzalez et al. | Aug 2021 | A1 |
20210259697 | Shelton, IV et al. | Aug 2021 | A1 |
20210259698 | Shelton, IV et al. | Aug 2021 | A1 |
20210282780 | Shelton, IV et al. | Sep 2021 | A1 |
20210282781 | Shelton, IV et al. | Sep 2021 | A1 |
20210306176 | Park et al. | Sep 2021 | A1 |
20210315579 | Shelton, IV et al. | Oct 2021 | A1 |
20210315580 | Shelton, IV et al. | Oct 2021 | A1 |
20210315581 | Shelton, IV et al. | Oct 2021 | A1 |
20210315582 | Shelton, IV et al. | Oct 2021 | A1 |
20210322014 | Shelton, IV et al. | Oct 2021 | A1 |
20210322015 | Shelton, IV et al. | Oct 2021 | A1 |
20210322017 | Shelton, IV et al. | Oct 2021 | A1 |
20210322018 | Shelton, IV et al. | Oct 2021 | A1 |
20210322019 | Shelton, IV et al. | Oct 2021 | A1 |
20210322020 | Shelton, IV et al. | Oct 2021 | A1 |
20210336939 | Wiener et al. | Oct 2021 | A1 |
20210353287 | Shelton, IV et al. | Nov 2021 | A1 |
20210353288 | Shelton, IV et al. | Nov 2021 | A1 |
20210358599 | Alvi et al. | Nov 2021 | A1 |
20210361284 | Shelton, IV et al. | Nov 2021 | A1 |
20220000484 | Shelton, IV et al. | Jan 2022 | A1 |
20220054158 | Shelton, IV et al. | Feb 2022 | A1 |
20220079591 | Bakos et al. | Mar 2022 | A1 |
20220160438 | Shelton, IV et al. | May 2022 | A1 |
20220175374 | Shelton, IV et al. | Jun 2022 | A1 |
20220230738 | Shelton, IV et al. | Jul 2022 | A1 |
20220241027 | Shelton, IV et al. | Aug 2022 | A1 |
20220249097 | Shelton, IV et al. | Aug 2022 | A1 |
20220323092 | Shelton, IV et al. | Oct 2022 | A1 |
20220323095 | Nott et al. | Oct 2022 | A1 |
20220323150 | Yates et al. | Oct 2022 | A1 |
20220331011 | Shelton, IV et al. | Oct 2022 | A1 |
20220331018 | Parihar et al. | Oct 2022 | A1 |
Number | Date | Country |
---|---|---|
2015201140 | Mar 2015 | AU |
2795323 | May 2014 | CA |
101617950 | Jan 2010 | CN |
104490448 | Mar 2017 | CN |
206097107 | Apr 2017 | CN |
107811710 | Mar 2018 | CN |
108652695 | Oct 2018 | CN |
2037167 | Jul 1980 | DE |
3016131 | Oct 1981 | DE |
3824913 | Feb 1990 | DE |
4002843 | Apr 1991 | DE |
102005051367 | Apr 2007 | DE |
102016207666 | Nov 2017 | DE |
0000756 | Oct 1981 | EP |
0408160 | Jan 1991 | EP |
0473987 | Mar 1992 | EP |
0929263 | Jul 1999 | EP |
1214913 | Jun 2002 | EP |
2730209 | May 2014 | EP |
2732772 | May 2014 | EP |
2942023 | Nov 2015 | EP |
3047806 | Jul 2016 | EP |
3056923 | Aug 2016 | EP |
3095399 | Nov 2016 | EP |
3120781 | Jan 2017 | EP |
3135225 | Mar 2017 | EP |
3141181 | Mar 2017 | EP |
2838234 | Oct 2003 | FR |
2509523 | Jul 2014 | GB |
S5191993 | Jul 1976 | JP |
S5373315 | Jun 1978 | JP |
S57185848 | Nov 1982 | JP |
S58207752 | Dec 1983 | JP |
H07132122 | May 1995 | JP |
H08332169 | Dec 1996 | JP |
2001029353 | Feb 2001 | JP |
2001195686 | Jul 2001 | JP |
2001340350 | Dec 2001 | JP |
2002272758 | Sep 2002 | JP |
2006117143 | May 2006 | JP |
2006288431 | Oct 2006 | JP |
2007123394 | May 2007 | JP |
2007300312 | Nov 2007 | JP |
2009039515 | Feb 2009 | JP |
2010057642 | Mar 2010 | JP |
2010131265 | Jun 2010 | JP |
2012065698 | Apr 2012 | JP |
2012239669 | Dec 2012 | JP |
2013144057 | Jul 2013 | JP |
2014155207 | Aug 2014 | JP |
2016174836 | Oct 2016 | JP |
2017047022 | Mar 2017 | JP |
2017513561 | Jun 2017 | JP |
2017526510 | Sep 2017 | JP |
2017532168 | Nov 2017 | JP |
20140104587 | Aug 2014 | KR |
101587721 | Jan 2016 | KR |
WO-9734533 | Sep 1997 | WO |
WO-0024322 | May 2000 | WO |
WO-0108578 | Feb 2001 | WO |
WO-0112089 | Feb 2001 | WO |
WO-0120892 | Mar 2001 | WO |
WO-03079909 | Oct 2003 | WO |
WO-2006001264 | Jan 2006 | WO |
WO-2007137304 | Nov 2007 | WO |
WO-2008053485 | May 2008 | WO |
WO-2008056618 | May 2008 | WO |
WO-2008069816 | Jun 2008 | WO |
WO-2008147555 | Dec 2008 | WO |
WO-2011112931 | Sep 2011 | WO |
WO-2013143573 | Oct 2013 | WO |
WO-2014031800 | Feb 2014 | WO |
WO-2014071184 | May 2014 | WO |
WO-2014134196 | Sep 2014 | WO |
WO-2015054665 | Apr 2015 | WO |
WO-2015129395 | Sep 2015 | WO |
WO-2016093049 | Jun 2016 | WO |
WO-2016100719 | Jun 2016 | WO |
WO-2016118752 | Jul 2016 | WO |
WO-2016206015 | Dec 2016 | WO |
WO-2017011382 | Jan 2017 | WO |
WO-2017011646 | Jan 2017 | WO |
WO-2017058617 | Apr 2017 | WO |
WO-2017058695 | Apr 2017 | WO |
WO-2017151996 | Sep 2017 | WO |
WO-2017183353 | Oct 2017 | WO |
WO-2017189317 | Nov 2017 | WO |
WO-2017205308 | Nov 2017 | WO |
WO-2017210499 | Dec 2017 | WO |
WO-2017210501 | Dec 2017 | WO |
WO-2018116247 | Jun 2018 | WO |
WO-2018152141 | Aug 2018 | WO |
WO-2018176414 | Oct 2018 | WO |
Entry |
---|
US 10,504,709 B2, 12/2019, Karancsi et al. (withdrawn) |
Flores et al., “Large-scale Offloading in the Internet of Things,” 2017 IEEE International Conference on Pervasive Computing and Communications Workshops (PERCOM Workshops), IEEE, pp. 479-484, Mar. 13, 2017. |
Kalantarian et al., “Computation Offloading for Real-Time Health-Monitoring Devices,” 2016 38th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EBMC), IEEE, pp. 4971-4974, Aug. 16, 2016. |
Yuyi Mao et al., “A Survey on Mobile Edge Computing: The Communication Perspective,” IEEE Communications Surveys & Tutorials, pp. 2322-2358, Jun. 13, 2017. |
Khazaei et al., “Health Informatics for Neonatal Intensive Care Units: An Analytical Modeling Perspective,” IEEE Journal of Translational Engineering in Health and Medicine, vol. 3, pp. 1-9, Oct. 21, 2015. |
Benkmann et al., “Concept of iterative optimization of minimally invasive surgery,” 2017 22nd International Conference on Methods and Models in Automation and Robotics (MMAR), IEEE pp. 443-446, Aug. 28, 2017. |
Trautman, Peter, “Breaking the Human-Robot Deadlock: Surpassing Shared Control Performance Limits with Sparse Human-Robot Interaction,” Robotics: Science and Systems XIIII, pp. 1-10, Jul. 12, 2017. |
Yang et al., “A dynamic stategy for packet scheduling and bandwidth allocation based on channel quality in IEEE 802.16e OFDMA system,” Journal of Network and Computer Applications, vol. 39, pp. 52-60, May 2, 2013. |
Takahashi et al., “Automatic smoke evacuation in laparoscopic surgery: a simplified method for objective evaluation,” Surgical Endoscopy, vol. 27, No. 8, pp. 2980-2987, Feb. 23, 2013. |
Miksch et al., “Utilizing temporal data abstraction for data validation and therapy planning for artificially ventilated newborn infants,” Artificial Intelligence in Medicine, vol. 8, No. 6, pp. 543-576 (1996). |
Horn et al., “Effective data validation of high-frequency data: Time-point-time-interval-, and trend-based methods,” Computers in Biology and Medic, New York, NY, vol. 27, No. 5, pp. 389-409 (1997). |
Stacey et al., “Temporal abstraction in intelligent clinical data analysis: A survey,” Artificial Intelligence in Medicine, vol. 39, No. 1, pp. 1-24 (2006). |
Zoccali, Bruno, “A Method for Approximating Component Temperatures at Altitude Conditions Based on CFD Analysis at Sea Level Conditions,” (white paper), www.tdmginc.com, Dec. 6, 2018 (9 pages). |
Slocinski et al., “Distance measure for impedance spectra for quantified evaluations,” Lecture Notes on Impedance Spectroscopy, vol. 3, Taylor and Francis Group (Jul. 2012)—Book Not Attached. |
Engel et al. “A safe robot system for craniofacial surgery”, 2013 IEEE International Conference on Robotics and Automation (ICRA); May 6-10, 2013; Karlsruhe, Germany, vol. 2, Jan. 1, 2001, pp. 2020-2024. |
Bonaci et al., “To Make a Robot Secure: An Experimental Analysis of Cyber Security Threats Against Teleoperated Surgical Robots,” May 13, 2015. Retrieved from the Internet: URL:https://arxiv.org/pdf/1504.04339v2.pdf [retrieved on Aug. 24, 2019]. |
Homa Alemzadeh et al., “Targeted Attacks on Teleoperated Surgical Robots: Dynamic Model-Based Detection and Mitigation,” 2016 46th Annual IEEE/IFIP International Conference on Dependable Systems and Networks (DSN), IEEE, Jun. 28, 2016, pp. 395-406. |
Phumzile Malindi, “5. QoS in Telemedicine,” “Telemedicine,” Jun. 20, 2011, IntechOpen, pp. 119-138. |
Staub et al., “Contour-based Surgical Instrument Tracking Supported by Kinematic Prediction,” Proceedings of the 2010 3rd IEEE RAS & EMBS International Conference on Biomedical Robotics and Biomechatronics, Sep. 1, 2010, pp. 746-752. |
Allan et al., “3-D Pose Estimation of Articulated Instruments in Robotic Minimally Invasive Surgery,” IEEE Transactions on Medical Imaging, vol. 37, No. 5, May 1, 2018, pp. 1204-1213. |
Kassahun et al., “Surgical Robotics Beyond Enhanced Dexterity Instrumentation: A Survey of the Machine Learning Techniques and their Role in Intelligent and Autonomous Surgical Actions.” International Journal of Computer Assisted Radiology and Surgery, vol. 11, No. 4, Oct. 8, 2015, pp. 553-568. |
Weede et al. “An Intelligent and Autonomous Endoscopic Guidance System for Minimally Invasive Surgery,” 2013 IEEE International Conference on Robotics ad Automation (ICRA), May 6-10, 2013. Karlsruhe, Germany, May 1, 2011, pp. 5762-5768. |
Altenberg et al., “Genes of Glycolysis are Ubiquitously Overexpressed in 24 Cancer Classes,” Genomics, vol. 84, pp. 1014-1020 (2004). |
Harold I. Brandon and V. Leroy Young, Mar. 1997, Surgical Services Management vol. 3 No. 3. retrieved from the internet <https://www.surgimedics.com/Research%20Articles/Electrosurgical%20Plume/Characterization%20And%20Removal%20Of%20Electrosurgical%20Smoke.pdf> (Year: 1997). |
Marshall Brain, How Microcontrollers Work, 2006, retrieved from the internet <https://web.archive.org/web/20060221235221/http://electronics.howstuffworks.com/microcontroller.htm/printable> (Year: 2006). |
CRC Press, “The Measurement, Instrumentation and Sensors Handbook,” 1999, Section VII, Chapter 41, Peter O'Shea, “Phase Measurement,” pp. 1303-1321, ISBN 0-8493-2145-X. |
Jiang, “‘Sound of Silence’: a secure indoor wireless ultrasonic communication system,” Article, 2014, pp. 46-50, Snapshots of Doctoral Research at University College Cork, School of Engineering—Electrical & Electronic Engineering, UCC, Cork, Ireland. |
Li, et al., “Short-range ultrasonic communications in air using quadrature modulation,” Journal, Oct. 30, 2009, pp. 2060-2072, IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control, vol. 56, No. 10, IEEE. |
Salamon, “AI Detects Polyps Better Than Colonoscopists” Online Article, Jun. 3, 2018, Medscape Medical News, Digestive Disease Week (DDW) 2018: Presentation 133. |
Misawa, et al. “Artificial Intelligence-Assisted Polyp Detection for Colonoscopy: Initial Experience,” Article, Jun. 2018, pp. 2027-2029, vol. 154, Issue 8, American Gastroenterolgy Association. |
Dottorato, “Analysis and Design of the Rectangular Microstrip Patch Antennas forTM0n0 operating mode,”Article, Oct. 8, 2010, pp. 1-9, Microwave Journal. |
Miller, et al., “Impact of Powered and Tissue-Specific Endoscopic Stapling Technology on Clinical and Economic Outcomes of Video-Assisted Thoracic Surgery Lobectomy Procedures: A Retrospective, Observational Study,” Article, Apr. 2018, pp. 707-723, vol. 35 (Issue 5), Advances in Therapy. |
Hsiao-Wei Tang, “ARCM”, Video, Sep. 2012. YouTube, 5 screenshots. Retrieved from internet: <https://www.youtube.com/watch?v=UldQaxb3fRw&feature=youtu.be>. |
Giannios, et al., “Visible to near-infrared refractive properties of freshly-excised human-liver tissues: marking hepatic malignancies,” Article, Jun. 14, 2016, pp. 1-10, Scientific Reports 6, Article No. 27910, Nature. |
Vander Heiden, et al., “Understanding the Warburg effect: the metabolic requirements of cell proliferation,” Article, May 22, 2009, pp. 1-12, vol. 324, Issue 5930, Science. |
Hirayama et al., “Quantitative Metabolome Profiling of Colon and Stomach Cancer Microenvironment by Capillary Electrophoresis Time-of-Flight Mass Spectrometry,” Article, Jun. 2009, pp. 4918-4925, vol. 69, Issue 11, Cancer Research. |
Cengiz, et al., “A Tale of Two Compartments: Interstitial Versus Blood Glucose Monitoring,” Article, Jun. 2009, pp. S11-S16, vol. 11, Supplement 1, Diabetes Technology & Therapeutics. |
Shen, et al., “An iridium nanoparticles dispersed carbon based thick film electrochemical biosensor and its application for a single use, disposable glucose biosensor,” Article, Feb. 3, 2007, pp. 106-113, vol. 125, Issue 1, Sensors and Actuators B: Chemical, Science Direct. |
“ATM-MPLS Network Interworking Version 2.0, af-aic-0178.001” ATM Standard, The ATM Forum Technical Committee, published Aug. 2003. |
IEEE Std 802.3-2012 (Revision of IEEE Std 802.3-2008, published Dec. 28, 2012. |
IEEE Std No. 177, “Standard Definitions and Methods of Measurement for Piezoelectric Vibrators,” published May 1966, The Institute of Electrical and Electronics Engineers, Inc., New York, N.Y. |
Shi et al., An Intuitive control console for robotic syrgery system, 2014, IEEE, p. 404-407 (Year: 2014). |
Choi et al., A haptic augmented reality surgeon console for a laparoscopic surgery robot system, 2013, IEEE, p. 355-357 (Year: 2013). |
Xie et al., Development of stereo vision and master-slave controller for a compact surgical robot system, 2015, IEEE, p. 403-407 (Year: 2015). |
Sun et al., Innovative effector design for simulation training in robotic surgery, 2010, IEEE, p. 1735-1759 (Year: 2010). |
Anonymous, “Internet of Things Powers Connected Surgical Device Infrastructure Case Study”, Dec. 31, 2016 (Dec. 31, 2016), Retrieved from the Internet: URL:https://www.cognizant.com/services-resources/150110_IoT_connected_surgicai_devices.pdf. |
Draijer, Matthijs et al., “Review of laser pseckle contrast techniques for visualizing tissue perfusion,” Lasers in Medical Science, Springer-Verlag, LO, vol. 2 4, No. 4, Dec. 3, 2008, pp. 639-651. |
Roy D Cullum, “Handbook of Engineering Design”, ISBN: 9780408005586, Jan. 1, 1988 (Jan. 1, 1988), XP055578597, ISBN: 9780408005586, 10-20, ChapterG, p. 138, right-hand column, paragraph 3. |
“Surgical instrumentation: the true cost of instrument trays and a potential strategy for optimization”; Mhlaba et al.; Sep. 23, 2015 (Year: 2015). |
Nabil Simaan et al., “Intelligent Surgical Robots with Situational Awareness: From Good to Great Surgeons”, DOI: 10.1115/1.2015-Sep-6 external link, Sep. 2015 (Sep. 2015), p. 3-6, Retrieved from the Internet: URL:http://memagazineselect.asmedigitalcollection.asme.org/data/journals/meena/936888/me-2015-sep6.pdf XP055530863. |
Anonymous: “Titanium Key Chain Tool 1.1, Ultralight Multipurpose Key Chain Tool, Forward Cutting Can Opener—Vargo Titanium,” vargooutdoors.com, Jul. 5, 2014 (Jul. 5, 2014), retrieved from the internet: https://vargooutdoors.com/titanium-key-chain-tool-1-1.html. |
Anonymous: “Screwdriver—Wikipedia”, en.wikipedia.org, Jun. 23, 2019, XP055725151, Retrieved from the Internet: URL:https://en.wikipedia.org/w/index.php?title=Screwdriver&oldid=903111203 [retrieved on Mar. 20, 2021]. |
Nordlinger, Christopher, “The Internet of Things and the Operating Room of the Future,” May 4, 2015, https://medium.com/@chrisnordlinger/the-internet-of-things-and-the-operating-room-of-the-future-8999a143d7b1, retrieved from the internet on Apr. 27, 2021, 9 pages. |
Screen captures from YouTube video clip entitled “Four ways to use the Lego Brick Separator Tool,” 2 pages, uploaded on May 29, 2014 by user “Sarah Lewis”. Retrieved from internet: https://www.youtube.com/watch?v=ucKiRD6U1LU (Year: 2014). |
Sorrells, P., “Application Note AN680. Passive RFID Basics,” retrieved from http://ww1.microchip.com/downloads/en/AppNotes/00680b.pdf on Feb. 26, 2020, Dec. 31, 1998, pp. 1-7. |
“ATM-MPLS Network Interworking Version 2.0, af-aic-0178.001” ATM Standard, The ATM Forum Technical Committe, published Aug. 2003. |
Lalys, et al., “Automatic knowledge-based recognition of low-level tasks in ophthalmological procedures”, Int J CARS, vol. 8, No. 1, pp. 1-49, Apr. 19, 2012. |
Hu, Jinwen, Stimulations of adaptive temperature control with self-focused hyperthermia system for tumor treatment, Jan. 9, 2012, Ultrasonics 53, pp. 171-177, (Year: 2012). |
Hussain et al., “A survey on resource allocation in high performance distributed computing systems”, Parallel Computing, vol. 39, No. 11, pp. 709-736 (2013). |
Extended European Search Report for Application No. 18203447.0, dated Jun. 28, 2019. |
Number | Date | Country | |
---|---|---|---|
20190125430 A1 | May 2019 | US |
Number | Date | Country | |
---|---|---|---|
62665177 | May 2018 | US | |
62665128 | May 2018 | US | |
62665129 | May 2018 | US | |
62665139 | May 2018 | US | |
62665134 | May 2018 | US | |
62665192 | May 2018 | US | |
62578804 | Oct 2017 | US | |
62578844 | Oct 2017 | US | |
62578855 | Oct 2017 | US | |
62578835 | Oct 2017 | US | |
62578817 | Oct 2017 | US | |
62578793 | Oct 2017 | US |